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populations,  the  incidence of malignant cutaneous melanoma  (hereafter  termed 
melanoma)  has  steadily  increased.  In  the  1970s  and  1980s,  laboratory  and 
epidemiological studies documented the possibility that solar radiation was the 
main environmental risk  factor  for most skin cancers,  including melanoma,  the 
basal cell carcinoma (BCC) and the squamous cell carcinoma (SCC).  
 
In 1992 a Working Group on Solar  and Ultraviolet Radiation  convened by  the 
International Agency  for Research on Cancer  (IARC, Lyon, France)  first placed 
solar radiation  in the IARC group 1 of sufficient evidence for carcinogenicity  in 
humans  (IARC,  1992).1  At  that  time,  UVB  was  known  for  its  carcinogenic 
properties  and  its  ability  to  cause  sunburns.  Epidemiological  research  found 
sunburns  to  be  associated  to  all  types  of  skin  cancers.  However,  laboratory 
studies  had  not  provided  evidence  that  UVB  was  involved  in  melanoma 
occurrence.  UVA  was  much  less  potent  than  the  UVB  for  triggering  DNA 
mutations  in animal experiments but  the  relevance of  these experiments  to  the 
human bare skin was uncertain. The Working Group did not consider there was 
sufficient  evidence  at  the  time  to  assign  specific wavelengths  to  group  1,  and 
both  UVA  and  UVB  were  classified  as  “probably  carcinogenic  to  humans” 
(group 2A). The Working Group also distinguished between the intermittent and 
the  chronic  sun  exposure pattern,  the  former being  associated with melanoma 
risk while  the  later  exposure  type was  associated with  SCC.  Intermittent  sun 
exposure is brisk sun exposure of usually sun‐protected skin areas during leisure 
activities or holidays, while  chronic  sun  exposure was  typical of  sun  exposure 
accumulated  over  lifetime.  The  intermittent  sun  exposure  concept  better 
explained why melanoma often arose in usually sun protected skin areas (e.g. the 
trunk)  of  affluent  people  spending  most  of  their  time  indoors.  Chronic  sun 
exposure was more  typical  of  outdoor workers  that  developed  squamous  cell 
carcinoma on usually sun‐exposed skin areas like the head and neck. In addition, 
studies  often  suggested  that  this  type  of  exposure  is  associated  with  slightly 
decreased risk of melanoma.  
 
                                                 
1 The sun emits the full ultraviolet radiation spectrum (100-400 nm), including the UVA (>315-400 nm), 
the UVB (>280-315 nm) and the UVC (100-280 nm). The stratospheric ozone layer completely blocks the 





childhood might be  the most  critical period  for  the occurrence of  sun‐induced 
biological  events  implicated  in  the  genesis  of  melanoma.  However,  how 
childhood  sun  exposure  influenced  melanoma  occurrence  in  adults  was  still 










Sun  exposure,  sunbed  use,  and  sunscreen  use  are  consequences  of  human 
behaviours  and  in  this  respect,  these  exposures  represent  some  sort  of 
“uncontrolled  natural  human  experiments”.  Epidemiological  studies  are  the 
main  methods  for  capturing  results  of  these  “natural  experiments”.  In  some 
instances,  as  we  will  see  with  sunscreen  use,  it  has  been  possible  to  verify 




accumulated  large  sets  of  data  that  could  help  shed  light  on  the  way  UV 
exposure was  involved  in  this malignancy. Therefore, using  several  significant 
results from our works, we will briefly discuss the hypothesis that melanoma can 















 Sections  2  to  5  start  with  a  brief  introduction  of  the  state  of  epidemiological 
knowledge on these issues at the time of the IARC Monograph of 1992, followed 
by  a  recall  of main  results  of  our  studies.  Epidemiological  studies  or  human 




A  general  discussion  in  Section  6  presents  how  our works  contributed  to  the 
tailoring  of  public  health  policies  and  to  the  understanding  of  melanoma 















tanning  is  often  termed  “UVA‐tanning”  as  the  spectrum  of  these  machines 
contains  96  to  99%  UVA  and  1  to  4%  UVB  (this  small  amount  of  UVB  is 







are  necessary  to  provoke  the  synthesis  of melanin.  Therefore,  the UV  energy 
output of most powerful modern  tanning machines may be  five 10  to 15  times 







sunbed  session. The  early  epidemiological  studies on  exposure  to artificial UV 
sources  often  explored  the use  of more dated  types  of both UV‐lamps, whose 
emission spectrum was much richer in UVB, or of small size UVA lamps, before 
large size canopies were commercially available. These studies generally limited 




this  fashion was  just starting and  too  few epidemiological data were available. 
Irrespective,  the  use  of  sunlamps  and  sunbeds  was  classified  as  ‘probably 




In  the  absence  of  a  valid  animal  model  for  human  melanoma  and  given  the 
ignorance  of  the  ultraviolet  wavelength  implicated  in  melanoma  genesis,  the 







In 1991‐92,  in order  to substantiate applications  for obtaining  funds  for studies, 
we  first made  an  ecological  description  of  patterns  of  sunbed  use  in  Belgium 
(Autier  et  al,  1991)  and  found  that melanoma  patients  reported  greater  use  of 







The  investigation of  relationships between  sunbed use and melanoma was  the 
primary goal of the EORTC multicenter study we designed in 1991 (Autier et al, 
1994a,b).2 This  case‐control  study,  conducted  in Belgium, Germany  and France 
took  place  at  a  time  when  the  public  was  not  particularly  aware  of  health 
hazards  associated with  sunbed use.  It  included  420 melanoma patients  of  all 
ages from hospital registries and 447 neighbourhood controls. The main finding 
was  a  positive  association  between  sunbed  use  and  melanoma  occurrence, 







old,  as  surveys  showed  that  the  vast  majority  of  tanning  salon  visitors  were 
under  40  years  old. We  therefore  supposed  that  the  impact  of  sunbed use  on 
melanoma  risk  should  be  mainly  visible  in  subjects  under  the  age  of  50. 
                                                 
2 Funded by the Europe Against Cancer Programme of the European Commission. 







well  aware  of  factors  associated with melanoma  occurrence,  including  sunbed 
use. This was the direct consequence of the growing dissemination of messages 
warning of the health hazards associated with sunbed use (De Vries et al, 2005). 
This  unsuccessful  study  demonstrated  that  in  the  European  context,  the  case‐
control  design  was  no  longer  adequate  for  investigations  of  health  hazards 
associated  with  sunbed  use  and  that  prospective  cohort  designs  had  to  be 
adopted.  Fortunately,  such  cohort  studies were  already  underway  in Norway 





We  performed  reviews  of  issues  surrounding  indoor  tanning  and  skin  cancer 
(Autier,  2004; Autier,  2005),  that  played  a  role  in  the  decision  of  the  IARC  to 
organize  a  systematic  review  with  meta‐analysis.  An  IARC  Expert  Group, 
convened  in  2005,  of  which  we  were  members.  Our  meta‐analysis  of 
epidemiological studies found a 75% (95% CI: 35 to 126%) increase in melanoma 
risk when  sunbed use  started before  30 years  of  age  (Figure  2.1),  as well  as  a 
higher  risk  for  first  exposure  distant  in  time,  i.e.  10  to  20  years  before  the 
diagnosis of melanoma (IARC, 2006; IARC, 2007). 
 
Fig 2.1 - Risk of melanoma in people < 30 years old at first 




These  findings  supported  accumulating  data  showing  that  childhood  and 
adolescence  are  periods  of  high  susceptibility  to  carcinogenic  effects  of  UV 
radiation. We therefore strongly advocated banning access of youths to tanning 





In 2004, after  the publication of  the primary  results  from  the Swedish‐Norway 
cohort  study  (Veierød  et  al,  2004),  we  made  the  prediction  that  melanoma 
associated with solarium use would be predominantly localised to the trunk and 
particularly  in women, because  it allows  exposure of  the  trunk  to UV without 
protection  (Boniol  et  al,  2004).  We  took  advantage  of  collaborations  with 
population‐based cancer registries operating in countries with high prevalence of 






days  are  rare.  In  a  collaborative  work  with  the  Iceland  Cancer  Registry  and 
Icelandic  dermatologists,  we  described  an  epidemic  of  melanoma  starting  in 
1995,  that was most probably due  to massive  exposure  of  Icelandic  youths  to 
artificial  tanning  devices  after  1985  (Héry  et  al,  2010).  Sunbed  use  in  Iceland 
expanded  rapidly  after  1985,  mainly  among  young  women.  In  2000,  it  was 
approximately two and three times the levels recorded in Sweden and in the UK, 
respectively. A particular feature of that epidemic was that  it mainly concerned 
melanoma occurring on  the  trunk of women under  the age of 50. Around year 
2000 the incidence of trunk melanoma in women had surpassed the incidence of 




This  study had  an  ecological design  that  is not  appropriate  for making  causal 
inference. The question however, was  to establish whether another cause could 
explain  the dramatic  increase  in melanoma  incidence, mainly  observed  on  the 
trunk  of  young  women.  We  carefully  examined  other  possible  causes  of  this 
dramatic  increase  of  melanoma  incidence,  including  changes  in  cancer 
registration and coding practice, changes in early detection by Icelandic doctors 
and  travels abroad. None of  these  factors could explain  the  specific  features of 
16













Epidemiological  data  published  after  the  IARC  report  of  2006  (IARC,  2006) 
further  documented  the  links  between  artificial  UV  tanning  and  cutaneous 
melanoma.  It  included  three  large case‐control studies  in  the U.S.A,  (Ting et al, 
2007; Clough‐Gorr et al, 2008; Lazovitch et al, 2010) the prospective U.S. Nurse’s 




popular,  particularly  amongst  teenagers  and  young  adults,  sharp  increases  in 
melanoma  incidence  on  the  trunk have been described  (Mowbray  et  al,  2007), 
sometimes surpassing  the  incidence on  lower  limbs  (Dal et al, 2007).  In  the UK 
and  the USA,  rebounds of  increase of melanoma  incidence  from 1998 onwards 
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The incidence of cutaneous malignant melanoma (melanoma) and of basal cell carcinoma is still increasing in most fair-skinned
populations. The fashion of intermittent exposure to solar ultraviolet (UV) radiations is considered the main cause of this increase.
In 20 years time, tan acquisition through exposure to artificial sources of UV radiations has become frequent among fair-skinned
adolescents and young adults. Modern sunbeds are powerful sources of UV radiations that do not exist in the nature, and repeated
exposures to high doses of UVA constitute a new phenomenon in humans. A large prospective cohort study on 106,379 Norwegian
and Swedish women conducted between 1991 and 1999 has provided evidence for a significant, moderate increase in melanoma risk
among regular sunbed users. Failure of past case-control studies to document with consistency the sunbed-melanoma association
was probably due to a too short latency period between sunbed use and melanoma diagnosis, and to too few subjects with high
total durations of sunbed use. Regulations of sunbed installation, operation and use should become standardised across the 25
European Union countries. Enforcement of regulations in tanning parlours remains inadequate. In contrast, the existence of regu-
lations is presented by many tanning salon operators as a guarantee that sunbed use is safe. We stress the need for the control of
information disseminated by the ‘‘tanning industry’’ on suppositions that sunbed use is safer than sun exposure, and on the hypo-
thetical health benefits of tanning. New fluorescent UV lamps are proposed that have a spectrum similar to the midday sun. Given
the known association between intermittent sun exposure and melanoma, public-health authorities should reconsider the soundness
of the commercialisation of these lamps.
 2004 Elsevier Ltd. All rights reserved.
Keywords: Melanoma; Skin cancer; Ultraviolet radiation; Epidemiology; Prevention1. Introduction
The incidence of cutaneous malignant melanoma
(melanoma) has steeply increased in the past 50 years
in most fair-skinned populations. For instance, from
1970 until 1997, a 2.5-fold increase in melanoma inci-
dence was observed in Finland, and a 3.6-fold increase
in White Americans [1,2]. From 1979 until 1998, a 2.4-
fold increase was observed in Scotland [3], and from
1980 and 2000, a 2.8-fold increase was estimated for
France [4]. Risk factors for the basal cell carcinoma
(BCC) are similar to risk factors for melanoma [5].0959-8049/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejca.2004.07.018
* Fax: +32 26005041.
E-mail address: philippe.autier@bordet.be.The incidence of BCC is also increasing sharply in most
fair-skinned communities, mainly in females [6].
The fashion of intermittent sun exposure that took
place after 1950 is considered as the main cause of the in-
creases in melanoma and in BCC. The depletion in ozone
observed in the stratospheric layers of the atmosphere is
not likely to contribute to the raising incidence of these
skin cancers. The ultraviolet (UV) radiation is deemed
to represent the part of the solar spectrum involved in
the genesis of melanoma [7]. In spite of increasing knowl-
edge on the association between sun exposure and the
considerable rise in skin cancer incidence, exposure to
artificial sources of UV radiation has become popular
in all fair-skinned populations around the world.
These artificial sources of UV radiation have various19
2368 P. Autier / European Journal of Cancer 40 (2004) 2367–2376denominations, e.g., tanning machines, UVA-tanning
devices, indoor tanning, sunbeds, and solarium. The sun-
bed fashion could contribute to the increase in skin can-
cer occurrence, in particular, of melanoma [8].
In this paper, we delineate the public-health issues in-
volved in sunbed use in 2004, and we stress the need to
promote actions going beyond the regulations of sunbed
use, especially actions aiming at controlling the informa-
tion disseminated by the ‘‘tanning industry’’ on sup-
posed safety and hypothetical health benefits of
sunbed use.2. Sunbed use is an intentional sun exposure behaviour
The melanoma epidemic affects mainly skin areas
usually covered by clothes, like the trunk, shoulders
and limbs, while lower increases in melanoma incidence
are observed on the more chronically sun exposed body
sites, like the head and neck [3,9]. Likewise, the increase
in BCC incidence is mainly observed on body sites that
are not chronically exposed to sunlight [6]. This epidemi-
ological feature points to the role attributed to the inter-
mittent sun exposure in the genesis of most melanoma
and BCCs. The most intense form of intermittent sun
exposure is the intentional sun exposure (ISE) that is
essentially motivated by the acquisition of a tan or by
the possibility to go uncovered in the sun [10]. During
ISE, significant portions of the trunk and of the limbs
are generally uncovered. Sunbathing and sunbed use
are the most typical ISE behaviours, and people at-
tracted to sunbathing activities are also more attracted
to indoor tanning [11].
In Europe, the sunbed fashion follows a strong South-
to-North gradient. The sunbed fashion started in the
1980s in the Nordic countries and extended in more
Southern countries in the 1990s. Surveys in Europe and
North America indicate that between 15% and 35% of
women, and between 5% and 10% of men 15–30 years
old have used sunbeds [12–14]. In Sweden, after 1995,
70% of females and 50% of males 18–50 years old re-
ported sunbed use [15,16]. In the late 1990s, the indoor
tanning fashion rapidly extended toMediterranean areas
like the north of Italy [17,18]. In the State of Victoria,
Australia – a sunny area with high records of skin cancers
– 9% of subjects 14–29 years old reported sunbed use in
the past years [19]. A substantial proportion of sunbeds
are used in private facilities. In Germany or Nordic coun-
tries, home-made solaria are not uncommon.3. The role of UVA and UVB in melanoma occurrence is
still unknown
At present, there are no scientific data indicating that
intentional exposure to UV radiations emitted by sun-beds is less harmful than intentional exposure to
sunlight.
The UV radiation reaching the earths surface com-
prises UVB (280–319 nm) and UVA (320–400 nm)
radiations. During a sunny day on the Mediterranean
coast, the solar UV spectrum at noon contains approx-
imately 5% of UVB and approximately 95% of UVA.
UVB is far more efficient than UVA at inducing the
synthesis of melanin, and producing a deep, persistent
tan. UVB is also 1000 times more potent than UVA
at inducing skin erythema (painless skin reddening)
or sunburn (painful skin reddening, sometimes with
blisters).
Until end of the 1980s, UVB was considered as the
carcinogenic part of the solar spectrum, and a shift in
usage occurred towards low pressure fluorescent tubes
emitting essentially in the UVA range, yielding the so-
called ‘‘UVA-tanning’’.
At the end of the 1980s, UVA was also suspected of
having carcinogenic potential. In 1992, the International
Agency for Research of Cancer classified UVB and
UVA radiations, as well as sunbeds, as ‘‘agents that
are probably carcinogenic to humans’’ (group 2A of
the IARC classification of carcinogenic agents) [7].
Biological mechanisms by which chronic sun expo-
sure causes squamous cell cancer (SCC) of the skin are
better known (e.g., the UVB-induced mutations found
in the p53 gene). In contrast, we still have a poor knowl-
edge of the biological mechanisms by which solar radia-
tions are involved in the genesis of melanoma and BCC
in humans.
3.1. Long-term health effects of high UVA doses are
unknown
In large powerful tanning units, the UVA irradiation
intensity may be 10–15 times higher than that of the
midday sun [20]. When UV output is calculated in
terms of biological activity, as estimated by the ery-
thema-effective irradiance, the emission of many sun-
beds is equivalent or surpasses the emission of the
midday sun on the Mediterranean Sea [20,21]. Such
powerful sources of UVA radiations do not exist in nat-
ure, and repeated exposures to high doses of UVA con-
stitute a new phenomenon in humans. If the role of
UVA in melanoma occurrence is uncertain, the UVA
doses per unit of time received by the skin during a typ-
ical sunbed session are far higher than what is experi-
enced during daily life or during sunbathing. We have
little idea of the likely long-term medical consequences
of such exposure. Worries are further reinforced by
knowledge that UVA penetrates deeper than UVB into
the skin. A recent study discovered DNA lesions typical
of UVA action in the basal epithelial layer of the hu-
man skin, the skin region where most melanocytes are
situated [22].20
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The term ‘‘UVA-tanning’’ is misleading, as the out-
put of a sunbed equipped with low pressure fluorescent
lamps always contains some UVB, which is critical for
the induction of a deep, persistent tan. In addition, most
of the DNA damage observed in the skin of sunbed
users is due to the fraction of UVB emitted by the fluo-
rescent lamps [23].
In the 1990s, regulations in some countries (e.g., Swe-
den, France) limited the maximum proportion of UVB
in the total UV energy output of sunbeds to 1.5%. How-
ever, in the real world, the UV output and spectral char-
acteristics of sunbeds vary considerably. The proportion
of UVB in UV energy output could vary from 0.5% to
4% [24,25], and may attain an emission spectrum similar
to the sun spectrum in the UVB range [20]. These differ-
ences are due to sunbed design (e.g., the numbers and
type of fluorescent tubes, the presence of high-pressure
UV lamps, the materials of the filters, the distance from
the canopy to the skin), to sunbed power, and to tube
aging.
3.3. Sunbed-induced sunburns
Sunburn experience during childhood or during
adulthood is a risk factor for melanoma, and the risk in-
creases with increasing numbers of sunburns [26]. Skin
erythema or burns are reported by 18–55% of sunbed
users [12,13,16,27]. Although UVB is more potent than
UVA for triggering sunburn, high fluxes of UVA
are capable of inducing skin erythemal reactions after
10–20 min in a subject who is naturally susceptible to
sunburns and having moderate tanning ability (i.e., Fit-
zpatrick skin phototype 2). The same subject engaging
in unprotected sunbathing in the midday sun would in-
cur an erythemal reaction after 20 min.
The high frequency of sunburn experience by sunbed
users shows that sunbed use is very close in nature to
sunbathing, and there is no reason to believe that sun-
burns experienced during sunbed sessions would convey
less melanoma risk than sunburns experienced during
sun exposure.4. Epidemiological data on sunbed use and melanoma
As there is no valid animal model for human mel-
anoma, and because we are still ignorant about the ef-
fects of UV radiation(s) and melanoma occurrence, the
study of any eventual link between sunbed use and mel-
anoma left to epidemiological investigations.
Seven epidemiological case-control studies specifi-
cally addressed the possible association between increas-
ing amounts of sunbed use and melanoma [12,15,28–32].
Two reviews concerning six studies [33,34] concludedthat some data raised the possibility of a moderate pos-
itive association between sunbed use and melanoma.
However, overall, the results lacked consistency and
no conclusive evidence could be drawn from these six
studies on the influence of sunbed use on melanoma
occurrence. A seventh case-control study conducted in
the UK explored sunbed use before 1989 [32]. It showed
no dose-response relationship between amounts of sun-
bed use and melanoma.
In 2003, MB Veierød and co-workers published the
results of a prospective cohort study of 106,379 women
in Norway and Sweden who were followed for an aver-
age of 8.1 years from 1991 until 1999 [26]. During the
follow-up, 187 cases of melanoma were diagnosed.
After adjustment for intermittent sun exposure and
host characteristics, the study found a 55% increase in
melanoma risk (95% Confidence Interval: 4–132%)
among the 18% of women aged 10–39 years old who re-
ported having used sunbed at least once a month when
they were 10–19, 20–29 or 30–39 years old. An increase
in melanoma risk was observed for all age groups, from
20 to 49 years old. Twelve sunbed sessions per year cor-
respond to the 12-session tanning programme proposed
by many commercial tanning facilities. Hence, the re-
sults of the Norwegian–Swedish study were consistent
with the existence of a moderate association between
regular sunbed use at least once a month and mel-
anoma occurrence.5. What are the differences between the Norway–Sweden
and case-control studies?
5.1. Methodological limitations of case-control studies
In the seven case-control studies, exposure to sunbeds
was assessed retrospectively, and compared between pa-
tients with melanoma (i.e., the cases) to subjects without
melanoma (i.e., the controls). These case-control studies
could suffer from three limitations:
1. Case-control studies are not optimal designs for dem-
onstrating an increase in Relative Risk when additive
risks are small, i.e., an estimated Relative Risk of
between 1.00 and 1.99.
2. The answers of melanoma patients on their past sun-
bed use could be biased because, at the moment of the
interview, they knew they had a melanoma (interview
bias).
3. The selection of controls may have included subjects
more inclined to have had more sunbed use than
average (selection bias).
The Norwegian–Swedish study was a longitudinal
cohort design. Sunbed use was assessed retrospec-
tively, but before any diagnosis of melanoma. So, the21
2370 P. Autier / European Journal of Cancer 40 (2004) 2367–2376Norwegian–Swedish study was less prone to interview
and selection biases at the inception of the cohort. In
addition, prospective cohort studies on large numbers
of subjects are more powerful designs than case-control
studies, and are thus more appropriate to reveal the
existence of moderately elevated risks.
5.2. Changing emission spectrum, latency period and
accumulated UV doses
Apart from methodological issues, the negative re-
sults of the case-control studies could be due to the fol-
lowing factors:
1. The UV lamps changed over time. Up to the mid-
1980s, arc mercury lamps having an emission spec-
trum rich in UVB (and even UVC) radiations were
commonly used as a substitute to the absence of sun-
shine, e.g., for the synthesis of vitamin D in children.
Hence, eventual carcinogenic effects could be attrib-
utable to exposure of children to these arc mercury
UV lamps, and not to modern tanning devices.
2. The latency period between exposure to artificial UV
sources and melanoma occurrence is probably several
decades [11]. Five of the seven case-control studies
examined sunbed use before 1990, and were con-
ducted in countries where the indoor tanning fashion
was still in its early phase. The latency period may be
the main reason why case-control studies yielded
inconsistent results, since sunbed use was not fre-
quent before 1985.
3. Only a few subjects included in the case-control studies
had more than 20 h of cumulative sunbed exposure.
How the Norway–Sweden study addressed these
factors?
1. In 1983, commercialisation of arc mercury lamps was
banned in Norway and Sweden. A further analysis of
the Norway–Sweden study showed that the increased
melanoma risk associated with sunbed use was not
due to the use of UV lamps before 1983 [35].
2. Women who participated in the Norway–Sweden
study were 30 years old or more at cohort inception.
The highest melanoma risk was found in women who
used sunbeds at least once per month when they were
20–29 years old [increase of 158% (95% CI: 48–
350%)]. Lower melanoma risks were found for sun-
bed use at least once a month during the third or
fourth decade of life. This result supports the hypoth-
esis that there is a latency period. In the Nordic coun-
tries, the sunbed fashion is popular since the late
1970s, and rates of sunbed use in those countries
are the highest in the world. Furthermore, women
are approximately two times more inclined than
men to utilise sunbeds. Hence, it is probable thatthe risk of melanoma associated with sunbed use
started to become apparent in the Norway–Sweden
study in women.
3. The Norway–Sweden study showed that before 1992
18% of the study women used sunbeds at least once a
month over 10 years, what is equivalent to at least
40 h of cumulative sunbed use, if one assumes a dura-
tion of 20 min for a typical sunbed session.
In conclusion, the results of the Norway–Sweden
study are consistent with the existence of a 55% (95%
CI: 4–132%) increase in melanoma risk associated with
40 h or more of sunbed use. Further follow-up of the co-
hort will inform us about the trends in melanoma risk
according to amounts of sunbed exposure.
5.3. Are 40 h of sunbed use equivalent to 40 h of
sunbathing?
Over a 10-year period, the duration of sunbathing
activities may exceed 400 h in suntan enthusiasts. So,
how significant are 40 h of sunbed use, compared with
400 h of sunbathing? In fact, durations of sunbed use
and of sunbathing are not readily comparable because:
 We do not know if sun exposure or sunbed use would
influence melanoma occurrence by acting through the
same biological mechanisms.
 If the UVA dose is the key element, then 20 min of
sunbed exposure represents a UVA dose equivalent
to 2–3 h of sun exposure in the summer midday sun,
but the dose rate of UVA received per unit of time
by skin cells is 5–10 times higher than that in the sun.
 The erythemal effectiveness of sunbed use is approxi-
mately two times that of the midday sun. If sunburns
are key indicators of biological events implicated in
the genesis of melanoma, then 20 min spent under a
sunbed could have the biological significance of 40
min of sunbathing in the summer midday sun.
 Sunscreens are often used during sunbathing, with
the net result for suntan worshippers that sunburn
occurrence is delayed, and time spent in the sun is
longer [36].
 Sunbathing may take place when the sun is less
bright, for instance at the end of the afternoon.
So, with our current state of knowledge about the
relationship between UV radiations and melanoma,
one should be cautious when comparing durations of
sunbathing with durations of sunbed use.6. Skin cancers other than melanoma
Two case-control studies examined past exposure to
sunbeds in patients with non-melanoma skin cancer.22
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associations between sunbed use and SCC and BCC
[38]. In the latter study, the estimated Relative Risk
associated with sunbed use was 2.5 (95% CI: 1.7–3.8)
for SCC and 1.5 (95% CI: 1.1–2.1) for BCC. These find-
ings are in line with data on non-melanoma skin cancers
in patients affected by severe psoriasis and treated with
PUVA therapy (a combination of UVA irradiation
and oral psoralen).7. Regulations of commercialisation, installation, opera-
tion and use of artificial tanning devices
Since 1990, many countries have issued specific rules
for sunbed installation, operation and utilisation. There
is a wide variation in the content of these rules. In the
European Union, there is no standardisation of regula-
tions on sunbed commercialisation and use. In some
countries (e.g., in the UK, Canada and the Nether-
lands), recommendations are formulated by, or in asso-
ciation with the sunbed industry, or organisations of
professional sunbed operators. In the US, the Food
and Drug Administration provides standards only for
the manufacturing of tanning devices, and regulations
for operation and utilisation vary considerably across
the States.
An important achievement of regulations is the
requirement for better information for consumers, as
well as the wearing of protective eyewear to protect
the eyes. Table 1 presents a list of criteria that should
prevent individuals to use sunbeds. In some countries
(e.g., in France), training of commercial tanning facili-
ties is mandatory, and tanning machine operators are in-
structed to refuse access to the sunbed to the consumer
meeting at least one criteria listed in Table 1. The needTable 1
Criteria that should prevent sunbed use*
1. To be less than 18 years of age.
2. To be pregnant.
3. To suffer from a febrile episode.
4. To suffer from significant eye vision impairment.
5. To have red hair.
6. To have melano-compromised skin, i.e., when the skin always sunburns w
ability to develop a tan.
7. To have a family history of eye or cutaneous melanoma.
8. To have large numbers of naevus (mole), in the order of more than 30 mol
9. To have a tendency to have freckling developing on the face when going
10. To have a history of frequent sunburn during childhood or during adult
11. To have pre-malignant (e.g., solar keratosis) or a history of malignant s
12. To have a sun damaged skin (wrinkles on the face, or irregular pigment
13. To wear cosmetics. Cosmetics may enhance sensitivity to UV exposure.
14. To be taking medications. Medications may increase sensitivity to UV, a
skin burns). Individuals should seek advice from their physician to deter
* After World Health Organisation (WHO) 2003 (60) and International Cto have trained operators has prevented the multiplica-
tion of automated tanning parlours, working without
the surveillance of an operator.
However, regulations and recommendations to con-
sumers are not a panacea because:
1. Their enforcement remains a challenge.
2. They do not apply to the private use of sunbeds.
3. They do not reflect the numerous uncertainties we
have on the association between UV exposure and
skin cancers, or other UV-induced lesions like the
premature skin aging and eye lesions.
4. Their potential impact on hazards associated with
sunbed use is probably marginal because after all,
they do not prevent individuals from receiving high
doses of UV radiation.
5. Indoor tanning operators take advantage of the exist-
ence of regulations for asserting that sunbed use is
secure.8. The tanning industry and the concept of ‘‘safe tan
acquisition’’
8.1. The tanning industry
The ‘‘tanning industry’’ can be understood as all
commercial activities developed around the behaviours
of intentional sun exposure, for tan acquisition or for
other reasons like the search of well-being. Products
promoted and sold by the tanning industry comprise
sunscreens, a variety of oral preparations deemed to in-
crease the resistance to UV aggressions or to facilitate
tan acquisition, swim suits permeable to UV radiations,
and the use of non-solar sources of UV presented as safeith no ability to tan or has a high susceptibility to sunburn with a poor




ed skin areas on the face and arms).
nd may sometimes lead to severe health complications (e.g., extensive
mine if the medication will make them UV-sensitive.
ommission on Non-Ionizing Radiation Protection (ICNIRP) 2003 (8).
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rated a large part of its marketing strategies around the
concept of ‘‘safe tan acquisition’’, that is the acquisition
of a tan without incurring (or with incurring less) detri-
mental effects of UV exposure, mainly sunburns, skin
cancers, and skin aging.
8.2. The dubious concept of ‘‘regulated’’ or ‘‘controlled’’
tan acquisition
For promoting the idea of the possibility of ‘‘safe (or
safer) tan acquisition’’, the sunbed industry has invented
the concept of ‘‘regulated’’ or ‘‘controlled tanning’’, as
opposed to beach tanning that would be ‘‘unregulated’’
or ‘‘uncontrolled’’ [39,40]. ‘‘Controlled’’ tan acquisition
would be safer than sunbathing because of the con-
stancy of several UV-exposure criteria, like, for instance,
a constant UV intensity in wavelength and in time. In
hot countries, like Italy and Australia, the ‘‘controlled
tan acquisition’’ concept is used for convincing consum-
ers that sunbed use represents a good substitute to beach
sunbathing.
But the perilous assertion that ‘‘controlled’’ tan
acquisition would be less aggressive than uncontrolled
tan acquisition is not supported by laboratory experi-
ments, it contradicts recent findings in basic science,
and denies epidemiological and behavioural data:
1. Subjects attracted by indoor tanning are also
attracted by sunbathing [11]. Hence, for most sunbed
users, amounts of indoor UV add to amounts of out-
door UV, with possible interactive processes that
could further increase the melanoma risk. In addi-
tion, the weak photoprotection against sunburns
afforded by a sunbed-induced tan may encourage
longer stays in the sun [41].
2. Surveys continually show the ignorance of tanning
parlours operators and the lack of enforcement of
basic utilisation rules [42–45].
3. DNA damage that is detectable after sunbed expo-
sure is comparable to DNA damage induced by expo-
sure to natural sunlight [46].
4. Tan induction is rather an indicator of skin aggres-
sion with DNA damage than a marker of skin photo-
protection [47,48].
5. The recurring induction of melanin synthesis could be
involved in skin carcinogenesis [49,50].
6. Sunbed use causes sunburns in 18–55% of users, and
these acute skin reactions are associated with mel-
anoma and BCC occurrence.
7. The UVB fraction present in the sunbed emission
spectrum may still have detrimental effects on the
skin.
8. We have no knowledge about the long-term effects of
repeated exposures to high UVA doses mixed with
some UVB.8.3. The questionable photoprotection properties of ‘‘pre-
vacation tan’’
The tanning industry and many sun-enthusiasts allege
that a ‘‘pre-vacation tan’’ acquired through sunbed use
would confer protection against sunburns and other del-
eterious effects of the sun. But photoprotection against
sunburns and DNA photodamage afforded by the facul-
tative pigmentation induced by tanning under the sun is
very low, just equivalent to a sun protection factor
(SPF) 3 sunscreen [51]. The tan induced by UVA-tan-
ning provides practically no photoprotection [52]. The
moderate skin thickening induced by sunbed use would
afford even less photoprotection than tanning [53].
Increasing numbers of laboratory data show that a
pre-vacation tan offers only little protection against
sun-induced DNA damage [41,54,55].9. New threats on the horizon
9.1. The UV-lamps rich in UVB radiation
Recently, new fluorescent lamps that have an emis-
sion spectrum resembling the emission spectrum of the
midday sun have been introduced into the market.
Exposure to these lamps enables a faster acquisition of
a deep tan. Exposure to UVB-rich lamps is similar to
intentional sun exposure in the midday sun, and is thus
likely to convey the same risk of skin cancer. Given the
known association between intermittent sun exposure
and melanoma, public-health authorities should recon-
sider the soundness of the commercialisation of these
lamps.9.2. Age of sunbed users
Age of sunbed users is a new concern: in Sweden,
sunbed use is popular among adolescents 14–17 years
old [56]. A large survey in 2004 in the schools of Lanark-
shire (UK) showed that 7% of children 8–11 years old
had used a sunbed [57]. This phenomenon is also ob-
served in Australia [58]. Most countries do not have reg-
ulation on a minimal age for indoor tanning [59].
Childhood and adolescence are periods of greater bio-
logical vulnerability to UV radiations, and thus prohibi-
tion of the use of tanning devices before 18 years old
seems wise [8,60].9.3. The hypothetical health benefits of UV radiations
The subtlest position for the defence of indoor tan-
ning is the recognition of good and bad effects of indoor
tanning, but that finally, good effects would outweigh
bad effects. The good health effects attributed by the tan-24
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healing of seasonal depression to the prevention of
breast, colon and prostate cancers. Advocacy texts is-
sued by the tanning industry seems to come to the con-
clusion that everything being considered, finally,
‘‘controlled skin damage’’ is somehow good for health
[61].
The generation of vitamin D is the main known ben-
efit of UV radiation. Vitamin D synthesis is activated by
UVB radiation, not by UVA radiation. In fair-skinned
European subjects, if dietary intakes of vitamin D are
inadequate, brief periods of exposure to summer sun-
light in everyday life on hands and face is all that is
needed to initiate vitamin D synthesis. Longer exposures
provide no additional benefit in this respect.
UV radiations are used for treating various skin con-
ditions such as psoriasis and dermatitis. Psoriasis pa-
tients treated over long periods of time with a
combination of UVA and oral psoralen have an in-
creased incidence in non-melanoma skin cancers
[62,63], and a significant increase in melanoma incidence
was found in one cohort of PUVA-treated psoriasis pa-
tients [64,65].
The role that UV radiation would have in the preven-
tion of cancerous diseases is largely based on ecological
data and on speculations on as yet unproven biological
mechanisms. At present, there is no sound scientific data
showing a protective effect of intentional exposure to
UV radiation on any cancer in humans.
In North European countries, and in Canada,
advertisements recommend sunbed use from November
to March to combat the ‘‘winter depression’’ or ‘‘sea-
sonal depression’’, attributed to the absence of days
with bright sunshine and to long periods of obscurity.
However, light therapy using white fluorescent lights is
as effective for the treatment of seasonal depression
[66]. Thus there is no reason to promote exposure to
potentially harmful UV radiation to treat that
condition.Table 2
Steps to be taken in the regulation of sunbed use and of information given
1. Devise regulations for the installation, operation and utilisation, independ
2. To prohibit sunbed use before 18 years old.
3. Rendering the use of protective eyewear (goggles) mandatory during sunb
4. Use of and speculations on concepts such as ‘‘safe’’, or ‘‘controlled’’, or ‘
5. Reference to hypothetical health benefits of outdoor or indoor ultraviolet (U
cancers and other major health conditions should not be authorised.
6. The existence of legal regulations on indoor tanning should not be used f
tanning.
7. Requirement to inform consumers visiting tanning parlours on the dangers
things:
(a) Increased risk of skin cancer, especially melanoma and basal cell carci
(b) Risk of sunburns and skin erythema.
(c) Risk of premature wrinkles.
(d) Risk of unpleasant and disgraceful pigmented skin lesions.
* The list should be included in information packages accompanying tan10. How credible is the precautionary principle?
The precautionary principle is frequently evoked in
the shaping of health or of environmental policies. In
brief, that principle consists of regulating the general
public use or the diffusion in the environment of a sub-
stance or of a device whose safety remains open to ques-
tion. In Europe, the precautionary principle is
frequently put forward to oppose the development of
innovations, even though there is no evidence for a det-
rimental impact on health or on the environment.
In spite of the scientifically established association be-
tween the intermittent exposure to solar UV radiation
and melanoma, and of the evidence that melanoma inci-
dence is doubling every 10 or 20 years in many fair-
skinned populations, the indoor tanning fashion has
undergone a considerable growth in the past 20 years.
Hence, although there was far more scientific evidence
for possible harmful health effects due to sunbed use
than for many other products, the precautionary princi-
ple has never been applied for protecting consumers
against the many health uncertainties regarding the
safety of artificial UV sources, and against the many
unverified beliefs utilised for the marketing of the sun-
bed fashion.11. The need to control information disseminated by the
tanning industry
For most people, information and advertisements
disseminated by the tanning industry are the main
source of information regarding tan acquisition and
sun protection. Behavioural studies in Europe
[17,67,68] show that people know about skin cancer
and the damaging affect of sunbathing, and about possi-
ble dangers associated with sunbed use, but that knowl-
edge does not alter their tanning behaviours in general.
In Europe and the USA, recommendations on sunbedto the general public*
ently of those set by the tanning industry.
ed sessions.
‘regulated’’ tan acquisition’’ should not be authorised.
V) exposures must be prohibited. The mention of preventive effects on
or advertising purposes, or for issuing claims on the safety of indoor
associated with sunbed use and sun exposure, including, among other
noma (BCC).
ning devices that are acquired for private use.
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make sunbed users more cautious, especially adolescents
and young adults [67–71].
The most relevant strategy for curbing sunbed use is
to obtain a change in attitudes toward sunbathing and
having a tan. In that respect, the principal public health
target should be to draw up regulations, independently
of those set by the tanning industry, and the control
of information and advertisements (Table 2). The tan-
ning industry should no longer have the possibility to
have recourse to claims on health benefits of outdoor
or indoor tanning in order to convince consumers to
use sunbeds.
Indeed, this strategy would concern other segments of
the tanning industry, such as sunscreen companies that
base their marketing strategy on the possibility of
acquiring a healthy and safe tan, thanks to the use of
their product.12. Conclusions
The Norway–Sweden study [26] has provided epide-
miological evidence that regular sunbed use is associated
with a moderate increase in the risk of melanoma. Large
numbers of people use sunbeds on a regular basis, and
sunbed use often starts during adolescence. So, in
2004, UV doses accumulated by many people though
sunbed use may be far higher than observed in the Nor-
way–Sweden study.
Public-health efforts should continue to disseminate
information on the dangers of UV radiations, and to
discourage sunbed use.
Regulation of sunbed installation, operation and use
is desirable, but enforcement of rules is by far the most
difficult challenge. In addition, regulations should be-
come harmonised in the European Union.
Advertisements and information disseminated by the
tanning industry to the general public should be control-
led. The sunbed manufacturers and operators should no
longer be able to claim health benefits of any sort attrib-
utable to sunbed use, and to other forms of intentional
sun exposure.
Close monitoring of sunbed use and of its immediate
consequences (e.g., skin erythema and sunburns) is now
well established in Sweden. There are signs of decreasing
trends in sunbed use among adolescents and young
adults in Sweden [68]. Is the sunbed fashion be levelling
off in Sweden? Similar surveys should be conducted in
other countries to monitor global exposure to privately
owned or commercially operated tanning devises. Bold-
eman et al. [68] have proposed an international harmo-
nisation of survey tools for the monitoring of sunbed use
and sunburn experience. Such an instrument is highly
desirable for comparing sunbed use habits and conse-
quences across countries and to follow the impact ofpolicies intended to discourage sunbed use or to combat
the ‘‘safe tan’’ concept. The survey tool could also in-
clude the monitoring of sun exposure and sun protection
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The association of use of sunbeds with cutaneous malignant melanoma
and other skin cancers: A systematic review
The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer
Exposure to solar ultraviolet (UV) radiation is a known cause of
skin cancer. Sunbed use represents an increasingly frequent
source of artificial UV exposure in light-skinned populations. To
assess the available evidence of the association between sunbed
use and cutaneous malignant melanoma (melanoma) and other
skin cancers, a systematic review of the literature till March 2006
on epidemiological and biological studies on sunbed use was per-
formed in Pubmed, ISI Web of Science, Embase, Pascal, Cochrane
library, Lilacs and Medcarib. Search for keywords in the title and
in the abstract was done systematically and supplemented by man-
ual searches. Only case–control, cohort or cross-sectional studies
were selected. Data were abstracted by means of a standardized
data-collection protocol. Based on 19 informative studies, ever-use
of sunbeds was positively associated with melanoma (summary
relative risk, 1.15; 95% CI, 1.00–1.31), although there was no con-
sistent evidence of a dose–response relationship. First exposure to
sunbeds before 35 years of age significantly increased the risk of
melanoma, based on 7 informative studies (summary relative risk,
1.75; 95% CI, 1.35–2.26). The summary relative risk of 3 studies
of squamous cell carcinoma showed an increased risk. For basal
cell carcinoma, the studies did not support an association. The evi-
dence does not support a protective effect of the use of sunbeds
against damage to the skin from subsequent sun exposure. Young
adults should be discouraged from using indoor tanning equip-
ment and restricted access to sunbeds by minors should be
strongly considered.
' 2006 Wiley-Liss, Inc.
Key words: artificial UV; sunbeds; melanoma; skin cancer; meta-
analysis
Sun exposure is the main environmental cause of skin cancer,
and ultraviolet (UV) radiation is the solar wavelength involved in
skin cancer, including the malignant cutaneous melanoma.1 People
may also be exposed to UV radiation through many artificial sour-
ces at home and in the workplace, with some individuals receiving
high doses. Sources of artificial UV radiation include various lamps
used in medicine, industry, business and research, as well as for
domestic and cosmetic purposes. Sunbeds and sunlamps used for
tanning purposes are the main source of deliberate exposure to arti-
ficial UV radiation. Although the contexts of sun exposure and
indoor tanning differ, both deliver UV radiation, and their health
effects would therefore be expected to be similar.
UV radiation wavelengths range between 100 and 400 nm and
are broadly categorized into UVA (>315–400 nm), UVB (>280–
315 nm) and UVC (100–280 nm). Modern indoor tanning equip-
ment mainly emits in the UVA range, but a fraction (i.e., <5%) of
this spectrum is in the UVB range.
Before 1990, UVB was usually considered the only carcino-
genic part of the solar spectrum, but since then UVA as well has
been suspected of having carcinogenic potential. In 1992, the
International Agency for Research on Cancer (IARC) classified
UVB and UVA radiation, as well as ‘‘use of sunlamps and sun-
beds,’’ as ‘‘probably carcinogenic to humans’’ (Group 2A of the
IARC classification of carcinogenic agents).1 More recently, the
10th Report on Carcinogens published by the National Toxicology
Program in the USA classified UVA radiation as a ‘‘known to be a
human carcinogen.’’2 Biological mechanisms by which chronic
sun exposure causes squamous cell cancer (SCC) of the skin have
become better known and chronic exposure to high UVB doses is
now considered as the main environmental cause of that skin
cancer.3 Biological mechanisms implicated in basal cell carci-
noma (BCC) start to be better known. In contrast, we still have
poor knowledge of the UV wavelength and the dose delivery pat-
tern at skin level implicated in the genesis of melanoma and of
BCC.4
Indoor tanning is widely practiced in most developed countries,
particularly in Northern Europe and the USA, and is gaining popu-
larity even in sunny countries such as Australia.5,6 The likely
impact of this fashion on skin cancer incidence is of substantial
concern, mainly for cutaneous malignant melanoma (hereafter
melanoma), a cancer of poor prognosis when diagnosed at an
advanced stage.
This paper summarizes a systematic review of epidemiological
and experimental studies on use of indoor tanning equipment and
skin cancer developed by a Working Group convened by IARC.
UV spectra from sunlight and indoor UV tanning appliances
During a sunny day on the Mediterranean coast, the solar UV
spectrum at noon contains 4–5% UVB and 95–96% UVA. When
UV output of a typical indoor tanning appliance is calculated in
terms of biological activity, as estimated by the erythema-effec-
tive irradiance, the emission of many tanning appliances is equiva-
lent to or exceeds the emission of the midday sun in southern
Europe.7,8 The UV intensity of powerful tanning appliances may
be 10–15 times higher than that of the midday sun,8 leading to
UVA doses per unit of time received by the skin during a typical
tanning session that are well above those experienced during ordi-
nary daily activities or even during sunbathing. As a result, the an-
nual UVA doses received by frequent indoor tanners may be 1.2–
4.7 times those received from the sun, in addition to those received
from the sun.9 This widespread repeated exposure to high doses of
UVA constitutes a new phenomenon for human beings.
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In the 1990s, regulations in some countries (e.g., France, Swe-
den) limited to 1.5% the maximum percentage of UVB in the UV
output of tanning appliances. However, in practice, the UV output
and spectral characteristics (i.e., amounts of UVA, UVB, visible
light and infrared radiation) of tanning appliances vary consider-
ably. The proportion of UVB in UV energy output could vary
from 0.5 to 4%,10,11 and may attain an emission spectrum similar
to the sun spectrum in the UVB range.8 These differences are due
to sunbed design (e.g., the numbers and type of fluorescent tubes,
the presence of high pressure UV lamps, the materials composing
filters, the distance from canopy to the skin), sunbed power and
tube ageing.
Biological effects of exposure to artificial UV radiation
relevant to carcinogenesis
A large body of experimental and epidemiological data strongly
indicates that the spectrum of UV radiation reaching the Earth’s
surface causes skin cancer.1,12,13 UVB is a complete carcinogen
that is absorbed by DNA and can damage DNA directly.13
Evidence of the mutagenic properties of UVA in humans has
been found in several studies.12–14 UVA radiation does cause
UVB-like cyclobutane pyrimidine dimers and 6-4 photoproducts,
albeit with a much lower efficacy than does UVB radiation. Most
of the DNA damage induced by UVA is indirect, through the
absorption of UVA photons by other cellular structures (chromo-
phores), with formation of reactive oxygen species that can trans-
fer UVA energy to DNA via mutagenic oxidative intermediates.15
Skin of human volunteers exposed to UVA lamps used in tan-
ning appliances show DNA damage, p53 mutations induced by
oxidative damage and alterations of the p53 protein similar to
those observed after sun exposure or after exposure of experimen-
tal animals.16–18
UVA penetrates deeper into human skin than does UVB.
Because UVA represents the largest proportion of the UV spec-
trum of tanning appliances and of solar radiation reaching the
Earth’s surface, far more UVA than UVB reaches the basal layers
of the epidermis where melanocytes and early keratinocytic cells
are located.
Both UVA and UVB radiation can affect the immune response
that may be involved in the promotion of melanoma,15,19,20 but
the 2 types of radiation seem to act differently.21,22 UVB induces
immunosuppression at both the local and systemic levels, while
UVA does not induce systemic immune suppression.23
To date, evidence obtained from experimental studies on the
involvement of high UVB doses in the causation of SCC is con-
sistent with observations in humans. In contrast, experimental
studies give conflicting results regarding the roles of UVB and
UVA in the induction of melanoma in humans. The same uncer-
tainties hold true for BCC, a type of tumor that shares some epide-
miological characteristics of melanoma.
Experiments carried out in animals cannot reproduce the com-
plex interplay in individuals between highly variable natural sus-
ceptibilities to UV radiation, sun exposure behaviors and exposure
to various sources of UV radiation. During indoor tanning, such
interrelationships may be critical, as users are more inclined than
the average population to engage in outdoor tanning activities,24
and indoor tanning sessions often precede or follow active sun ex-
posure or outdoor tanning.
Effects of artificial UV on human skin
Skin redness or burning are reported by 18–55% of users of
indoor tanning equipment in Europe and North America.25
Although UVB is far more potent than UVA in causing sunburn,
high fluxes of UVA are capable of inducing skin redness in indi-
viduals sensitive to sunlight or with only moderate tanning ability.
In individuals who tan easily, exposure to tanning appliances
will lead first to the oxidation of melanin already present in super-
ficial keratinocytic layers of the skin, known as immediate pig-
ment darkening.26 A more permanent tan is acquired with accu-
mulation of exposure, depending on tanning ability and on the
amount of UVB present in the UV spectrum of the lamps.
Immediate pigment darkening has no photoprotective effect
against UV-induced skin redness or sunburn.27 Moreover a UVA-
induced permanent tan provides little photoprotection28,29 and the
skin thickening caused by UVA affords only very little photopro-
tection.30 Studies in humans show that a prevacation tan induced
artificially offers virtually no protection against sun-induced DNA
damage.31–33
Exposure to artificial UV for tanning purposes
Few people had used indoor tanning equipment before 1980 but
by the end of the 1990s more than 60% of women and 50% of
men aged 18–50 years in Northern Europe reported having ever
used indoor tanning equipment.34 Indeed, prevalence of indoor
tanning is increasing so rapidly in many countries that current esti-
mates may be outdated rapidly. The most frequent motivations for
indoor tanning are the acquisition of a so-called safe tan and prep-
aration of the skin before sun exposure.25
Use of indoor tanning equipment is more prevalent among
women and among both men and women younger than 35 years.
Earliest studies in Sweden and in the USA tended to find indoor
tanning to be more prevalent among adolescents with fair skin
types who are more prone to sunburn.35–37 More recent studies in
the USA found either the opposite38–40 or no association.41
Few studies have assessed the compliance of indoor tanning facil-
ity operators or consumers with recommendations and regulations.
Overall, information provided by tanning salon operators on health
risks and on duration and frequency of exposure is often incomplete,
and there is a lack of identification of highly sun-sensitive subjects or
of subjects taking photosensitizing medications.6,42–44
About 17–35% sunbed users reported that they did not wear eye
protection.10,41,43 In some surveys, 16% of sunbed users may have
had more than 100 sessions per year,10 and most users tend to
exceed the recommended exposure times.41,44,45
Since 1989, a total of 16 studies (18 reports) have examined
prevalence of indoor tanning among children and adolescents
aged 8–19 years in Australia, Europe and the USA.46,47 All studies
showed a frequent use by adolescents and children, sometimes at a
very young age. According to the most recent studies, 30% of ado-
lescents in Sweden and 24% of adolescents in the USA aged 13–
19 years reported ever-use of indoor tanning equipment and 8 and
12% respectively were frequent users (10 times per year or more).
In a recent survey in the United Kingdom, while 7% of children
aged 8–11 years reported exposure to a sunbed in the past 6
months, as many as 48% expressed a desire to use a sunbed.48
Epidemiological studies on indoor tanning and skin cancer
As existing animal models of human melanoma are inconsis-
tent, evidence of an association between indoor tanning and skin
cancer must be sought predominantly from epidemiological stud-
ies. Few studies have addressed this topic specifically, but some
studies included 1 or more secondary questions about indoor tan-
ning. We systematically analyzed the results from the relevant
studies and compiled them in a metaanalysis.
Methods
The methodology used for the literature search is summarized
in Table I. The minimal common information about exposure to
indoor tanning appliances for all studies was ‘‘ever exposed.’’ For
those studies wherein ‘‘ever exposed to indoor tanning appliances
versus never’’ was not strictly assessed49,50 we used the informa-
tion closest to this category.
Most estimates included all subjects and combined sexes in the
analysis. Some studies presented results separately for women and
men, with no combined data, in which case both estimates were
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included. Since the studies used different age categories for classi-
fying age at first exposure, we considered as ‘‘young exposure’’
those exposures that started before 35 years of age.
Every measure of association adjusted for the maximum num-
ber of confounding variables, and corresponding confidence inter-
val (CI), was transformed into logarithms of relative risk (log RR)
and the corresponding variance was calculated.51 Where no esti-
mates were reported, the crude estimates were calculated from
tabular data, using asymptotic Mantel-Haenszel methods to evalu-
ate the 95% CI of the log odds ratio.
The homogeneity of the effects across studies was assessed using
the large sample test based on the v2-test. The summary relative risk
was estimated using random effects models even when heterogeneity
was found to be not statistically significant, in order to be conserva-
tive. Publication bias was investigated by funnel plot regression.52
Studies on melanoma
We identified 23 studies on use of indoor tanning equipment
and melanoma (Table II).34,49,50,53–73 All studies used the case–
control design, except for 1 cohort study.50 A case–control study
was considered population-based when cases were derived from a
population-based cancer registry and controls were selected from
the general population. Of these 23 studies, 4 studies were
excluded from the metaanalysis because they did not include esti-
mates of the relative risk for cutaneous melanoma associated with
exposure to tanning appliances.53,55,57,62
Studies used for the metaanalysis included a total of 7,355
cases. The first study was published in 1981 and the last in 2005.
Fifteen studies were carried out in European countries, 4 of which
in Scandinavian countries, and 2 were in the United States, 1 in
Canada and 1 in Australia.
Studies on basal cell and squamous cell carcinomas
Nine case–control studies have examined the association
between indoor tanning and either BCC or SCC of the skin.74–82
All studies reported a risk estimate except one,74 which was there-
fore excluded. A further 3 studies that did not distinguish between
TABLE I – METHOD USED FOR THE LITERATURE SEARCH
The literature to March 2006 was searched using the following
databases: Pubmed, ISI Web of Science (Science Citation
Index Expanded), Embase, Pascal, Cochrane library, Lilacs
and Medcarib. The following keywords and their
corresponding French translation were used for search in the
PASCAL database: skin cancer, squamous cell carcinoma,
SCC, basal cell carcinoma, BCC and melanoma for diseases.
To define exposure, the following keywords were used:
sunbed, sunlamp, artificial UV, artificial light, solaria,
solarium, indoor tanning, tanning bed, tanning parlour,
tanning salon and tanning booth.
Search for keywords in the title and in the abstract was done
systematically. Manual search was done of references cited in
the selected articles, and in selected reviews or books on
melanoma and skin cancer. All participants of the working
group were asked to report any additional published or
submitted study. No language restriction was applied.
Primary inclusion criteria were developed for the selection of
relevant articles, which were case–control, cohort or cross-
sectional studies published as an original article. Ecological
studies, case reports, reviews and editorials were not
considered eligible.
The selected articles were reviewed, and data were abstracted by
means of a standardized data-collection protocol. When
another article on the same study was published
simultaneously, additional relevant or missing information
was retrieved from the companion paper.






Veierød et al. (2003)50 Norway, Sweden 187 106,3791 1.55 (1.04–2.32)
Population-based case–control
studies
Adam et al. (1981)54 UK 169 207 2.93 (1.16–7.40)
Gallagher et al. (1986)55 Canada 595 595 3
Holman et al. (1986)56 Australia 511 511 1.1 (0.6–1.8)
Osterlind et al. (1988)59 Denmark 474 926 0.73 (0.53–1.01)
Zanetti et al. (1988)60 Italy 208 416 0.9 (0.4–2.0)
Beitner et al. (1990)62 Sweden 523 505 3
Walter et al. (1990)63 Canada 583 608 4
Westerdahl et al. (1994)70 Sweden 400 640 1.3 (0.9–1.8)
Holly et al. (1995)68 USA 452 930 0.94 (0.74–1.2)
Chen et al. (1998)69 USA 624 512 1.13 (0.82–1.54)
Walter et al. (1999)64 Canada 583 608 1.54 (1.16–2.05)
Westerdahl et al. (2000)73 Sweden 571 913 1.2 (0.9–1.6)
Other case-control studies
Klepp and Magnus (1979)53 Norway 78 131 3
Holly et al. (1987)57 USA 121 139 3
Swerdlow et al. (1988)58 UK 180 120 2.94 (1.41–6.17)
MacKie et al. (1989)61 UK 280 180 1.3 (0.2–7.9) for men;
1.2 (0.5–3.0) for women
Dunn-Lane et al. (1993)65 UK 100 100 1.16 (0.54–2.47)
Garbe et al. (1993)66 Germany 280 280 1.5 (0.9–2.4)
Autier et al. (1994)67 Belgium, France, and Germany 420 447 0.97 (0.71–1.32)
Naldi et al. (2000)71 Italy 542 538 0.78 (0.45–1.37)
Kaskel et al. (2001)49 Germany 271 271 1.00 (0.6–1.8)
Bataille et al. (2004)72 UK 413 416 1.19 (0.84–1.68)
Bataille et al. (2005)34 Belgium, France, the Netherlands,
Sweden, UK
597 622 0.90 (0.71–1.14)
ALM, acral lentiginous melanoma; HC, histologically confirmed; LMM, lentigo maligna melanoma; M, melanoma; MM, malignant melanoma;
NM, nodular melanoma; SSM, superficial spreading melanoma.
1Cohort size.–2Values in parentheses are 95% CI .–3Because no estimate of risk was reported in these studies, we did not include them in the
metaanalysis.–4The study by Walter et al. (1990)63 was reanalyzed in the 1999 publication. We used the relative risk adjusted for potential con-
founders presented in the 1999 publication.
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these 2 major types of skin cancer75–77 were also excluded from
review, leaving 5 studies for consideration.
Relative risk for melanoma
Thirteen of 19 studies presented positive estimates for ‘‘ever’’
versus ‘‘never’’ exposed to indoor tanning equipment, but only 4
were statistically significant50,54,58,64 (Fig. 1). Seven of these stud-
ies reported only crude relative risks, and 1 adjusted for age and
sex only. Results of the metaanalysis are shown in Table III. The
summary estimate indicated a significant positive association
between ‘‘ever’’ versus ‘‘never’’ indoor tanning and melanoma
(RR, 1.15; CI, 1.00–1.31) and the v2-test for heterogeneity was
statistically significant.
To decrease the influence of possible biases, estimates were cal-
culated including only the cohort and the 9 population-based
case–control studies. The summary relative risk was very similar
apart from having wider CIs (RR, 1.17; CI, 0.96–1.42). In an anal-
ysis restricted to the 8 studies that adjusted for confounders related
to sun exposure and sun sensitivity,50,60,61,64,69–71,73 the summary
relative risk remained similar to that obtained from all 19 studies,
but the CI widened (RR, 1.19; CI, 0.33–4.30).
Seven studies presented estimates relevant for the evaluation of
‘‘first exposure in youth’’ versus ‘‘never’’ (Fig. 2). All relative
risks were adjusted for confounders related to sun exposure or sun
sensitivity, except in the study by Walter et al.64 A significant
75% increase in risk was detected (Table III) and the v2-test for
heterogeneity was nonsignificant.
Five studies investigated time since exposure and reported esti-
mates that allowed comparisons between recent and more distant
exposure.34,58,63,67,69 Metaanalytic estimates were greater for
exposures more distant in time when compared to those for more
recent exposures (Table III).
There was some indication for a dose-effect relationship in 2
studies,67,70 but not in the other two.69,73 But metrics used for
assessing duration were all different and therefore did not permit
metaanalytic synthesis. Only 4 studies explored the role of natural
sensitivity to sunlight on risk associated with indoor tanning, and
overall, they found no consistent result.34,64,72,73
Type of indoor tanning equipment
No epidemiological study has been able to explore in a rigorous
way amounts of UVA and UVB received by indoor tanning users.
The study by Chen et al.69 obtained information concerning the
type of sunbed or sunlamp used (e.g., desktop models, floor mod-
els, beds or walk-in booths). This information was obtained by
showing to subjects pictures of various types of sunlamps and sun-
FIGURE 1 – Relative risk for cu-
taneous melanoma associated with
ever use of indoor tanning equip-
ment: estimates of 19 studies and
summary estimate (relative risks
were presented separately for men
and women in the study by
MacKie et al.61).
TABLE III – METAANALYSIS OF EPIDEMIOLOGICAL STUDIES ON INDOOR TANNING AND RISK







Ever use of indoor tanning equipment 19 1.15 (1.00–1.31) 0.013
First exposure in youth 7 1.75 (1.35–2.26) 0.55
Exposure distant in time 5 1.49 (0.93–2.38) 0.018
Exposure recent in time 5 1.10 (0.76–1.60) 0.81
Squamous cell carcinoma
Ever use of indoor tanning equipment 3 2.25 (1.08–4.70) 0.10
Basal cell carcinoma
Ever use of indoor tanning equipment 4 1.03 (0.56–1.90) 0.06
1Values in parentheses are 95% CI.–2v2-test: the degrees of freedom are given by the number of risk
estimates included minus 1.
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beds. The study found a nonsignificant elevated risk of malignant
melanoma associated with the use of desktop sunlamps and heavy-
weight floor-model sunbeds and a statistically significant tripled
risk associated with use of more than 2 types of sunlamps, com-
pared with no use of sunbeds. The study by Bataille et al.34
reported no impact of the type of device used on melanoma risk.
The relative risks of melanoma associated with ever-use of
sunbed/sunlamp reported in the studies did not vary with year of
publication or first year of study period, and funnel plot regression
gave no indication of publication bias (ever-use of sunbed/sun-
lamps, p 5 0.80; first exposure in youth, p 5 0.10). This observa-
tion suggests that the apparent increased risk for ever use and for
age at first use were unlikely to be explained by the earlier types
of indoor tanning appliance used.
Before 1980, exposure to artificial UV radiation was more
likely to take place at home with devices that emitted greater
amounts of UVB radiation, whereas exposure in the 1980s
increasingly occurred in commercial salons using equipment that
emitted mainly UVA. The Norway–Swedish prospective study
provided evidence that the increased melanoma risk associated
with exposure to tanning appliances was not due to the type of UV
lamps used before 1983.83
Relative risk for squamous cell carcinoma
and basal cell carcinoma
The metaanalysis was based on the 5 studies78–82 reporting type-
specific risk estimates (Table III). Metaanalytic estimates suggested
a significant effect of exposure to indoor tanning appliances for
SCC, but not for BCC. Funnel plot regression gave no indication of
publication bias (p 5 0.26 and 0.77 for SCC and BCC, respec-
tively).
The study by Karagas et al.81 gave the most detailed results,
and the trends were consistent with the results reported for mela-
noma. Results were adjusted for sun sensitivity but not for sun ex-
posure, since adjustment for sun exposure did not change the risk
estimates. Depending on age at first use, the risks for BCC and
SCC were found to increase by 10% (OR, 1.1; CI, 0.9–1.5) and
20% (OR, 1.2; CI, 0.9–1.6) respectively for each decade younger
the person was at first use of indoor tanning equipment.
Discussion
Investigation of the association between indoor tanning and
skin cancers poses challenging problems, as indoor tanning has
been in widespread use only recently. Based on our knowledge
about the relationship between sun exposure and risk for mela-
noma, it could be stated that associations after long latency peri-
ods, such as would be expected for melanoma and BCC, may not
be detectable yet. Also, since the fashion of indoor tanning has
been increasing steadily, the failure to distinguish between distant
and recent exposures in most epidemiological studies may mask
an actual increase in risk with exposure early in life.
Our systematic review of published studies mainly from Europe
and North America of the association of use of indoor tanning
equipment with skin cancers revealed an association of age at first
use of less than 35 years with melanoma risk. These studies consis-
tently indicated a moderate strength of association, with a summary
relative risk of 1.75 (1.35–2.26). This result suggests a greater vul-
nerability of younger people to the carcinogenic impact of indoor
tanning. Also, it is in agreement with the knowledge that age at ex-
posure may influence the relative risk for skin cancer associated
with UV exposure, and that exposure to sunlight in childhood is an
important contributing factor for melanoma risk in adults.84,85
The association with ever-use of such equipment, or use more
than 15–20 years prior to diagnosis of melanoma, was weak, and
evidence regarding a dose–response relationship was scant. The
evidence is limited by concerns over characterization of exposure
and recall of exposure by individuals, potential confounding by
sun exposure or other variables and the low power to detect asso-
ciations that become evident only following a prolonged lag pe-
riod after exposure. Our results are similar to a previous metaanal-
ysis,86 but our systematic review is more exhaustive and included
more studies.
In Scandinavian countries use of indoor tanning equipment has
been popular since the late 1970s and the prevalence of use in
those countries is the highest in the world. In the Norwegian–
Swedish prospective study the highest risk for melanoma was
found in women who used indoor tanning equipment at least once
per month when they were 20–29 years old. These results support
the hypothesis that a certain lag period is needed before the impact
FIGURE 2 – Relative risk for cu-
taneous melanoma associated with
first use of indoor tanning equip-
ment at age <35 years: estimates of
7 studies and summary estimate.
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of exposure to tanning appliances on melanoma incidence
becomes apparent. It also underlines the greater vulnerability of
younger subjects to harmful effects of indoor tanning.
The positive association between use of indoor tanning equip-
ment and melanoma risk reported here is consistent with the
knowledge that melanoma is caused primarily by exposure to solar
radiation. The limited evidence for a positive association between
indoor tanning and SCC is consistent with its known dependence
on dose of UV radiation to the skin. Thus the biological plausibil-
ity of a causal association between indoor tanning and risk for
melanoma and SCC is strong.
On balance, the evidence pertaining to the strength, consistency,
dose–response and temporal sequence of the association of the use
of indoor tanning equipment with melanoma risk, and of the coher-
ence and biologic plausibility of the association, leads us to conclude
that there is convincing evidence to support a causal relationship,
particularly with exposure before the age of 35 years. This evidence
is strongly suggestive and further studies could clarify our under-
standing of this association and allow more definitive conclusions.
We are cognizant of the importance of this issue for the health
of light-skinned populations. The strength of the existing evidence
suggests that policy makers should strongly consider enacting
measures such as restricting minors and discouraging young adults
from using indoor tanning equipment, in order to protect the gen-
eral population from additional risk for melanoma and squamous
cell skin cancer.
References
1. IARC. Solar and ultraviolet radiation. Lyon: International Agency for
Research on Cancer, 1992. IARC monographs on the evaluation of
carcinogenic risks to humans, vol. 55.
2. National Toxicology Program. 10th Report on Carcinogens: substan-
ces profiles. Research Triangle Park, US Department of Health and
Human Services, Public Health Service, 2002.
3. de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA
damage, repair, mutations and oncogenic pathways in skin cancer.
J Photochem Photobiol B 2001;63:19–27.
4. de Gruijl FR. Photocarcinogenesis: UVA vs. UVB radiation. Skin
Pharmacol Appl Skin Physiol 2002;15:316–20.
5. Paul CL, Girgis A, Tzelepis F, Walsh RA. Solaria use by minors in
Australia: is there a cause for concern? Aust N Z J Public Health 2004;
28:90.
6. Paul CL, Stacy F, Girgis A, Brozek I, Baird H, Hughes J. Solaria com-
pliance in an unregulated environment: the Australian experience. Eur
J Cancer 2005;41:1178–84.
7. Wester U, Boldemann C, Jansson B, Ullen H. Population UV-dose
and skin area—do sunbeds rival the sun? Health Phys 1999;77:436–
40.
8. Gerber B, Mathys P, Moser M, Bressoud D, Braun-Fahrlander C.
Ultraviolet emission spectra of sunbeds. Photochem Photobiol 2002;
76:664–8.
9. Miller SA, Hamilton SL, Wester UG, Cyr WH. An analysis of UVA
emissions from sunlamps and the potential importance for melanoma.
Photochem Photobiol 1998;68:63–70.
10. MacGintley J, Martin CJ, MacKie RM. Sunbeds in current use in
Scotland: a survey of their output and patterns of use. Br J Dermatol
1998;139:428–38.
11. Wright AL, Hart GC, Kernohan E, Twentyman G. Survey of the vari-
ation in ultraviolet outputs from ultraviolet A sunbeds in Bradford.
Photodermatol Photoimmunol Photomed 1996;12:12–16.
12. Pfeifer GP, You YH, Besaratinia A. Mutations induced by ultraviolet
light. Mutat Res 2005;571:19–31.
13. Griffiths HR, Mistry P, Herbert KE, Lunec J. Molecular and cellular
effects of ultraviolet light-induced genotoxicity. Crit Rev Clin Lab
Sci 1998;35:189–237.
14. Robert C, Muel B, Benoit A, Dubertret L, Sarasin A, Stary A. Cell
survival and shuttle vector mutagenesis induced by UVA and UVB
radiation in a human cell line. J Invest Dermatol 1996;106:721–8.
15. Halliday G. Inflammation, gene mutation and photoimmunosuppres-
sion in response to UVR-induced oxidative damage contributes to
photocarcinogenesis. Mut Res 2005;571:107–20.
16. Woollons A, Clingen PH, Price ML, Arlett CF, Green MH. Induction
of mutagenic DNA damage in human fibroblasts after exposure to ar-
tificial tanning lamps. Br J Dermatol 1997;137:687–92.
17. Whitmore SE, Morison WL, Potten CS, Chadwick C. Tanning salon
exposure and molecular alterations. J Am Acad Dermatol 2001;44:
775–80.
18. Persson AE, Edstrom DW, Backvall H, Lundeberg J, Ponten F, Ros
AM, Williams C. The mutagenic effect of ultraviolet-A1 on human
skin demonstrated by sequencing the p53 gene in single keratinocytes.
Photodermatol Photoimmunol Photomed 2002;18:287–93.
19. Kripke ML. Antigenicity of murine skin tumors induced by UV light.
J Natl Cancer Inst 1974;53:1333–6.
20. Singh RK, Gutman M, Reich R, Bar-Eli M. Ultraviolet B irradiation
promotes tumorigenic and metastatic properties in primary cutaneous
melanoma via induction of interleukin-8. Cancer Res 1995;55:3669–
74.
21. Phan TA, Halliday GM, Barnetson RS, Damian DL. Spectral and
dose dependence of ultraviolet radiation-induced immunosuppression.
Front Biosci 2006;11:394–411.
22. Aboutalebi S, Strickland FM. Immune protection, natural products,
and skin cancer: is there anything new under the sun? J Drugs Derma-
tol 2006;5:512–7.
23. Ullrich SE. Mechanisms underlying UV-induced immune suppres-
sion. Mutat Res 2005;571:185–205.
24. Autier P, Joarlette M, Lejeune F, Lienard D, Andre J, Achten G. Cuta-
neous malignant melanoma and exposure to sunlamps and sunbeds: a
descriptive study in Belgium. Melanoma Res 1991;1:69–74.
25. Autier P. Perspectives in melanoma prevention: the case of sunbeds.
Eur J Cancer 2004;40:2367–76.
26. Pedeux R, Al-Irani N, Marteau C, Pellicier F, Branche R, Ozturk M,
Franchi J, Dore JF. Thymidine dinucleotides induce S phase cell cycle
arrest in addition to increased melanogenesis in human melanocytes.
J Invest Dermatol 1998;111:472–7.
27. Black G, Matzinger E, Gange RW. Lack of photoprotection against
UVB-induced erythema by immediate pigmentation induced by 382
nm radiation. J Invest Dermatol 1985;85:448–9.
28. Gange RW, Blackett AD, Matzinger EA, Sutherland BM, Kochevar
IE. Comparative protection efficiency of UVA- and UVB-induced
tans against erythema and formation of endonuclease-sensitive sites
in DNA by UVB in human skin. J Invest Dermatol 1985;85: 362–4.
29. Rivers JK, Norris PG, Murphy GM, Chu AC, Midgley G, Morris J,
Morris RW, Young AR, Hawk JL. UVA sunbeds: tanning, photopro-
tection, acute adverse effects and immunological changes. Br J Der-
matol 1989;120:767–77.
30. Sheehan JM, Potten CS, Young AR. Tanning in human skin types II
and III offers modest photoprotection against erythema. Photochem
Photobiol 1998;68:588–92.
31. Hemminki K, Bykov VJ, Marcusson JA. Re: Sunscreen use and dura-
tion of sun exposure: a double-blind, randomised trial. J Natl Cancer
Inst 1999;91:2046–7.
32. Bykov VJ, Marcusson JA, Hemminki K. Protective effects of tanning
on cutaneous DNA damage in situ melanoma. Dermatology 2001;
202:22–6.
33. Ruegemer J, Schuetz B, Hermann K, Hein R, Ring J, Abeck D. UV-
induced skin changes due to regular use of commercial sunbeds. Pho-
todermatol Photoimmunol Photomed 2002;18:223–7.
34. Bataille V, Boniol M, De Vries E, Severi G, Brandberg Y, Sasieni P,
Cuzick J, Eggermont A, Ringborg U, Grivegnee AR, Coebergh JW,
Chignol MC, et al. A multicentre epidemiological study on sunbed
use and cutaneous melanoma in Europe. Eur J Cancer 2005;41:2141–9.
35. Mermelstein RJ, Riesenberg LA. Changing knowledge and attitudes
about skin cancer risk factors in adolescents. Health Psychol 1992;
11:371–6.
36. Boldeman C, Beitner H, Jansson B, Nilsson B, Ullen H. Sunbed use
in relation to phenotype, erythema, sunscreen use and skin diseases. A
questionnaire survey among Swedish adolescents. Br J Dermatol
1996;135:712–6.
37. Robinson JK, Rademaker AW, Sylvester JA, Cook B. Summer sun
exposure: knowledge, attitudes and behaviors of Midwest adolescents.
Prev Med 1997;26:364–72.
38. Cokkinides VE, Weinstock M, O’Connell MC, Thun MJ. Use of
indoor tanning sunlamps by US youth, ages 11–18 years, and by their
parent or guardian caregivers: prevalence and correlates. Pediatrics
2002;109:1124–30.
39. Demko CA, Borawski EA, Debanne SM, Cooper KD, Stange KC.
Use of indoor tanning facilities by white adolescents in the United
States. Arch Pediatr Adolesc Med 2003;157:854–60.
40. Geller AC, Colditz GA, Oliveria S, Emmons K, Jorgensen C, Aweh
GN, Frazier AL. Use of sunscreen, sunburning rates, and tanning bed
use among more than 10,000 US children and adolescents. Pediatrics
2002;109: 1009–14.
1121SUNBED USE AND RISK OF MELANOMA AND SKIN CANCERS
34
41. Oliphant JA, Forster JL, McBride CM. The use of commercial tanning
facilities by suburban Minnesota adolescents. Am J Public Health
1994;84:476–8.
42. Culley CA, Mayer JA, Eckhardt L, Busic AJ, Eichenfield LF, Sallis
JF, Quintana PJ, Woodruff SI. Compliance with federal and state
legislation by indoor tanning facilities in San Diego. J Am Acad Der-
matol 2001;44:53–60.
43. Rhainds M, De Guire L, Claveau J. A population-based survey on the
use of artificial tanning devices in the province of Quebec, Canada.
J Am Acad Dermatol 1999;40:572–6.
44. Kwon HT, Mayer JA, Walker KK, Yu H, Lewis EC, Belch GE. Pro-
motion of frequent tanning sessions by indoor tanning facilities: two
studies. J Am Acad Dermatol 2002;46:700–5.
45. Hornung RL, Magee KH, Lee WJ, Hansen LA, Hsieh YC. Tanning
facility use: are we exceeding Food and Drug Administration limits?
J Am Acad Dermatol 2003;49:655–61.
46. Lazovich D, Forster JL, Sorensen G, Emmons K, Stryker JE, Demi-
erre MF, Hickle A, Remba N. Characteristics associated with use or
intention to use indoor tanning among adolescents. Arch Pediatr Ado-
lesc Med 2004;158:918–24.
47. Lazovich D, Forster J. Indoor tanning by adolescents: prevalence,
practices and policies. Eur J Cancer 2005;41:20–7.
48. Hamlet N, Kennedy K. Reconnaissance study of sunbed use by pri-
mary school children in Lanarkshire. J Public Health 2004;26:31–3.
49. Kaskel P, Sander S, Kron M, Kind P, Peter RU, Krahn G. Outdoor
activities in childhood: a protective factor for cutaneous melanoma?
Results of a case-control study in 271 matched pairs. Br J Dermatol
2001;145:602–9.
50. Veierød MB, Weiderpass E, Thorn M, Hansson J, Lund E, Armstrong
B, Adami HO. A prospective study of pigmentation, sun exposure,
and risk of cutaneous malignant melanoma in women. J Natl Cancer
Inst 2003;95:1530–8.
51. Greenland S. Quantitative methods in the review of epidemiologic lit-
erature. Epidemiol Rev 1987;9:1–30.
52. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect
publication bias in meta-analysis. Stat Med 2001;20:641–54.
53. Klepp O, Magnus K. Some environmental and bodily characteristics
of melanoma patients. A case-control study. Int J Cancer 1979;23:
482–6.
54. Adam SA, Sheaves JK, Wright NH, Mosser G, Harris RW, Vessey
MP. A case-control study of the possible association between oral
contraceptives and malignant melanoma. Br J Cancer 1981;44:45–
50.
55. Gallagher RP, Elwood JM, Hill GB. Risk factors for cutaneous malig-
nant melanoma: the Western Canada Melanoma Study. Recent
Results Cancer Res 1986;102:38–55.
56. Holman CD, Armstrong BK, Heenan PJ, Blackwell JB, Cumming FJ,
English DR, Holland S, Kelsall GR, Matz LR, Rouse IL, Singh A,
Ten Seldam REJ et al. The causes of malignant melanoma: results
from the West Australian Lions Melanoma Research Project. Recent
Results Cancer Res 1986;102:18–37.
57. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic
nevi as a major risk factor for malignant melanoma. J Am Acad Der-
matol 1987;17:459–68.
58. Swerdlow AJ, English JS, MacKie RM, O’Doherty CJ, Hunter JA,
Clark J, Hole DJ. Fluorescent lights, ultraviolet lamps, and risk of cu-
taneous melanoma. Br Med J 1988;297:647–50.
59. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-con-
trol study of cutaneous malignant melanoma. II. Importance of UV-
light exposure. Int J Cancer 1988;42:319–24.
60. Zanetti R, Rosso S, Faggiano F, Roffino R, Colonna S, Martina G. A
case-control study on cutaneous malignant melanoma in the province
of Torino, Italy. Rev Epidemiol Sante Publique 1988;36:309–17 [in
French].
61. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor
chart for cutaneous melanoma. Lancet 1989;2:487–90.
62. Beitner H, Norell SE, Ringborg U, Wennersten G, Mattson B. Malig-
nant melanoma: aetiological importance of individual pigmentation
and sun exposure. Br J Dermatol 1990;122:43–51.
63. Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P.
The association of cutaneous malignant melanoma with the use of
sunbeds and sunlamps. Am J Epidemiol 1990;131:232–43.
64. Walter SD, King WD, Marrett LD. Association of cutaneous malig-
nant melanoma with intermittent exposure to ultraviolet radiation: re-
sults of a case-control study in Ontario, Canada. Int J Epidemiol 1999;
28:418–27.
65. Dunn-Lane J, Herity B, Moriarty MJ, Conroy R. A case control study
of malignant melanoma. Ir Med J 1993;86:57–59. Erratum in: Ir Med
J 1993;86:135.
66. Garbe C, Weiss J, Kruger S, Garbe E, Buttner P, Bertz J, Hoffmeister
H, Guggenmoos-Holzmann I, Jung EG, Orfanos CE. The German
melanoma registry and environmental risk factors implied. Recent
Results Cancer Res 1993;128:69–89.
67. Autier P, Dore JF, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesar-
ini JP, Lienard D, Liabeuf A, Joarlette M, Chemaly P, Hakim K, et al.,
for the EORTC Melanoma Cooperative Group. Cutaneous malignant
melanoma and exposure to sunlamps or sunbeds: for the EORTC mul-
ticenter case-control study in Belgium, France and Germany. Int J
Cancer 1994;58:809–13.
68. Holly EA, AstonDA, Cress RD, AhnDK, Kristiansen JJ. Cutaneousmel-
anoma in women. I. Exposure to sunlight, ability to tan, and other risk
factors related to ultraviolet light. Am J Epidemiol 1995;141: 923–33.
69. Chen YT, Dubrow R, Zheng T, Barnhill RL, Fine J, Berwick M. Sun-
lamp use and the risk of cutaneous malignant melanoma: a popula-
tion-based case-control study in Connecticut, USA. Int J Epidemiol
1998;27:758–65.
70. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N, Brandt L,
Jonsson PE, Moller T. Use of sunbeds or sunlamps and malignant
melanoma in southern Sweden. Am J Epidemiol 1994;140:691–9.
71. Naldi L, Gallus S, Imberti GL, Cainelli T, Negri E, La Vecchia C, on
behalf of the Italian Group for Epidemiological Research in Derma-
tology. Sunlamps and sunbeds and the risk of cutaneous melanoma.
Eur J Cancer Prev 2000;9:133–4.
72. Bataille V, Winnett A, Sasieni P, Newton-Bishop JA, Cuzick J. Expo-
sure to the sun and sunbeds and the risk of cutaneous melanoma in the
UK: a case-control study. Eur J Cancer 2004;40:429–35.
73. Westerdahl J, Ingvar C, Masback A, Jonsson N, Olsson H. Risk of cu-
taneous malignant melanoma in relation to use of sunbeds: further
evidence for UV-A carcinogenicity. Br J Cancer 2000;82:1593–9.
74. Boyd AS, Shyr Y, King LE Jr. Basal cell carcinoma in young women:
an evaluation of the association of tanning bed use and smoking.
J Am Acad Dermatol 2002;46:706–9.
75. O’Loughlin G, Moriarty MJ, Herity B, Daly L. A re-appraisal of risk
factors for skin carcinoma in Ireland. A case-control study. Ir J Med
Sci 1985;154:61–5.
76. Herity B, O’Loughlin G, Moriarty MJ, Conroy R. Risk factors for
non-melanoma skin cancer. J Ir Med 1989;82:151–2.
77. Hogan DJ, To T, Wilson ER, Miller AB, Robson D, Holfeld K, Lane
P. A study of acne treatments as risk factors for skin cancer of the
head and neck. Br J Dermatol 1991;125:343–8.
78. Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of
the skin. A case-control study in the Montreal region. Cancer 1985;
55:907–11.
79. Bajdik CD, Gallagher RP, Astrakianakis G, Hill GB, Fincham S,
McLean DI. Non-solar ultraviolet radiation and the risk of basal and
squamous cell skin cancer. Br J Cancer 1996;73:1612–4.
80. Corona R, Dogliotti E, D’Errico M, Sera F, Iavarone I, Baliva G,
Chinni LM, Gobello T, Mazzanti C, Puddu P, Pasquini P. Risk factors
for basal cell carcinoma in a Mediterranean population: role of recrea-
tional sun exposure early in life. Arch Dermatol 2001;137:1162–8.
81. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Wein-
stock MA. Use of tanning devices and risk of basal cell and squamous
cell skin cancers. J Natl Cancer Inst 2002;94:224–6.
82. Walther U, Kron M, Sander S, Sebastian G, Sander R, Peter RU,
Meurer M, Krahn G, Kaskel P. Risk and protective factors for spo-
radic basal cell carcinoma: results of a two-centre case-control study
in southern Germany. Clinical actinic elastosis may be a protective
factor. Br J Dermatol 2004;151:170–8.
83. Veierød MB, Weiderpasss E, Lund E, Armstrong BK, Adami HO.
Re: A retrospective study of pigmentation, sun exposure, and risk of
cutaneous malignant melanoma in women. J Natl Cancer Inst
2004;96:337–8.
84. Autier P, Dore JF, for EPIMEL and EORTC Melanoma Cooperative
Group. Influence of sun exposures during childhood and during adult-
hood on melanoma risk. Int J Cancer 1998;77:533–7.
85. Whiteman DC, Whiteman CA, Green A. Childhood sun exposure as a
risk factor for melanoma: a systematic review of epidemiologic stud-
ies. Cancer Causes Control 2001;12:69–82.
86. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk
of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers
Prev 2005;14:562–6.
1122 IARC WORKING GROUP
35
American Journal of Epidemiology
ª The Author 2010. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of
Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.
DOI: 10.1093/aje/kwq238
Original Contribution
A Melanoma Epidemic in Iceland: Possible Influence of Sunbed Use
Clarisse He´ry, Laufey Tryggvado´ttir, Thorgeir Sigurdsson, Elı´nborg O´lafsdo´ttir,
Bardur Sigurgeirsson, Jon G. Jonasson, Jon H. Olafsson, Mathieu Boniol, Graham B. Byrnes,
Jean-Francxois Dore´, and Philippe Autier*
* Correspondence to Dr. Philippe Autier, International Prevention Research Institute, 95 Cours Lafayette, 69002 Lyon, France
(e-mail: philippe.autier@i-pri.org) (current address).
Initially submitted July 29, 2009; accepted for publication December 22, 2009.
Since 1980, sunbed use and travel abroad have dramatically increased in Iceland (64–66N). The authors
assessed temporal trends in melanoma incidence by body site in Iceland in relation to sunbed use and travel
abroad. Using joinpoint analysis, they calculated estimated annual percent changes (EAPCs) and identified the
years during which statistically significant changes in EAPC occurred. Between 1954 and 2006, the largest in-
crease in incidence in men was observed on the trunk (EAPC ¼ 4.6%, 95% confidence interval: 3.2, 6.0). In
women, the slow increase in trunk melanoma incidence before 1995 was followed by a significantly sharper
increase in incidence, mainly among women aged less than 50 years, resembling an epidemic incidence curve
(1995–2002: EAPC ¼ 20.4%, 95% confidence interval: 9.3, 32.8). In 2002, the melanoma incidence on the trunk
was higher than the incidence on the lower limbs for women. Sunbed use in Iceland expanded rapidly after 1985,
mainly among young women, and in 2000, it was approximately 2 and 3 times the levels recorded in Sweden and in
the United Kingdom, respectively. Travels abroad were more prevalent among older Icelanders. The high preva-
lence of sunbed use probably contributed to the sharp increase in the incidence of melanoma in Iceland.
Iceland; melanoma; ultraviolet rays
Abbreviations: CI, confidence interval; EAPC, estimated annual percent change; UV, ultraviolet; UV-A, ultraviolet A; UV-B,
ultraviolet B; UV-C, ultraviolet C.
Editor’s note: An invited commentary on this article ap-
pears on page 000, and the authors’ response is published
on page 000.
Cutaneous malignant melanoma is a potentially deadly
cancer that occurs predominantly in sun-sensitive subjects,
that is, subjects with light skin and poor ability to tan (1).
Intermittent exposure to ultraviolet (UV) radiation is the
main environmental cause of cutaneous malignant mela-
noma (2). Intermittent sun exposure consists of intense ex-
posure to UV radiation of skin areas normally sun protected,
such as the trunk. UV radiation reaching the earth’s surface
contains ultraviolet A (UV-A) (>320–400 nm) and ultravi-
olet B (UV-B) (>280–320 nm) radiation. More recently, UV
radiation (wavelength, 100–400 nm, encompassing ultravi-
olet C (UV-C), UV-B, and UV-A), as well as UV-emitting
tanning devices, has been classified as carcinogenic to hu-
mans (group 1 carcinogens) by a Working Group of the
International Agency for Research on Cancer (3).
Until about 1990, melanoma incidence in Iceland was
below that of other Nordic countries (4), as expected from
its northern latitude (between 64 and 66N), frequent cloud
cover, and consequent low natural UV radiation. However,
melanoma incidence sharply increased in both genders dur-
ing the 1990s and, in 2000, the incidence in Icelandic
women was the highest of all Nordic countries (4). The
indoor tanning fashion was suspected as a possible cause
of this increase. A few years ago, we predicted that mela-
nomas associated with solarium use would be preferentially
localized to the trunk (5). We therefore performed a detailed
analysis of temporal trends in melanoma incidence in
1
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Iceland and of changes in exposure to sources of UV radi-
ation, mainly sunlight and artificial tanning devices.
MATERIALS AND METHODS
The population-based Icelandic Cancer Registry provided
information on invasive melanoma incidence from 1955 to
2007 (6). Melanoma incidence rates for all body sites, by
sex, were analyzed by using the Joinpoint Regression Pro-
gram, version 2.7 (7), to identify periods with distinct trends
between 1955 and 2007. The analysis was stratified by gen-
der, by age (0–49 and 50 years of age), and by anatomic
site. The NORDCAN online database provided Nordic in-
cidence and mortality data on cancer from 1945 until 2006
(4). All rates were standardized to the World Standard
Population.
Data on sunbed numbers were provided by the Icelandic
Radiation Protection Institute (8). Further information on
sunbed use came from surveys of melanoma risk factors
in the Icelandic population conducted in 2001–2002 (8)
and in 2002 (9). Information on travel abroad was provided
by a survey done in 2001–2002 (10) and from the National
Statistical Institute of Iceland (11).
RESULTS
Melanoma incidence
In 1955–2007, 861 melanoma cases (306 in men and 555
in women) were reported to the Icelandic Cancer Registry.
In the period 1955–1959, the age-standardized incidence
rate of melanoma in Iceland was less than 1/100,000 in
men and 2.2/100,000 in women. Until around 1990, despite
an annual increase of 4.1%, the melanoma incidence re-
mained lower in Iceland than in the other Nordic countries
(Figure 1), but during the period 1998–2002, the age-























































































































Figure 1. Trends in cutaneous melanoma incidence (1945–2007, men (A) and women (B)) andmortality (1953–2007, men (C) and women (D)) in
Nordic countries. Incidence rates are 5-year moving averages with 2007 being the last possible year. The y-axis scale of mortality is approximately
4 times lower than that of incidence. ASR, age-standardized rate. Data source: NORDCAN (4), age adjusted on the World Standard Population.
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Joinpoint analysis of incidence data from 1955 through
2007 for men showed a steady 4.8% estimated annual per-
cent change (EAPC) (95% confidence interval (CI): 3.8, 5.9)
without breakpoint, whereas for women a statistically sig-
nificant breakpoint was observed in 1992 (Figure 2). Before
1992, the EAPC in incidence was 3.3% (95% CI: 1.9, 4.7)
per year for women, but from 1992 until 2001, it was 11.8%
(95% CI: 5.1, 18.8). A second breakpoint was observed in
2001, followed by a nonsignificant 6.3% (95% CI: 13.5,
1.4) decrease until 2007.
The age distribution of melanoma cases for men showed
no significant change (P¼ 0.85) before and after 1992, with
the number of cases tripling in men of both age groups
(Table 1; Figure 3). In contrast, melanoma incidence rates
increased by 3 times in women younger than 50 years and
only slightly in women aged 50 or more years between
1955–1992 and 1993–2007 (P < 0.001) (Table 1; Figure
3). Moreover, using joinpoint analysis, we found that
women younger than 50 years required 2 joinpoints (P <
0.001), with an EAPC of 2.3% (95% CI: 0.1, 4.6) from 1955
to 1991, an EAPC of 15.5% (95% CI: 6.8, 24.8) between
1991 and 2001, and an EAPC of 9.0% (95% CI: 18.1,
1.1) until 2007. For women 50 years of age or older, no
joinpoint was required (P ¼ 0.63), as the incidence in-
creased steadily (EAPC ¼ 2.6%, 95% CI: 1.7, 3.5).
The largest increase over the period was observed on the
trunk in men (EAPC ¼ 4.6%, 95% CI: 3.2, 6.0) and on the
lower limbs in women (EAPC ¼ 3.5%, 95% CI: 2.5, 4.6)
(Figure 4). From the period 1955–1992 to the period 1993–
2007, the frequency of melanoma on the trunk more than
tripled in both sexes (Table 1). Although trunk melanoma
increased steadily in men, in women the slow increase be-
fore 1995 was followed by a significantly sharper increase in
incidence, resembling an epidemic incidence curve (1995–
2002: EAPC ¼ 20.4%, 95% CI: 9.3, 32.8) (Figure 4). As
a consequence, in 2002 the incidence of trunk melanoma
among women was higher than the incidence of melanoma
on the lower limbs. The site with the largest percentage
increase in incidence for women after 1992 was the trunk

























Figure 2. Joinpoint (JP) analysis of cutaneous melanoma incidence
in Iceland (1955–2007) by sex. ASR, age-standardized rate.
Table 1. Numbers and Body Site Distribution of Cutaneous Melanomas Diagnosed in Iceland
During the Time Period, 1955–2007
Men Women
1955–1992 1993–2007 1955–1992 1993–2007
No. % No. % No. % No. %
All sites
Age, <50 years 35 37.2 89 38.4 75 38.1 232 60.3
Age, 50 years 59 62.8 143 61.6 122 61.9 153 39.7
Age, <50 years
Head and neck 5 14.3 8 9.0 8 10.7 10 4.3
Trunk 13 37.2 54 60.6 16 21.3 83 35.8
Upper limbs 6 17.1 7 7.9 12 16.0 26 11.2
Lower limbs 9 25.7 17 19.1 33 44.0 99 42.7
Others 2 5.7 3 3.4 6 8.0 14 6.0
Total 100 100 100 100
Age, 50 years
Head and neck 17 28.8 45 31.5 33 27.0 30 19.6
Trunk 16 27.1 57 39.8 14 11.5 27 17.6
Upper limbs 8 13.6 16 11.2 22 18.0 29 19.0
Lower limbs 15 25.4 23 16.1 49 40.2 64 41.8
Others 3 5.1 2 1.4 4 3.3 3 2.0
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Bearing in mind that, in Figure 1, the y-axis scale is 4
times lower than that of incidence, melanoma mortality
from 1974 until 2007 did not parallel changes in incidence
rates. Melanoma mortality in Iceland mostly stayed slightly
below the rates observed in other Nordic countries and, from
1974 until 2007, remained quite stable around 1.0 and 1.4/
100,000 in women and in men, respectively.
Sunbed use
In 1979, there were only 3 sunbed salons in Reykjavik,
but their number increased rapidly and, in 1988, 56 facilities
offered cosmetic tanning with 207 sunbeds (1.5 beds/1,000
inhabitants). In 2004, a campaign was launched by the Ice-
landic health authorities to discourage sunbed use, focusing
particularly on teenage girls. In 2005, the number of pub-
licly available sunbeds in the Reykjavik area decreased to
144 and further decreased to 97 in 2008 (T. Sigurdsson,
personal communication, 2008).
The 2002 survey indicated that 70% of women and 35%
of men had used a solarium (9). Among users, 42% of
women and 30% of men reported a burn in a solarium. In
the 2001–2002 survey (8), 16% of women and 12% of men
aged 20–39 years had used a solarium more than 100 times
during their lifetime. In contrast, these proportions were 2%





























































Figure 3. Joinpoint (JP) analysis of cutaneous melanoma incidence






























ASR, Head and Neck





























ASR, Head and Neck
JP, Head and Neck
Figure 4. Joinpoint (JP) analysis of cutaneous melanoma incidence
in Iceland (1955–2007) by morphologic site for women (A) and for
men (B). ASR, age-standardized rate.
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Capacent-Gallup surveys done in the period 2004–2007 in-
dicated that, on average, 26% of the Icelandic population
had used a sunbed in the previous 12 months, representing
2.8 sessions per adult (16–75 years) per year (8). Among
teenagers, each year about 50% of girls and 30% of boys
used sunbeds in the last 12 months (T. Sigurdsson,
B. Sigurgeirsson, and J. H. Olafsson, personal communica-
tion, 2008).
Sun exposure
Travel abroad to more southern areas represents an im-
portant source of sun exposure for Icelanders. In 1970,
65,941 voyages abroad by Icelanders were recorded, and
this number steadily increased to 937,315 in 2006 (11). This
increase went uninterrupted without slowing in recent years.
In 2001–2002, 6% of women and 5% of men aged 20–39
years had travelled abroad 10 times or more during their
lifetime (10). In contrast, these proportions were 17%
among women and men aged 50 years or more.
DISCUSSION
This study had an ecologic design in which data were
compared at the population level rather than at the individ-
ual level. The number of cases is relatively low, owing to the
small population of Iceland. Ecologic correlation does not
imply causation, but we found that sunbed use likely played
an important role in affecting the melanoma incidence
trends observed in Iceland. This hypothesis is supported
by the sharp increase in incidence on the trunk in younger
women who also had the highest records of sunbed use,
which allows women to expose the trunk to UV radiation
without protection. It is further supported by the decline in
incidence in women observed after 2001, following the de-
cline in sunbed use. Sunbed use in Iceland often started
during the teen years, and the sharp increases in melanoma
incidence are in agreement with the estimates of increased
risk when sunbed use starts before approximately 35 years
of age (risk ¼ 1.75, 95% CI: 1.35, 2.26) (12, 13). As young
Icelanders have fewer cumulative trips abroad but higher
cumulative sunbed use than older Icelanders do, intermittent
sun exposure in more southern latitudes alone is a less plau-
sible explanation for increases in young men and women
after 1994.
Compared with midday sunlight on the Mediterranean
Sea, the UV radiation spectrum of sunbeds contains a greater
proportion of UV-A, and the UV radiation intensity of pow-
erful tanning units may be 10–15 times higher than that of
the midday sun (14, 15), leading to UV-A doses per unit of
time received by the skin during a typical tanning session
well above those experienced during daily life or even dur-
ing sunbathing. Such levels of repeated exposures to high
UV-A doses constitute a new phenomenon for human be-
ings. The whole UV radiation spectrum (including UV-A)
and UV-emitting tanning devices are now considered as
carcinogenic to humans (3). The Icelandic data also suggest
that the time lag between exposure and melanoma occur-
rence may be relatively short, in the order of a few years.
One possible hypothesis underlying a short lag time would
be the stimulation, by repeated high UV-A doses, of melano-
cytes in preexisting nevi that developed earlier during life.
The average of 2.8 sunbed sessions per year in 2004–2007
in Iceland (8) is around 3 times higher than that estimated
for the United Kingdom in 1996 (16) and around 2 times
higher than that estimated for Sweden in 2005–2006 (17,
18). Before 2000, in most light-skinned communities, the
increase in melanoma incidence in men was apparent
mainly on the trunk, followed by the head and neck. In
women, it was apparent mainly on the lower limbs (19).
As in Iceland, the increase in melanoma incidence in Swed-
ish women has been most pronounced on the trunk, and in
1996 the melanoma incidence on the trunk became equal to
the incidence on the lower limbs (20). In Northern Ireland,
incidence increases in men and women are more pro-
nounced for trunk melanoma (21). In the United Kingdom,
a rebound increase of melanoma incidence from 1998 on-
ward has been reported for women 20–39 years of age (16).
Other reasons for the increases in incidence have been
sought. No modification in cancer registration modalities
has occurred that can explain changes in incidence. A frac-
tion of the rising incidence may be due to markedly in-
creased awareness and screening for melanoma in Iceland,
initiated around 1990 by activities of the Icelandic Derma-
tological Association and the Icelandic Cancer Society.
However, a screening effect is not likely to be specific to
the female trunk.
The melanoma epidemic that occurred in 1987–1992 in
the Hunter district of New South Wales, Australia, did not
affect melanoma mortality, and it was concluded that the
epidemic consisted mainly of a nonmetastasizing form of
melanoma (22, 23). Likewise, because there is no efficient
treatment for metastatic melanoma, the absence of change in
melanoma death rates after 1974 in Iceland suggests that
most of the epidemic was due to a non–life-threatening form
of melanoma.
There is the possibility of synergistic effects between
early detection and sunbed use: Intense exposure to UV
radiation is known to induce changes in nevi appearance
(24, 25) that could lead to more visits to dermatologists
and to more excisions of suspicious pigmented skin lesions.
The low-background UV radiation and the high use of
sunbeds make Iceland an interesting place for studying the
effects of sunbed use on melanoma risk. A case-control
study investigating the relations between melanoma and
past sunbed use in Iceland has been envisioned, but the
population has been well informed about the dangers of
sun exposure and of indoor tanning (26, 27), which raises
issues of selection and recall bias. A follow-up study is de-
sirable, but several years will be needed before results be-
come available.
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UVB‐induced  skin  damage,  including  cancers  resembling  the  human  SCC. 
Epidemiological studies consistently showed that a history of sunburn was a risk 
factor for all skin cancers. UVB is about one thousand more erythemogenic than 
the UVA. Although UVB  represents  less  than 6% of  the  solar UV wavelengths 
reaching  the Earth’s  surface,  it  contributes  to  80%  of  sunburn  occurrence. The 
sun protection factor (SPF) was introduced in the 1980s as the standard indicator 
informing of the ability of the sunscreen to delay sun‐induced erythema. It was 






the  1980s  (reviewed  in  Autier  et  al,  1995),4  all  cosmetic  companies  ceased  to 
incorporate  5‐MOP  in  their  tanning  lotions  and  the  regulatory  bodies  of most 
countries banned commercialisation of such lotions. Notwithstanding, the French 
company Bergaderm succeeded in commercialising 5‐MOP sunscreens in France, 
Belgium  and  Greece.  The  rationale  for  5‐MOP  sunscreen  was  that  the 
acceleration  of  tan  acquisition was  deemed  to  increase  resistance  against UV‐
induced  DNA  damage.  Animal  experiments  tested  this  combination  of  UVB 
filters and 5‐MOP termed “photochemoprotection” and found results supporting 
the claim that these products could decrease the risk of skin cancer (Young et al, 
1988).  Furthermore,  sun  protection  provided  by  “photochemoprotection” 
seemed more  efficient  than when  a  regular  sunscreen was  used,  especially  in 




The  1992  IARC Monograph  briefly mentioned  sunscreens  in  an  appendix  and 
remained  rather  vague  on  their  usefulness  for  sun  protection.  One  sentence 
                                                 
4 The IARC classified the association of 8‐MOP plus UVA in group 1 carcinogens for humans in 
1987. 
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referred  to  5‐MOP  sunscreens  saying  that  their  “role  remained  controversial”. 
The appendix allocated only few sentences on findings by observational studies 
that  sunscreen  use  was  never  associated  with  decreased  melanoma  risk,  but 
rather  often  associated  with  moderate  increases  of  melanoma  risk.  The  1992 





Studies  backing  the  public use  of  5‐MOP  sunscreens were  the  target  of many 
criticisms  (e.g. Morrisson,  1990)  but  none  impressed  French, Belgian  or Greek 
regulatory authorities. The puzzling results on higher melanoma risk associated 
with sunscreen were also the target of criticism, as the hypothesis that sunscreen 
use does not prevent malignant melanoma  among  those whose  skin  is  highly 
exposed  to  sunlight  is  implausible  on  the  basis  of  animal  and  human models 
(Marshall et al, 2003). On methodological grounds, the two major critiques were 
on the influence of “residual confounding” and the “confounding by indication”. 
“Residual  confounding”  means  that  the  apparent  sunscreen‐melanoma 
association could be due to the effect of sun exposure or characteristics of natural 




The  confounding  by  indication  remains  an  intractable  threat  to  validity  in 
observational  studies  (Boscoe  et  al,  2009)  that  refers  to  the  fact  that  subjects 
taking or not  taking  a  specific  substance may differ  in  so many genuine ways 
that  it  is  practically  impossible  to  have  the  adequate  data  that  would  allow 
proper control of this confounding effect. In this respect, sunscreen users would 
be  subjects  at higher  risk of melanoma  than non‐users, because of greater  sun 











Many  tourists  from  diverse  origins  could  have  used  5‐MOP  sunscreens when 
visiting France or Greece; we therefore issued a warning and a recommendation 






control  study  of  1992‐93  found  that  the  use  of  sunscreen was  associated with 
higher melanoma risk (Autier et al, 1995). We performed more detailed statistical 
analyses  than prior studies, which showed  that whatever  the  level and  type of 
sun exposure or of sun sensitivity characteristics, sunscreen use was  invariably 
associated  with  increased  melanoma  risk.  Hence,  we  could  rule  out  the 
possibility  of  confounding  by  sun  exposure  or  by  natural  sun  sensitivity. 
However,  the  case‐control  design  was  unable  to  rule  out  the  possibility  of 
confounding by indication.  
 
Most  sunscreens are used when  sun exposure  takes place during  leisure  times 
and holidays, that is, during intermittent sun exposure sessions ‐ the type of sun 
exposure typically associated with melanoma occurrence. Further thinking led us 
to  notice  that  to  date,  most  basic,  clinical  or  epidemiological  studies  on  sun 







Acquire  melanocytic  nevi  result  from  the  monoclonal  expansion  of  single 
melanocytes. Common acquired nevi develop after birth and their number peaks 





objective  to  assess  how  past  sun  exposure  and  the  different  types  of  sun 
protection influenced their nevus counts.5 The study took advantage of the short 
                                                 













was  associated  with  lower  nevus  count;  both  relationships  followed  a  dose‐
response curve (Autier et al, 1998a).  
 
Fig. 3.1 - Sunscreen use, wearing clothes and nevi 
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This  finding  ruled  out  confounding  by  indication  because  subjects  wearing 






The  study  also  found  that  in  cases where higher quantities  of  sunscreen were 
used,  generally  fewer  clothes  were  worn  (Severi  et  al,  2002).  An  unexpected 
consequence  of  this  study  was  that  it  substantiated  the  fact  that  studies  that 
found  a  positive  association  between  sunscreen  use  and  melanoma  were 
probably  less  likely  to  be  published  than  studies  that  found  a  negative 
association. An example was the publication just after our own in 1998 of results 





The nevus  study  in  schoolchildren  convinced us  that  sunscreen use was a  risk 
factor for melanoma and that the risk was tightly bound to conditions associated 
with  their use. Sunscreens have no  carcinogenic properties by  themselves. The 
mechanism by which sunscreens could increase melanoma risk was suggested by 
H.  Beitner  and  co‐workers,  who  hypothesised  that  “[sunscreens]  allow 
individuals  with  poor  tanning  ability  to  spend  more  time  in  the  sun  than 
otherwise  possible”(Beitner  et  al,  1990).  The  likelihood  of  this  hypothesis was 
supported  by  the  common  observation  that  sunscreen use during  intermittent 
sun  exposure  behaviours  was  associated  with  exposure  of  longer  durations 
without decreases in sunburn occurrence (IARC, 2001; Autier et al, 2009). Indeed, 
nothing  warns  sunscreen  users  engaged  in  sunbathing  that  their  extended 
exposure  has  reached  UVB  doses  corresponding  to  their  specific  sunburning 
threshold. 
 





included  89  French  and  Swiss  paid  volunteers,  18‐25  years  of  age, who were 
willing  to  spend  their holidays  in  sunny  locations. The volunteers  ignored  the 
actual trial endpoint. They were randomly allocated to a group receiving a SPF 
10  sunscreen and a group  receiving a SPF 30  sunscreen. No  sign on  sunscreen 
bottles  informed on  the SPF, and  the  two sunscreens had  the same consistency 
and flavour. The main finding was a 25 to 30% increase of sunbathing duration 
in SPF 30 volunteers as compared to SPF 10 volunteers, without any difference in 
sunburn experience.  In 1998, we resumed a second  trial using exactly  the same 





In addition  to  extended  sun  exposure duration, a plethora of other  changes  in 
sun exposure behaviours was observed in the two trials, all consistently showing 
that  the SPF 30  sunscreen allowed greater  tolerance  to high  fluxes of UVB,  for 
example sunbathing in the midday sun (Figure 3.2). Sunbathing typically entails 
brisk  exposure  of  the  trunk  to  sunlight  and  trial  results  showed  that  in  the 
absence of sunscreen use,  this usually sun protected site would not stand  long 




                                                 
6 The two trials were supported by grants of the Europe Against Cancer programme of the European 
Commission. 
7 The devise and manufacturing of the UV-dosimeters was funded by the European Melanoma Group 
(EMG), a Belgian non-governmental organisation that supported researches on melanoma.  
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Fig. 3.2 – EORTC Randomised trials of 1997 and 1998: Subjects 
who used a SPF 30 sunscreen tended to start earlier their sun 
exposure, while the reverse was true for subjects who used the 
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intentional  sun  exposure  (IARC,  2001; Autier  et al,  2007; Autier, 2009). The non‐
intentional  sun  exposure  (NISE) pattern  represents  sun  exposure during daily 
life activities, without a special willingness to acquire a tan or to be able to spend 
a  long  time  in  the  sun.  The  so‐called  chronic  sun  exposure  pattern  usually 




The  intentional sun exposure  (ISE) pattern  is sun exposure with an  intention  to 
stay  in  the sun with  large uncovered skin areas, or/and  to acquire a  tan.  ISE  is 
characteristic of light‐skinned subjects who spend most of their daily life indoors 
but enjoy  intense sun exposure during holidays. The so‐called  ‘intermittent sun 





We  recently  performed  two  reviews  that  illustrated  the  relevance  of  the 
distinction  between  ISE  and  NISE  for  explaining  results  of  epidemiological 
studies  and  of  randomised  trials  with  sunscreens.  The  first  was  a  systematic 
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review of  all observational  and  randomised  studies on  sunscreen use  and  sun 






The  second  review  outlined  in  detail  the  main  findings  from  studies  on 
sunscreens and the proposed mechanisms by which sunscreen use for ISE could 
be  involved  in  melanoma  occurrence  (Autier,  2009).  We  also  improved  the 
definition of the “compensation mechanism” as the extra amount of time spent in 
the  sun  resulting  from  sunscreen use, until  sunburn occurrence. This extended 
period may  lead  to an accumulation of additional unfiltered UV  that might be 
involved  in melanoma occurrence. Compensation  increases with  increasing SPF 
and the quantity of sunscreen applied. Consequently, high SPF sunscreen during 





1.  The  combination  of  oral  intake  of  8‐MOP  or  of  skin  application  of  5‐MOP 
followed by whole body UVA  irradiation was  introduced  in  the  1970s  for  the 
treatment  of  severe  psoriasis  (Melsky  et  al,  1977;  Fitzpatrick &  Pathak,  1984). 






2.  The  associations we  found  between  sunscreen  use, wearing  of  clothes  and 
nevus  counts  were  confirmed  by  the  majority  of  studies  conducted  in 
schoolchildren or adolescents in Europe, Israel and Australia (Luther et al, 1996, 
Azizi  et  al,  2000;  Dulon  et  al,  2002;  Darlington  et  al,  2002;  Bauer  et  al,  2005; 
English et al, 2005;   Waschmuth et al, 2005), with  the exception of one study  in 















used a broad‐band  sunscreen had a  slightly  (but  statistically  significant)  lower 
count of nevi at  the end of  the  trial  (Gallagher et al, 2000). The effect however,  
was  confined  to  those  children with  numerous  freckles  ‐  a  known  hereditary 
characteristic associated with higher sun sensitivity. This trial did not typical of  
ISE situations. We expressed strong concern towards the statistical analysis used 
in  this  study,  judging  it  to  be  flawed.  The  analysis  had  no  adjustment  for  an 
imbalance  in major  confounding  factors at baseline, no  covariance analysis  for 





3.  The  randomized  trial  conducted  by  A  Green  and  co‐workers  in  Nambour 
(Queensland,  Australia)  demonstrated  that  regular  sunscreen  use  by  light‐








cancer  and  melanoma  in  older  subjects    are  caused  by  the  accumulation  of 
exposure to ultraviolet (UV) radiation and   the Nambour trial documented that 





up  to which point  the results of  this  trial are valid  for all circumstances during 
which  sunscreen  is used. The  first  question was  addressed  by Goldenhersh & 







why  melanoma  and  other  skin  cancer  incidence  is  about  5  times  higher  in 
Queensland  than  in  Northern  European  countries  (Coory  et  al,  2006).  The 
Nambour  trial  included  subjects  eager  to  protect  their  skin  against  harmful 
effects of the tropical sun, and most trial participants regularly adopted other sun 
protection method such as staying  in  the shade and wearing a hat when  in  the 
sun. In addition, sun exposure was similar between the daily and discretionary 
sunscreen  groups. Hence,  the Nambour  trial  took  place  in  the  context  of  non 
intentional  sun exposure  (NISE) and  the key  finding  is  that a  sunscreen use  is 
effective  for skin cancer prevention when  this use  is not a mean  to extend sun 






during non‐intentional  sun  exposure. However,  results of  this  trial  should not 
represent a green light for suggesting that unrestricted intentional sun exposure 
is  safe when  a  sunscreen  is  used.  People  should  rather  be warned  about  the 
possibility  that  extension  of  intentional  sun  exposure may  increase  the  risk  of 
melanoma.  Institutions active  in cancer prevention are urged  to be cautious on 
the  way  results  from  the  Nambour  trial  will  be  explained  to  the  public  and 
translated in public health recommendations.   
 
4. A  one‐week  randomised  trial was  organised  in  a  French  holiday  resort  for 
assessing sun exposure duration according to sunscreen use (Dupuy et al, 2005). 
Our re‐assessment of data published on  this  trial  found  that  in reality,  the  trial 





found  no  increased  risk  of melanoma  associated with  sunscreen  use  and  one 
meta‐analysis  found  an  increased  risk  (Geffeller  et  al,  2002). These  four meta‐
analyses  did  not  perform  sensitivity  analysis  as  we  did  for  sunbed  use  and 
melanoma  (IARC,  2006),  with  pooling  of  results  from  population  and  non‐
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population‐based  studies. Most  non  hospital‐based  observational  studies,  both 
case‐control  or  prospective  cohort  studies,  found  no  decrease  or  moderately 
increased risk of melanoma or basal cell cancer with sunscreen use. In contrast, 
the majority of hospital‐based studies found decreased melanoma risk associated 
with  sunscreen  use.  Finally,  because  of  evidence  that  publication  biases 
prevented the publication of unwanted results on sunscreen use and melanoma, 





1.  The  group  of  AR  Young  performed  new  experiments  and  found  that 
epidermal  tanning  with  or  without  furocoumarin  (the  chemical  family  of 
psoralens)  is not  effective  in preventing  skin  cancer  in  the nude mouse model 
(Kipp et al, 1998; IARC 2001).  
 
2.  There  is  mounting  evidence  that  facultative  tanning  induction  is  mainly  a 
consequence of UV‐induced DNA photodamage (Pedeux et al, 1998; Gilchrest & 
Eller, 1999; Cui et al, 2007). The rapid suntan acquisition after use of 5 or 8‐MOP 
is most  probably  due  to  their  unique mechanisms  of  action  that  considerably 
enhance  the DNA damage  induced by UVA wavelength. The respective role of 
UV and 5 or 8‐MOP in melanoma risk is impossible to assess in epidemiological 
studies.  Nonetheless,  taken  together  with  the  mechanism  of  action  of  these 
molecules,  the  epidemiological  data  demonstrates  that  UVA  may  react  with 
natural  photocarcinogenic  compounds  in  increasing  the  melanoma  risk.  Our 




3.  Sunscreen  supporters  typically  argue  that  new  sunscreen  formulations  can 
effectively  filter out both  the UVA and  the UVB radiation. The vast majority of 
sunscreen products are sold to subjects willing to enjoy ISE. Thus, the question is 
whether  the  generalisation  of  UVA‐UVB  blocking  agents  in  sunscreen 
formulation  is  likely  to  reduce  the  melanoma  risk  associated  with  ISE.  The 
answer is likely to be negative because the compensatory behaviour induced by 
sunscreen use  (Autier,  2009) will ultimately  lead  to  accumulation of UV doses 
capable of triggering a facultative tan, which is an indisputable marker that UV‐

























Sunscreen Use, Wearing Clothes, and Number of Nevi in
6- to 7-Year-Old European Children
Philippe Autier, Jean-Franc¸ois Dore´, Maria S. Cattaruzza, Franc¸oise Renard,
Heike Luther, Flaminia Gentiloni-Silverj, Ester Zantedeschi, Maura Mezzetti,
Isabelle Monjaud, Martine Andry, John F. Osborn, Andre´ R. Grivegne´e
For the European Organization for Research and Treatment of Cancer Melanoma
Cooperative Group
Background: Previous epidemiologic studies have suggested
that sunscreen use is associated with an increased risk of
melanoma skin cancer. Because high nevi (mole) count in
adults is a strong predictor of melanoma, we conducted a
study examining the number of nevi in 6- to 7-year-old Eu-
ropean children, according to their sunscreen use. Methods:
Whole-body and site-specific counts of nevi 2 mm or larger
were performed in 631 children in their first year of primary
school in four European cities. Independently, parents were
interviewed regarding sun exposure, sunscreen use, and
physical sun protection of their child. Results: After adjust-
ment for sun exposure and host characteristics (e.g., skin
phototype, eye color), the relative risk for high nevus count
on the trunk was 1.68 (95% confidence interval [CI] = 1.09–
2.59) for the highest level of sunscreen use and 0.59 (95% CI
= 0.36–0.97) for the highest level of wearing of clothes while
in the sun. The sun protection factor had no effect on nevus
counts despite a high median value of 17.4. Sunburn number
was not associated with nevus count. The highest risk asso-
ciated with sunscreen use was found among children who
had never experienced sunburn. Conclusions: In white, Eu-
ropean children, sunscreen use appears to be associated with
development of nevi, probably because it allows longer sun
exposures. Wearing clothes may be an effective way to pre-
vent proliferation of nevi. Since a high nevus count is a
strong predictor of melanoma, sunscreen use may be in-
volved in melanoma occurrence because it may encourage
recreational sun exposure. [J Natl Cancer Inst 1998;90:
1873–80]
Since 1982, evidence has developed about the association
between sunburn and skin cancers (1,2). Sunscreens are able to
delay sunburn occurrence, and experiments in rodents and in
humans have shown that sunscreens could prevent solar-induced
skin lesions, including nonmelanoma cancers (3–7). Therefore,
these products have been widely advocated for the prevention of
skin cancers (8). The ability of sunscreens to retard ultraviolet-
induced skin reddening is called the sun protection factor (SPF).
It is believed that the higher the SPF, the more efficient the
protection against cancer. Also, high SPF sunscreens (i.e., 15 or
higher) are capable of removing some of the ultraviolet A ra-
diation; now, specific blocking agents for ultraviolet A radiation
are incorporated in many sunscreens, mainly in those recom-
mended for children.
In contrast, epidemiologic studies have not only failed to
show any decrease in melanoma risk associated with sunscreen
use but also suggested sunscreen use to be a determining factor
for an increased risk of melanoma (9). That increased risk was
also found with basal cell carcinoma of the skin (10–12). Hence,
doubts have been cast on the efficacy of sunscreens to prevent
melanoma. However, most epidemiologic studies reported before
have collected data mainly related to earlier sunscreens of low SPF,
and assessment of past sunscreen use may not have been accurate.
Most nevi are acquired (13), and their development in chil-
dren is influenced by sun exposure (14–16). Because high nevus
count in adults is a strong predictor of melanoma (17), we con-
ducted a study examining the number of nevi in 6- to 7-year-old
European children according to sunscreen use. Studying young
children should enable a better examination of the latest genera-
tion of high-SPF sunscreens and help to reduce memory bias,
since only a few recent years of exposure are considered. Fur-
thermore, sun exposure during early life seems to represent a key
determinant for melanoma occurrence during adulthood (18).
SUBJECTS AND METHODS
Study Design
The study was conducted during the period from October 1995 through Feb-
ruary 1997 in elementary schools of Brussels, Bochum, Lyons, and Rome.
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Brussels is situated in a temperate climate, Bochum and Lyons in a semiconti-
nental climate, and Rome in a Mediterranean climate. The protocol was accepted
by ethics committees of the Jules Bordet Institute (Brussels, Belgium), St. Josef
Hospital (Bochum, Germany), Centre Le´on Be´rard (Lyon, France), and Institute
of Hygiene, University ‘‘La Sapienza’’ (Rome, Italy). The study design has been
described elsewhere (9). The study comprised the following two independent
components: 1) count of nevi in Caucasian children during their first year of
primary school (6–7 years old) and 2) interview of parents about sun exposure
history, physical protection, sunscreen use, and sunburn history of their child.
Skin examiners and interviewers had no contact and remained unaware of the
findings of each other. School administrators, teachers, parents, and interviewers
were carefully blinded about the study hypothesis and about nevus counts of
children.
In each city, schools of different socioeconomic profile were chosen to avoid
clustering of risk factors. In schools where directors gave permission, parents of
all children in their first year of primary school were invited to participate in the
study, regardless of their ancestry and ethnic background. Written informed
consent from the parents was obtained before children were examined.
Count of Melanocytic Nevi
Skin examinations took place in schools. Hair and eye color were assessed by
examiners. Counting of nevi followed guidelines developed by English et al.
(19). In each study site, all children were examined by the same physician trained
for the recognition of skin pigmented lesions. A nevus was defined as any brown
or black pigmented macula or papule darker in color than the surrounding skin,
having one dimension of at least 2 mm. Counting of nevi was done by use of
transparent plastic slides pierced with a 2-mm hole. Like other researchers (20),
we made no special effort to differentiate between nevi and solar lentigines,
which are rare in children and generally of small size. The scalp was not ex-
plored, but attention was given to the border between head and neck skin and the
hair. The genital area and buttocks were not examined. Because some children
wore large underclothes ample enough to hide nevi, the upper limit for nevus
counting was set at the anterosuperior iliac spine and the lower limit at the bend
of the buttocks. The density of freckles on the face, on both arms, and on the
shoulders was assessed by use of standard freckling charts.
Interviews of Parents
Home interviews of parents were performed by nonmedical, trained, female
interviewers. The principal goal of the interview was to reconstruct the history
of sun exposure, sun protection, and sunburn experience from birth to the mo-
ment of the skin examination. The most frequent setting for sun exposure and
sunscreen use was holidays. A ‘‘holiday period’’ was defined as any period of
5 days or more outside the parents’ home(s). For each holiday period, the
following questions were systematically asked: (a) During which year(s) and
month(s) did holidays take place? (b) How many weeks did they last? (c) Place
and latitude? [Latitude was derived from a geographical map inserted in the
questionnaire.] (d) Was the weather sunny? (e) Did the child go in the sun? (f)
Did the child go outside during the hot hours of the day? (g) When in the
sunlight, did the child wear a shirt? (h) When in the sunlight, did the child wear
trousers? (i) Could the child go naked or almost naked in the sun? (j) Was a
sunscreen applied on the child’s skin? (k) What was the SPF indicated on the
sunscreen bottles? If different sunscreens were used during a holiday period,
SPFs of initial, second, and eventual third sunscreen were recorded.
For questions (d) to (j), answers were collected in a semiquantitative way
according to four or five categories, e.g., from ‘‘never’’ to ‘‘always.’’ Another
section of the questionnaire inquired about the sun exposure, the sunscreen use,
and other sun protection methods during periods that were not holidays (e.g.,
when at home in the garden).
Questions on sunburns were in a separate section, inquiring about all sunburn
episodes from birth to the moment of the skin examination. A sunburn episode
could occur during a holiday period or during a sunny day in the garden. For
each sunburn episode, body sites involved as well as sunburn-induced pain or
fever were recorded. Questions about the country of birth of both parents and
grandparents were asked, so that the Caucasian origin of the children could be
assessed. During the course of the interview, the skin phototype of the child,
according to the Fitzpatrick classification (21), was determined as follows: Chil-
dren with skin phototype I were those who never tanned but always sunburned
when going unprotected in the sun for the first time during the year; children
with skin phototype II were those who first sunburned but got a tan after;
children with skin phototype III were those who rarely sunburned and always got
a deep tan after; and children with skin phototype IV were those who always
tanned and never sunburned.
Construction of Exposure Indexes
Synthesis of data was done by the construction of exposure indexes. For sun
exposure, we first made a selection between holiday periods, excluding those
during which there had been no sunny weather or those during which the child
did not go outside. All reported holiday periods represented a total of 15 026
7-day weeks, 14 512 (97%) of which satisfied both conditions, which repre-
sented a mean of 23 sunny holiday weeks per child (range 4 0–138 weeks).
The sun exposure during a given holiday period was computed as the duration
multiplied by the intensity of sun exposure. Duration was calculated as the
‘‘number of holiday weeks’’ multiplied by the ‘‘amount of sunny weather.’’
Intensity was calculated as ‘‘the latitude of holiday area’’ multiplied by the
‘‘child having been in the sun’’ multiplied by ‘‘the child could go outside during
the hot hours of the day.’’ Then, for each child, the sun exposure experiences
were summed across all holiday periods in order to yield the ‘‘sun exposure
index’’ that was then divided in tertiles.
The sunscreen use during a given holiday period was reported as ‘‘never,’’
‘‘sometimes,’’ ‘‘often,’’ and ‘‘always.’’ An arbitrary value of 0, 1, 2, and 3 was
given to each reported sunscreen use, respectively, and these values were
summed across all holiday weeks to yield the ‘‘total sunscreen use.’’ Children
who never used sunscreens were set as the referent category. The remaining
children were classified in tertiles. ‘‘Total sunscreen use’’ encompassed the time
dimension of exposure to sunscreens but did not provide information about the
amount of sunscreen used during a typical holiday week. Thus, we also com-
puted the ‘‘average sunscreen use’’ as the total sunscreen use divided by the total
number of holiday weeks. Children were classified in the categories ‘‘never,’’
‘‘rare,’’ ‘‘sometimes,’’ ‘‘often,’’ and ‘‘always’’ when their average sunscreen
use was equal to 0, greater than 0 and less than 1, greater than 1 and less than
2, greater than 2 and less than 3, and equal to 3, respectively.
SPF of sunscreens was averaged across all holiday weeks during which sun-
screens were used. The SPF of the first sunscreen used was utilized, since the
SPFs of first, second, and eventual third sunscreen used were highly correlated
(Pearson’s product–moment correlation coefficient r>.90). When a responder
did not remember the exact SPF of a sunscreen used but only if the sunscreen had
a low, moderate, or high ability to protect against ultraviolet radiation, the SPF
of ‘‘low or moderately protective’’ sunscreen was set to 8, and the SPF of a
‘‘highly protective’’ sunscreen was set to 15. If, for a given holiday period, a
responder reported sunscreen use but could not remember if it was a low,
moderate, or highly protective sunscreen, then the average SPF used by the child
was assigned a default value.
Wearing a shirt was almost always accompanied by the wearing of trousers
(Pearson’s product–moment correlation coefficient r 4 .90). Similar to average
sunscreen use, the wearing of clothes was computed as the summation across all
holiday weeks of the reported wearing of shirt or trousers and then divided by the
total number of holiday weeks. Categories were defined according to possible
answers in the questionnaire.
Statistical Analysis
Similar to other studies of nevi in children (14–16), the distribution of nevi
was skewed to the right. Therefore, univariate analysis used the nonparametric
Kruskal–Wallis test.
The adjustment for confounders was done by use of Poisson regression. How-
ever, a Poisson distribution assumes equal mean and variance. The mean and
variance of the distribution of nevi were not equal. We, therefore, used Poisson
models with extra-Poisson variation. Taking into account extra-Poisson variation
does not modify parameter estimates (i.e., the relative risks [RRs]) but confi-
dence intervals (CIs) are wider. In a first step, modeling considered partial
regression equations that included the sex, the study place, the skin phototype,
and the eye color together with one of the three following variables: sun expo-
sure, total sunscreen use, and wearing of clothes. In a second step, full models
that included all of the seven aforementioned variables were fitted. Modeling
was done by use of the GENMOD module of the SAS statistical package (SAS
Institute Inc., Cary, NC; 1997).
The Pearson’s product–moment correlation coefficient was used to provide a
numerical indicator of the strength of the relationship between exposure vari-
ables. All P values resulted from use of two-sided statistical tests.
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RESULTS
Parents who agreed to participate represented 682 (55%) of
the 1234 apparently eligible children approached. Fifty-one chil-
dren were eliminated from the study because the child was not
of Caucasian origin, the skin examination was not performed
(e.g., the child was not willing to be examined), or the parents
could not be reached for the interview. The participation rate
was about the same in all schools, and there was no difference in
sex distribution between participants and nonparticipants. The
final sample comprised 631 children (321 boys and 310 girls).
Mothers were present during 93% of interviews, and the re-
sponder was not the mother or the father for four children.
The median number of nevi 2 mm or larger was six (range 4
0–82). Propensity to get sunburns was the host characteristic that
best predicted the nevus count; the median numbers for skin
phototypes IV, III, II, and I were 4, 8, 8, and 8.5, respectively
(Kruskal–Wallis test; P<.001). Nevus count was not associated
with hair color (data not shown); however, for eye color, the
median total nevus count was five in children with dark eyes,
seven if their eyes were hazel or green, and seven if their eyes
were blue or gray (Kruskal–Wallis test; P<.001).
Determinants of Sunscreen Use
Thirty-four (5%) of 631 children had never used sunscreens.
Half of the children who ever used a sunscreen received a prod-
uct of higher SPF than that used by their parents, and one quarter
of the parents stated that they had bought sunscreens specifically
recommended for children.
If sunscreens were used during 12 965 (89%) of the 14 512
holiday weeks, the quantity of sunscreen used during holiday
weeks could greatly vary; i.e., the best predictor of average
sunscreen use was the possibility to go naked (or almost naked)
in the sun, whereas there was an inverse relationship between
average sunscreen use and wearing clothes when being in the
sun. Because of the highly variable quantity of sunscreen used
during the holiday weeks, there was a poor association between
the sun exposure index and average sunscreen use. Average
sunscreen use was associated with the skin phototype (with in-
creasing use from skin phototype IV to I) and a positive history
of sunburn episode.
SPF of sunscreens was not known for 2% of holiday periods
during which sunscreens were used. For children who ever used
sunscreens, the median SPF was 17.4. That median SPF re-
mained constant over the past 6 years. The median SPF in-
creased with higher susceptibility to sunlight, from 15.0 in chil-
dren with skin phototype IV to 19.5 in children with skin
phototype I (Kruskal–Wallis test; P<.001).
Sunscreen Use and Nevus Count
In all study places, the median numbers of nevi tended to
increase with total or average sunscreen use during holiday pe-
riods, whereas the reverse was true for wearing clothes while in
the sun (Table 1).
Median nevus counts increased with both increasing sun ex-
posure and average sunscreen use (Table 2). Adjusted RRs de-
rived from Poisson regression models allowed us to remove the
effect of skin phototype and of eye color on nevus counts. An
RR indicates the likelihood of having an increased number of
nevi as compared with a referent category in which the exposure
of interest is minimal. Risk for higher nevus count increased
with both increasing sun exposure and sunscreen use, and the
increase in risk was more pronounced on the trunk. When the
sun exposure index was high, children who often or always used
sunscreens had a nevus number about two times greater than
children who never used a sunscreen. In contrast, when sun
exposure index was low, the increase in nevus count with in-
creasing sunscreen use was much less pronounced and never
reached statistical significance. The effect of a given amount of
sun exposure (i.e., low, intermediate, or high) on nevus number
was dependent on the amount of sunscreen use.
Table 3 displays results from Poisson regression models ap-
plied on nevus counts on the trunk (an intermittently sun-
exposed body area) and on the head and neck (a chronically
sun-exposed body area). In partial models, the sun exposure
index was a marked risk factor for trunk nevus counts. Head and
neck nevus numbers seemed unaffected by sun exposure. Total
sunscreen use was positively associated with trunk nevus counts.
A trend was noticeable between sunscreen use and head and
neck nevus counts, although no RR reached statistical signifi-
cance (i.e., unity not included in the 95% CI). A negative rela-
tionship between nevus count and wearing clothes emerged,
with the highest effect on the trunk. The changes in RRs between
the partial and the full models provided the most important
information; i.e., on the trunk, the risks associated with total
sunscreen used decreased but remained significant with consis-
tent dose–response trends. The effect of the sun exposure index
substantially decreased and was no longer significant. The pro-
tective effect of wearing clothes became more apparent with
maximal effect on the trunk and the apparition of a consistent
dose–response trend. Because wearing clothes while in the sun
was inversely correlated to sunscreen use, this latter variable
negatively confounded the association between physical sun
protection and lower nevus count.
The joint influence of sunscreen use and SPF is examined in
Table 4. RRs increased with increasing average sunscreen use,
but no change was observed with increasing average SPF.
We also examined the influence of sunscreen use during pe-
riods other than the holidays. Habits of sun exposure, sunscreen
use, and other sun protection methods during holiday and non-
holiday periods were highly correlated. To minimize the effects
of sunscreen use and of sun exposure during holidays, we re-
stricted the analysis to the 189 children who reported a total of
fewer than 12 sunny holiday weeks. In those children, the use of
a sunscreen during recreational sun exposure at home was as-
sociated with a higher risk of whole-body nevus count (RR 4
1.46; 95% CI 4 1.14–1.89) after adjustment for sex, eye color,
skin phototype, study site, and average sunscreen use during the
holiday weeks. Last, after adjustment for skin phototype and
recent sun exposure, the density of freckles on the face, the arms,
and the shoulders was statistically significantly higher (i.e., unity
not included in the 95% CI) in children who had used sunscreens
during the last year.
Sunburns and Nevus Count
Sunburns were reported in 340 children (54%), who experi-
enced a total of 583 sunburn episodes. Eighty-eight percent of
these episodes occurred during the holiday periods. Table 5
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shows site-specific risk for nevus number according to number
of site-specific sunburns. Although shoulders were by far the
most frequently affected area, nevus count in that area was mini-
mally influenced by the number of sunburns. The same lack of
influence holds true for the head and neck. Only nevus count on
the trunk (shoulders not included) seemed to increase with sun-
burn experience, but successive adjustments decreased the effect
of sunburns on that body site. The first sunburn episode occurred
before 3 years of age in 20% of children with a positive sunburn
history; 23% of all episodes were painful, and fever occurred in
3%. No association was found between nevus count and these
last three factors (data not shown).
Sunburns, Sunscreen Use, and Nevus Count
Fig. 1 suggests a more complex relationship between sun-
burns and nevi. Positive sunburn history first seemed to increase
nevus count; however, as sunburns became numerous, the nevus
count tended to decrease. To explore this phenomenon, we
cross-tabulated total sunscreen use with sunburn experience
(Table 6). Compared with the results in Table 3, the risk levels
associated with sunscreen use were highest if there was no sun-
burn experience. Among children with low total sunscreen use,
an increased number of sunburns seemed to increase nevus
count. Among children with numerous sunburns, increasing sun-
screen use was associated with lower nevus count. For children
with both high sunscreen use and at least three sunburn episodes,
the RR for higher nevus count was about the same as for children
without sunburn experience and who never used a sunscreen.
These results indicated a strong negative interaction between the
effect of sunscreen use and sunburn experience on nevus count,
on both additive and multiplicative scales (P<.001 for the mul-
tiplicative interaction).
Table 7 helps to interpret these intriguing data. Relative to
children free of sunburn experience, children with a history of at
least three sunburn episodes were more sun sensitive (i.e., skin
phototype I–II), had less occasions to go naked in the sunlight,
and were more likely to wear clothes when in the sun. Children
with highest RRs in Table 6 presented a similar high frequency
of having gone naked in the sun and of low physical sun pro-
tection. In contrast, children with both high sunscreen use and at
least three sunburn episodes seemed less likely to have gone
naked in the sunlight and tended to benefit more from physical
protection.
DISCUSSION
Our results provide evidence that sunscreen use is involved in
proliferation of nevi, whereas wearing clothes in the sun pre-
vents the sun-induced development of nevi. Similar associations
between nevus counts and sunscreen use in children were pre-
viously reported (16,22), but no adjustment for sun exposure had
been made.
Our participation rate was comparable to the rates reported by
















Never 34 6.0 2.0 2.0 4.0 3.5
Low 180 11.0 6.0 4.0 7.0 6.0
Intermediate 213 12.0 8.0 2.0 8.0 6.0
High 204 11.0 10.0 4.5 9.0 8.0
P† .045 .004 .095 .062 <.0001
Average sunscreen use‡
Never 34 7.0 1.0 2.0 4.0 3.5
Rare 84 9.0 4.0 3.0 7.5 5.0
Sometimes 157 9.0 4.0 2.0 9.0 6.0
Often 214 11.0 3.0 2.5 9.0 6.0
Always 142 13.0 3.0 7.0 8.5 9.5
P .023 .032 .093 .23 .0003
Average wearing of clothes§
Never 17 12.0 —\ —\ 8.0 8.0
Rare 124 15.0 7.0 4.0 9.0 8.0
Sometimes 438 11.0 3.0 2.5 8.0 6.0
Often 52 9.0 2.0 1.0 0.0 6.0
P .31 .13 .33 .033 .01
*Estimate of the total quantity of sunscreen used from birth to the moment of the skin examination. This esimate was computed as the summation across all holiday
weeks of the reported sunscreen use, using an arbitrary value of 0, 1, 2, and 3 attributed to the possible answers to that question, i.e., ‘‘never,’’ ‘‘sometimes,’’
‘‘often,’’ and ‘‘always.’’ Children who ever used sunscreens were classified in tertiles.
†P values were determined from Kruskal–Wallis statistical test.
‡Estimate of the average quantity of sunscreen used during a typical holiday week from birth to the moment of the skin examination. This estimate was computed
as the ‘‘total sunscreen use’’ divided by the total number of holiday weeks. Children were classified in the categories ‘‘never,’’ ‘‘rare,’’ ‘‘sometimes,’’ ‘‘often,’’
and ‘‘always’’ when their ‘‘average sunscreen use’’ was equal to 0, greater than 0 and less than 1, greater than 1 and less than 2, greater than 2 and less than 3,
and equal to 3, respectively.
§Estimate of the average wearing of shirt or trousers during a typical holiday week from birth to the moment of the skin examination. Similar to ‘‘average
sunscreen use,’’ it was computed as the summation across all holiday weeks of the reported wearing of clothes and then divided by the total number of holiday weeks.
Categories were defined according to possible answers in the questionnaire.
\No children in these categories.
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most other studies of nevi in children (15,16,22–24). Because
parents, teachers, and school administrators were blind to the
study hypothesis, it is highly improbable that the decision to
participate in the study could have been influenced by the
amounts of sunscreen used or the nevus count. It is, thus, hardly
credible that all presumed protective properties of sunscreens
would have been concentrated in the nonparticipants. Interob-
server variability could account for a portion of the differences
in nevus counts between study places. However, nevus counts in
Bochum were equivalent to those obtained during a previous
study (22) in a similar population of children. Interobserver vari-
ability is unlikely to have changed the trends observed because
1) in each study place, data were consistent with sunscreen use
being associated with higher nevus number and, 2) there is no
reason to believe that correct ranking of children according to
their nevus count was not preserved.
We also performed statistical analysis with the use of logistic
regression methods (using children in the second or third tertile
of the nevus distribution as an end point) or least-square regres-
sion approaches (logarithm of the nevus number as end point).
The Poisson regression method yielded more conservative re-
sults than did the two other methods.
Did our study correctly assess sun exposure? In European
populations, intermittent sun exposure is regarded as the sun
exposure pattern most implicated in melanoma occurrence (25),
and sunburns are indicators of intermittent sun exposure pattern
Table 2. Sun exposure, sunscreen use, and number of nevi in 631 European
children 6–7 years old
Average sunscreen use when
in the sun during holidays*
Sun exposure index†
Low Intermediate High
No. of children in each category
Never 16 10 8
Rare/sometimes‡ 76 72 93
Often 56 79 79
Always 57 52 33
Median whole-body No. of nevi, RR of higher nevus count, and 95% CI§
Never 3.0 1.5 5.5
1.00\ 0.57 1.05
— 0.21–1.55 0.47–2.38
Rare/sometimes 4.0 6.5 7.0
1.15 1.49 1.26
0.70–1.92 0.91–2.44 0.77–2.06
Often 4.0 6.0 8.0
1.13 1.20 1.70
0.67–1.92 0.73–1.98 1.01–2.70
Always 9.0 9.0 10.0
1.32 1.44 2.13
0.80–2.19 0.87–2.39 1.28–3.54
Median No. of nevi on the trunk, RR of higher nevus count, and 95% CI§
Never 1.0 1.0 2.5
1.00\ 0.61 1.29
— 0.20–1.87 0.54–3.05
Rare/sometimes 2.0 2.0 3.0
1.16 1.36 1.42
0.65–2.09 0.77–2.50 0.81–2.51
Often 2.0 2.0 4.0
1.22 1.24 1.96
0.67–2.22 0.69–2.21 1.12–3.44
Always 3.0 4.0 4.0
1.39 1.55 2.44
0.77–2.50 0.86–2.78 1.36–4.39
*Estimate of the average quantity of sunscreen used during a typical holiday
week from birth to the moment of the skin examination. This estimate was
computed as the ‘‘total sunscreen use’’ divided by the total number of holiday
weeks. Children were classified in the categories ‘‘never,’’ ‘‘rare,’’ ‘‘some-
times,’’ ‘‘often,’’ and ‘‘always’’ when their ‘‘average sunscreen use’’ was equal
to 0, greater than 0 and less than 1, greater than 1 and less than 2, greater than
2 and less than 3, and equal to 3, respectively.
†Computed as the duration (in weeks) multiplied by the intensity of sun
exposure during the different holiday periods, summed across all holiday peri-
ods, and then divided in tertiles.
‡Categories ‘‘rare’’ and ‘‘sometimes’’ of Table 1 were collapsed to allow
sufficient numbers of children in each ‘‘average sunscreen use’’ by ‘‘sun expo-
sure index’’ category.
§Adjusted for sex, study site, skin phototype, and eye color; RR 4 relative
risk; CI 4 confidence interval.
\Referent category.
Table 3. Relative risk (RR) for number of nevi 2 mm or larger associated
with variables related to sun exposure in 631 European children 6–7 years old
Variable










Low\ 1.00 1.00 1.00 1.00
— — — —
Intermediate 1.09 0.98 1.13 1.06
0.90–1.31 0.80–1.19 0.91–1.41 0.84–1.34
High 1.45 1.20 1.09 0.98
1.21–1.74 0.97–1.49 0.86–1.37 0.75–1.29
Total sunscreen use¶
Never\ 1.00 1.00 1.00 1.00
— — — —
Low 1.26 1.25 1.33 1.28
0.83–1.92 0.81–1.93 0.80–2.22 0.75–2.17
Intermediate 1.36 1.28 1.41 1.32
0.90–2.06 0.83–1.97 0.85–2.35 0.77–2.26
High 1.91 1.68 1.56 1.48
1.27–2.88 1.09–2.59 0.94–2.60 0.86–2.54
Average wearing of clothes¶
Never\ 1.00 1.00 1.00 1.00
— — — —
Rare 1.13 0.96 1.08 0.97
0.76–1.70 0.64–1.45 0.63–1.85 0.55–1.70
Sometimes 0.90 0.79 0.99 0.92
0.60–1.35 0.53–1.20 0.58–1.68 0.53–1.59
Often 0.61 0.59 0.73 0.72
0.37–1.01 0.36–0.97 0.40–1.37 0.38–1.35
*Estimate of the total quantity of sunscreen used from birth to the moment of
the skin examination. This estimate was computed as the summation across all
holiday weeks of the reported sunscreen use, using an arbitrary value of 0, 1, 2,
and 3 attributed to the possible answers to that question, i.e., ‘‘never,’’ ‘‘some-
times,’’ ‘‘often,’’ and ‘‘always.’’ Children who ever used sunscreens were clas-
sified in tertiles. Trunk includes shoulders.
†Partial model: RRs and 95% confidence intervals (CIs) were derived from a
Poisson regression model including one of the three variables (sun exposure
index or total sunscreen use or average wearing of clothes) plus sex, study place,
eye color, and skin phototype.
‡Full model: RRs and 95% CI were derived from a Poisson regression model
including all three variables plus sex, study place, eye color, and skin phototype.
§Computed as the duration (in weeks) multiplied by the intensity of sun
exposure during the different holiday periods, summed across all holiday peri-
ods, and then divided in tertiles.
\Referent category.
¶Estimate of the average wearing of shirt or trousers during a typical holiday
week from birth to the moment of the skin examination. Similar to ‘‘average
sunscreen use,’’ it was computed as the summation across all holiday weeks of
the reported wearing of clothes and then divided by the total number of holiday
weeks. Categories were defined according to possible answers in the question-
naire.
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(2). In our study, each year, a child had an average of 4 weeks
of sunny holidays, during which 88% of the sunburn episodes
occurred. Thus, it seems that the greater part of the intermittent
sun exposure experienced by European children takes place dur-
ing these holiday periods. Also, sun exposure and sun protection
attitudes during holiday and non-holiday periods were highly
correlated. Hence, the sun exposure index that we used may be
considered as a valid reflection of the sun exposure experienced
by young, European children.
The effects of sunscreen use on nevus number cannot be
explained by underlying host characteristics fostering both sun-
screen use and proliferation of nevi. There is always the possi-
bility of an unknown confounder. But given the magnitude of the
observed effect of sunscreen use on nevus counts, such a con-
founder should be strongly associated with both sunscreen use
and nevus number and would have been identified by the nu-
merous epidemiologic studies performed on skin cancers and
nevi during the past 20 years.
The marked effect of sunscreen use on RRs associated with
sun exposure in Tables 2 and 3 indicates that a substantial part
of all sun exposure was rendered possible by the use of sun-
screens. Reciprocally, the decrease in RRs associated with sun-
screen use observed in Table 3 indicates that the risk conveyed
by sunscreen use proceeds from the possibility of longer sun
exposure. Because nevus count is the strongest host factor pre-
dicting melanoma and because nevi share many common epide-
miologic and biologic similarities, our findings could apply to
melanoma.
As suggested by Bech-Thomsen and Wulf (26), could our
results be due to application of insufficient quantities of sun-
screens? If so, it is difficult to understand why nevus counts
increased with increasing average sunscreen use. Also, this ar-
gument would assume that if an insufficient quantity of sun-
screen is present on the skin, the ultraviolet-induced develop-
ment of nevi is not inhibited. We are aware of no experimental
data supporting the plausibility of such a hypothesis.
The SPF had no effect on occurrence of nevi. SPF measure-
Table 4. Relative risk (RR) for number of nevi 2 mm or larger on the trunk




















Rare 1.05 1.10 1.33 1.03 0.37
Sometimes 1.33 1.66\ 1.29 0.88 1.22
Often 1.10 1.93\ 1.29 1.39 1.98\
Always 2.03\ 1.21 2.24\ 1.39 1.90\
*Adjusted for sex, study place, skin phototype, eye color, sun exposure index,
wearing of clothes while being in the sun, and number of sunburns.
†Estimate of the average quantity of sunscreen used during a typical holiday
week from birth to the moment of the skin examination. This estimate was
computed as the ‘‘total sunscreen use’’ divided by the total number of holiday
weeks. Children were classified in the categories ‘‘never,’’ ‘‘rare,’’ ‘‘some-
times,’’ ‘‘often,’’ and ‘‘always’’ when their ‘‘average sunscreen use’’ was equal
to 0, greater than 0 and less than 1, greater than 1 and less than 2, greater than
2 and less than 3, and equal to 3, respectively.
‡Average SPF was never lower than 4.
§Referent category.
\Lower bound of 95% confidence interval does not include 1.00.
Table 5. Site-specific relative risk (RR) for number of nevi 2 mm or larger according to site-specific number of sunburns*
Head and neck Shoulders Arms Trunk Legs
No. (%) of children with ø1 sunburn on
the site
114 (18) 238 (38) 48 (8) 60 (9) 29 (5)
Total No. of sunburns on the site 187 351 69 85 41
Sunburn episodes in which the site was
involved, %
32 60 12 15 7
Variables in the Poisson regression model
Site-specific sunburns, sex, study place 1.16† 1.19 1.16 1.41 0.92
0.93–1.46 0.97–1.45 0.94–1.43 1.08–1.83 0.67–1.27
Site-specific sunburns, sex, study 1.11 1.15 1.15 1.36 0.91
place, sun exposure index, total
sunscreen use
0.89–1.40 0.94–1.40 0.92–1.42 1.04–1.77 0.66–1.26
Site-specific sunburns, sex, study 1.00 1.05 1.09 1.26 0.84
place, sun exposure index, total
sunscreen use, skin phototype
0.80–1.27 0.86–1.30 0.88–1.35 0.97–1.64 0.61–1.17
*583 sunburn episodes were reported, but one episode could involve more than one body site.
†RRs and 95% confidence intervals associated with body site-specific number of sunburns included in the model as a continuous variable. The referent category
are children without sunburn on the site.
Fig. 1. Sunburn number and nevi count.
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ment in the European community follows standardized proto-
cols. Although errors may have occurred in SPF reporting, it is
difficult to consider misclassification of SPFs as the only re-
sponsible factor for the total absence of effect on nevus counts
when large quantities of high-SPF sunscreens were used. The
most probable explanation is that SPF is not related to the bio-
logic phenomena implicated in formation of nevi and, by exten-
sion, to occurrence of melanoma.
Armstrong et al. (27) found quite a similar association pattern
between sunburns and nevus count as described in Fig. 1. In our
study, highest nevus counts were found among children free of
sunburn experience and who used large quantities of sunscreens
or among children with numerous sunburns and low sunscreen
use. We already described such a negative interaction in a study
on melanoma (28). In that study, melanoma risk was highest
when sunscreen use was coupled with absence of sunburn ex-
perience. A possible explanation for the negative interaction
observed in children is that some parents confronted with the
high sunburn frequency of their children adopted the whole sun
protection panoply. It is difficult to ascertain whether these par-
ents made a difference between the various sun-protection meth-
ods; however, in view of the data, it seems that, in that subgroup
of children, high sunscreen use represented a marker of adoption
of effective sun-protection methods, such as wearing clothes or
avoiding going naked in the sun. In contrast, it is probable that
the children with numerous sunburns who did not benefit from
effective sun-protection methods experienced further ultraviolet
irradiation that resulted in higher nevus counts. These findings
Table 6. Sunscreen use, sunburn, and relative risk for number of nevi 2 mm
or larger on the trunk*
Total sunscreen use†
Sunburn episodes on the trunk‡
Never 1–2 ø3
No. of children in each category
Never 25 9 0
Low 89 77 14
Intermediate 87 98 28
High 90 91 23
Relative risk and 95% confidence interval for nevi count
Never 1.00§ 1.77\ —
— 0.80–3.95
Low 1.32 1.57 3.91
0.78–2.22 0.91–2.71 1.92–7.96
Intermediate 1.59 1.41 2.22
0.94–2.66 0.83–2.40 1.16–4.26
High 2.21 1.89 1.21
1.33–3.67 1.11–3.22 0.59–2.49
*Shoulders included for both sunburn and nevus counts.
†Estimate of the total quantity of sunscreen used from birth to the moment of
the skin examination. The estimate was computed as the summation across all
holiday weeks of the reported sunscreen use, using an arbitrary value of 0, 1, 2,
and 3 attributed to the possible answers to that question; i.e., ‘‘never,’’ ‘‘some-
times,’’ ‘‘often,’’ and ‘‘always.’’ Children who ever used sunscreens were clas-
sified in tertiles.
‡Number of sunburn episodes experienced from birth to the moment of the
skin examination.
§Referent category.
\Adjusted for sex, study place, skin phototype, eye color, sun exposure index,
and average wearing of clothes.




Highest study degree obtained by the father‡
Never 3.0 3.0 —§
Low 4.0 4.0 5.0
Intermediate 5.0 4.0 5.0
High 5.0 5.0 6.0
Skin phototype I–II, %
Never 4 38 —
Low 15 27 29
Intermediate 20 39 27
High 27 42 48
Children who sometimes or often went naked in the sunlight during holidays, %\
Never 60 13 —
Low 67 62 57
Intermediate 48 57 46
High 58 48 39
Children who, during last-year holidays, were sun protected with clothes, %
Never 20 13 —
Low 34 42 36
Intermediate 56 55 75
High 37 51 70
*Estimate of the total quantity of sunscreen used from birth to the moment of the skin examination. Computed as the summation across all holiday weeks of the
reported sunscreen use, using an arbitrary value of 0, 1, 2, and 3 attributed to the possible answers to that question; i.e., ‘‘never,’’ ‘‘sometimes,’’ ‘‘often,’’ and
‘‘always.’’ Children who ever used sunscreens were classified in tertiles.
†Number of sunburn episodes experienced from birth to the moment of the skin examination.
‡Median level of highest study degree obtained by the father: 3.0 4 secondary school, inferior level (studies up to ±15 years old); 4.0 4 secondary school,
superior level (studies up to ±18 years old); 5.0 4 high school, nonuniversity; 6.0 4 university studies.
§No children in that category.
\Proportions were derived from individual averages computed across all weeks of sunny holidays.
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Sunscreen Use and Duration of Sun Exposure:
a Double-Blind, Randomized Trial
Philippe Autier, Jean-Franc¸ois Dore´, Sylvie Ne´grier, Danie`le Lie´nard, Renato
Panizzon, Ferdy J. Lejeune, David Guggisberg, Alexander M. M. Eggermont
For the European Organization for Research and Treatment of Cancer Melanoma
Group
Background: In epidemiologic studies, sunscreen use is asso-
ciated with increased risk of cutaneous melanoma, basal cell
skin cancer, and higher numbers of nevi. It has been pro-
posed that sunscreens may encourage prolonged sun expo-
sure because they delay sunburn occurrence. We examined
whether, under habitual conditions of sunscreen use, the
sun-protection factor (SPF) had an influence on sun-
exposure duration. Methods: Before the 1997 summer holi-
days, we randomly assigned 87 French and Swiss partici-
pants who were 18–24 years of age to receive an SPF 10 or
an SPF 30 sunscreen. Neither medical personnel nor study
participants were aware of their sunscreen assignment. Par-
ticipants were asked to complete daily records of their sun
exposure. To avoid influencing the recreational sun-
exposure habits of the study participants, no recommenda-
tion was made about sun exposure or sun protection. Fur-
thermore, participants were told that the trial end point was
the number of pigmented skin lesions before and after the
holidays. One subject was lost to follow-up. All statistical
tests were two-sided. Results: The SPF 10 (n = 44) and SPF
30 (n = 42) groups had equivalent mean holiday durations
(19.4 days versus 20.2 days) and mean quantities of sun-
screen used (72.3 g versus 71.6 g). The mean cumulative sun
exposures for the two groups were 58.2 hours and 72.6
hours, respectively (P = .011). The mean daily durations of
sunbathing were 2.6 and 3.1 hours, respectively (P = .0013),
and, for outdoor activities, they were 3.6 and 3.8 hours, re-
spectively (P = .62). There was no difference in sunburn
experience between the two groups. Conclusions: Use of
higher SPF sunscreen seems to increase the duration of rec-
reational sun exposure of young white Europeans. [J Natl
Cancer Inst 1999;91:1304–9]
Sun exposure is believed to be the main environmental de-
terminant of skin cancers (1), and sunburn experience is asso-
ciated with skin cancer occurrence (2). Sunscreens are able to
delay sunburns and to reduce some UV-induced skin lesions,
such as nonmelanoma tumors in rodents, local immunologic
depression, mutations of the p53 (also known as TP53) gene in
keratinocytes, and the incidence of actinic keratoses in humans
(2–7). As a consequence, sunscreen use has become recom-
mended as a sun-protection method, and that protection is
deemed to increase with increasing sun-protection factor (SPF).
The SPF indicates the ability of a sunscreen to delay the skin
erythemal reaction induced by the solar radiation.
In contrast to the results of experimental studies, observa-
tional studies have repeatedly found sunscreen use to be asso-
ciated with higher risk of cutaneous melanoma and basal cell
skin cancer and with higher counts of nevi (8–16). By way of
explaining this difference, it has been hypothesized that, because
they delay sunburn occurrence, sunscreens could allow pro-
longed sun exposure, a situation that could lead to increased skin
cancer risk (1,9).
If the hypothesis that sunscreen use encourages longer sun
exposure is correct, then higher SPF should lead to greater sun-
exposure duration (17). We conducted a two-center, double-
blind, randomized study to determine whether, in the habitual
conditions of sunscreen use by European young adults, the SPF
had an influence on duration of sun exposure.
SUBJECTS AND METHODS
Study Subjects
Study subjects were healthy, paid volunteers 18–24 years old recruited in
universities in Lyon (France) and Lausanne (Switzerland) and from nonmedical
disciplines. Participants had to have a positive history of sunburn in the past and
to be regular sunscreen users intending to have at least 15 days of holidays in
sunny areas during the next 2 months. Volunteers with a current skin disease,
even minor, or who had a history of a skin disease that lasted for 1 year or more
were not eligible. Pregnant women, subjects with a chronic physical illness, or
subjects taking a photosensitizing medication were also ineligible.
Participants were randomly assigned to receive an SPF 10 or an SPF 30
sunscreen. The two sunscreens used in this study were broad spectrum, com-
mercially available, high-quality preparations from the same brand. The two
sunscreens were prepared with the same chemical absorbents and mineral–oxide
reflectants active in the UV A and B wavelengths, but the SPF 30 sunscreen
contained a higher concentration of these substances. Both sunscreens had the
same appearance, fragrance, color, and texture. They were bought from a local
retailer and repackaged in unidentifiable tubes. Five tubes of 60 mL per partici-
pant were prepared by an experienced pharmacist (average, 373-g gross weight).
The study was conducted in accordance with the principles of the Helsinki
declaration and was submitted for approval to an Ethical Review Committee of
the Centre Le´on Be´rard (Lyon) and of the Centre Hospitalier Universitaire
Vaudois (Lausanne). Each participant signed a written informed consent before
randomization.
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Study Design
The trial design is shown in Fig. 1. The study end point was the duration of
recreational sun exposure. Recreational sun exposure included sunbathing and
other outdoor activities, such as walking, playing, and enjoying sport (e.g.,
swimming or boating) in the sun. To avoid the possibility that knowledge of the
actual end point could influence sun-exposure behavior, the stated study end
point for participants and all persons in contact with them was the influence of
different types of sunscreens on pigmented lesions of the skin. Since nevus
counting and the assessment of the freckling index merely served to distract
subjects from the real study objective, data on pigmented skin lesions are not
presented.
Data from a 1992 survey in Connecticut (18) suggested a difference of 0.33
hour in daily sun exposure (standard deviation of 2 hours) between sunscreen
users and nonusers. Assuming an average of 10 days with sun exposure
per participant, to detect a 0.33-hour difference in daily sun exposure, with
90% power and a two-sided alpha error of 5%, at least 80 subjects had to be
included.
A person who had no contact with the participants or the medical personnel
involved in the study performed the randomization on an individual basis. By use
of a table of random numbers, a five-digit random number was assigned to each
set of five sunscreen tubes. Next the sets were ordered by successive random
numbers.
Potential participants were invited to attend a medical examination. Following
eligibility checking, the freckling index (face, arms, and shoulders) was assessed
and the numbers of nevi were counted on both arms and on the back. A pho-
tograph of the back was also taken. Randomized sets of five sunscreen tubes
were given to participants on a consecutive basis. To keep the trial close to
participants’ habitual conditions of recreational sun exposure, no recommenda-
tion was made either about sun exposure or about sunscreen use. Participants
were asked to complete a standard daily diary recording detailed data on their
sun exposure: hours and type of sun exposure (e.g., sunbathing, swimming, and
boating), amount of clothing (e.g., nude, naked breasts, and one- or two-piece
swimming suit), number of sunscreen applications, time of application (i.e.,
before or after starting sun exposure), and sunburn or skin-reddening experience
(sunburn was defined as an episode of painful skin erythema; skin reddening was
defined as an episode of painless skin erythema). If another sunscreen was used,
the participant was asked to record the day and time of day the other sunscreen
was used, the commercial name, the SPF, and the motive for changing to another
product.
In September, the participants attended a second medical examination during
which all sunscreen tubes were taken back and weighed. The daily diaries were
collected and verified for completeness. In case there were missing data, the
participants were directly asked to provide the missing information during that
second medical examination. Participants also completed a questionnaire on
their lifetime sun-exposure habits, sunburn experience, and sunscreen use. Their
skin phototype was determined according to their propensity to sunburn or to get
a tan when going unprotected in the mid-day sun (19): The skin phototype I
subject always burns and never tans, the skin phototype II subject always burns
first and tans after, and the skin phototype III subject sometimes burns but
always gets a deep tan. In this study, there were no skin type IV subjects, i.e.,
subjects who never burn and always get a deep tan.
Statistical Analysis
Sun-exposure durations were calculated from the daily record diaries. Missing
or imprecise data on sun-exposure hours remained for 5 (0.4%) of the 1312 days
with sun exposure. Sun exposures during these 5 days could thus not be included
in the calculations of sun-exposure duration. After data entry, the randomization
code was broken and the analysis was performed. Student’s t test, the uncor-
rected x2, and the Wilcoxon rank sum test were used for testing univariate
statistical associations. Least-squares regression multivariate analysis was used
to assess the influence of different factors on study end point. All statistical tests
were two-sided.
RESULTS
In June through July 1997, 87 healthy participants who were
18–24 years old (51 females; 36 males) were recruited in Lyon
and Lausanne for the trial. One participant was considered lost to
follow-up (French, female, skin type III, SPF 30 group) after
she did not attend the second medical examination in September
and did not return the daily record diary to study investigators.
This subject could not be included in the analysis.
There was no major imbalance in the distribution of baseline
characteristics between the two groups (Table 1), who showed
similar patterns of skin phototype, skin com-
plexion, past sun-exposure habits, sunburn
experience, and sunscreen use. SPF 10 par-
ticipants spent their holidays in 139 different
areas, of which 47% were countrysides or
lakes, 26% were very sunny areas (e.g., the
Mediterranean coast), and 27% were other
places (e.g., swimming pools in cities). SPF
30 participants spent their holidays in 127
different areas, of which 50% were country-
sides or lakes, 28% were very sunny areas,
and 22% were other places.
In both groups, the duration of holidays
and the number of sunny days during which
they either sunbathed or had outdoor activi-
ties were equivalent (Table 2). Participants
used nearly equal quantities of sunscreen,
and none exhausted the sunscreen received at
the initial medical visit. The average quantity
of sunscreen used represented 20% of the
quantity received, ranging from 0% to 65%
(one participant in the SPF 30 group did not
use any sunscreen at all). Sunscreen use was
associated more with sunbathing activities
than with outdoor activities (data not
shown).
The use of the SPF 30 sunscreen was as-
sociated with a greater number of hoursFig. 1. Trial design.
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spent in the sun (Table 2). Sun exposure of participants who
used the SPF 30 sunscreen was, on average, 25% longer than
that of participants who used the SPF 10 sunscreen. The higher
sun exposure associated with the SPF 30 sunscreen was ob-
served in both study sites. To verify that the observed dif-
ference was not due to exceptional sun exposure of some SPF 30
participants, we analyzed the data after elimination of one par-
ticipant in the SPF 10 group and two participants in the SPF 30
group having total sun-exposure duration three standard devia-
tions above the mean. The difference in the number of hours
spent in the sun remained about the same.
The mean daily duration of sun exposure, sunbathing, or
outdoor activities was calculated by use of the number of days
on which these activities occurred. The increase in daily sun
exposure associated with the SPF 30 sunscreen was observed
mainly for sunbathing activities. The increase in sunbathing du-
ration was retrieved in the three subgroups of skin color at initial
medical examination, despite the small numbers of participants
in the skin color categories.
The starting hour of sunbathing activities was identical in
both groups during the first holiday day with sunbathing (Fig. 2).
As the holidays progressed, however, SPF 30 participants tended
to start sunbathing systematically earlier than SPF 10 partici-
pants, resulting in more sun exposure during the middle of the
day.
The numbers of sunburns or of skin-reddening episodes were
comparable in both groups (Table 2). Despite the use of potent
sunscreens, 45% of the participants reported one or more sun-
burns and 81% reported one or more skin-reddening episodes.
There was no association between the quantities of sunscreen
used and the number of sunburn or skin-reddening episodes
(data not shown). Body sites involved in skin-reddening or sun-
burn episodes were similar in the two groups (data not shown),
except for the anterior part of the trunk, where nine women in
the SPF 10 group and three in the SPF 30 group reported at least
one skin-reddening or sunburn episode (P 4 .075).
Because clothes normally cover them during time spent out-
doors, women’s breasts are highly sensitive to the sun. Five
women in the SPF 10 group and eight in the SPF 30 group
sunbathed with naked breasts (Table 3). All sunbathing sessions
with naked breasts were preceded by sunscreen applications to
the trunk. While duration of holidays and numbers of skin ery-
themal episodes were identical in the two groups of women, the
use of the SPF 30 sunscreen was associated with five times
longer sunbathing with naked breasts. Also, while women in the
SPF 30 group were more inclined to sunbathe with naked breasts
in the early days of their vacation, most women in the SPF 10
sunscreen group waited at least 1 week before exposing their
breasts to the sun.
To verify that our results were not the consequence of mul-
tiple small confounding effects, we fitted a least-squares regres-
sion model using accumulated hours of sun exposure as the
dependent variable. The model included number of days of holi-
days, number of sunscreen applications, randomization group,
number of sunburns, sex, and study site. The main predictors of
accumulated sun exposure were the duration of holidays
(P<.001) and the number of daily sunscreen applications (P 4
.008). These results are not surprising, since duration of sun
exposure is positively associated with duration of holidays and
staying in the sun encourages sunscreen use. The SPF of the
sunscreen used was a statistically significant predictor of dura-
tion of total sun exposure (P 4 .010), independent of the effect
of other variables. The remaining variables were not associated
with sun-exposure duration (P>.20 for all).
Eleven French participants, seven in the SPF 10 group and
four in the SPF 30 group, used another sunscreen than that
provided. Alternative products were used, for a total of 18 days
in the SPF 10 group and 7 days in the SPF 30 group. The SPFs
of the alternative sunscreens were 5, 6, 6, 10, 10, 20, and 20 in
the SPF 10 group and 8, 30, 30, and 60 in the SPF 30 group
(Wilcoxon rank sum test for the difference in SPF: P 4 .070),
suggesting that alternative products used by SPF 30 participants
were of higher SPF than alternative products used by SPF 10
participants.
DISCUSSION
The results of this randomized trial demonstrate that recre-
ational sun exposure is of longer duration when a high SPF
sunscreen is used than when a low SPF sunscreen is used. Simi-
lar results were found in two independent study sites and mainly
concerned sunbathing activities. Two findings in particular attest
Table 1. Baseline characteristics of participants
Characteristic





French 33 (75) 32 (76)
Swiss 11 (25) 10 (24)
Females 27 (61) 23 (55)
Males 17 (39) 19 (45)
Skin phototype†
I 1 (2) 1 (3)
II 14 (32) 14 (33)
III 29 (66) 27 (64)
Skin complexion‡
Pale 8 (18) 8 (19)
Medium 25 (57) 26 (62)
Dark 11 (25) 8 (19)
Average No. of holiday weeks spent
each year in sunny areas since 15 y old
None 1 (2) 1 (3)
1–2 15 (34) 11 (26)
3–4 18 (41) 22 (52)
5–6 6 (14) 5 (12)
ø7 4 (9) 3 (7)
Likes to sunbathe 32 (73) 33 (78)
Before study, sunbathed during the
hot hours of the day since age 15 y
18 (41) 17 (40)
Before study, use of a sunscreen
during sunny holidays or during
leisure times in the sun
Rarely 11 (25) 9 (21)
Sometimes 8 (18) 10 (24)
Often 18 (41) 16 (38)
Always 7 (16) 7 (17)
History of sunburn before age 15 y 33 (75) 30 (71)
History of sunburn after age 14 y 35 (79) 32 (76)
*SPF 4 sun-protection factor.
†When going in the sun, a skin phototype I subject always burns and never
tans, a skin phototype II subject always burns first and tans after, and a skin
phototype III subject sometimes burns but always gets a deep tan (19). In this
study, there were no skin phototype IV subjects (i.e., who never burn and always
get a deep tan).
‡Determined by examining the inner side of upper arms.
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to the sense of security conferred by potent sunscreens. First, the
use of the SPF 30 sunscreen led to a greater amount of sunbath-
ing during hours of the day during which the UV radiation
usually reaches its peak value. Second, women using the SPF 30
sunscreen sunbathed longer with naked breasts while incurring a
lower number of sunburns or skin-reddening episodes on that
part of the body.
Participants in the two study arms were similar in terms of
natural susceptibility to sunlight, history of sun exposure and
sunburn, duration of holidays, and the types of places they va-
cationed. Furthermore, our data suggest that those participants
who used SPF 30 sunscreen actually increased their sun expo-
sure over the course of the holidays (Fig. 2). Therefore, it is
unlikely that the difference in sun-exposure duration stemmed
from differences in baseline characteristics and choice of holi-
day location; rather, it appears to be related to protection from
burning conferred by the stronger sunscreen.
Data collection was done prospectively by use of standard
diaries completed on a daily basis. Therefore, biases in the re-
cording of sun-exposure duration have probably been minimal.
If some bias was present, however, it is reasonable to assume
that it has been equally distributed among the two study groups.




(n 4 42) P†
Total No. of holiday days 854 848
Mean No. of holiday days (range) 19.4 (12–43) 20.2 (14–46) .57
No. of days (% of total No. of holiday days) during which
Participant did not go outside‡ 146 (17) 107 (13)
Participant went outside but did not become exposed to the sun 65 (8) 77 (9)
There was sun exposure 643 (75) 664 (78)
There was sunbathing 328 (38) 347 (41)
There were outdoor activities 467 (55) 514 (60)
There were sunbathing and outdoor activities 152 (18) 197 (23)
Mean (95% CI) quantity of sunscreen used, g 72.3 (60.2–84.4) 71.6 (53.7–89.5) .95
Range, g 12–167 0–244§
Accumulated hours of
Sun exposure 2559 3048
Sunbathing 852 1075
Outdoor activities 1707 1973
Mean (95% CI) total hours of sun exposure per participant 58.2 (52.0–64.4) 72.6 (63.5–81.7) .011
French participants 62.3 (55.2–69.4) 74.9 (63.6–86.2) .063
Swiss participants 45.8 (35.4–56.2) 65.1 (52.9–77.3) .027
Exclusion of three participants with highest exposure\ 56.6 (51.0–62.2) 68.0 (61.5–74.5) .010
Range for all participants 17–126 30–199
Mean (95% CI) hours of daily
Sun exposure¶ 4.0 (3.3–4.7) 4.6 (3.9–5.3) <.0001
Outdoor activities¶ 3.6 (2.9–4.3) 3.8 (3.0–4.6) .62
Sunbathing¶ 2.6 (2.1–3.1) 3.1 (2.5–3.7) .0013
Skin complexion pale at initial examination, h 1.9 (1.2–2.6) 3.0 (1.9–4.2) <.001
Skin complexion medium at initial examination, h 2.6 (2.1–3.2) 3.0 (2.4–3.5) .034
Skin complexion dark at initial examination, h 2.8 (1.9–3.7) 2.9 (1.9–3.9) .73
No. of sunburn or of skin-reddening episodes 159 159 .99
No. of sunburn episodes 42 34 .90
No. of skin-reddening episodes 117 125 .85
*SPF 4 sun-protection factor; 95% CI 4 95% confidence interval.
†Student’s t test for testing of difference between means, x2 statistics for testing of difference between numbers; P values are two-sided.
‡Because of bad weather, or of absence of eagerness to go outside, or of a sunburn in the previous days.
§One participant in SPF 30 group did not use any sunscreen.
\Exclusion of participants with total sun exposure three standard deviations above the mean: one participant in the SPF 10 group (126 hours of total sun exposure)
and two participants in the SPF 30 group (127 and 199 hours of total sun exposure).
¶Accumulated hours of sun exposure, outdoor activities, or sunbathing divided by the number of days during which there was sun exposure, outdoor activities,
or sunbathing.
Fig. 2. Mean hour of start of sunbathing activities in days with sunbathing. Days
without sunbathing were skipped. The time in the figure is the so-called “sum-
mer hour” in Continental Europe, equivalent to the solar hour plus 2 hours.
Blank squares represent sun-protection factor (SPF) 30 participants; black
circles represent SPF 10 participants. Error bars represent 95% confidence
intervals. Student’s t test for the difference in mean hour: P>.90 for the first day;
P<.050 for days 2–9 (P values are two-sided).
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We thus consider that the reported sun-exposure durations in this
study are a valid reflection of the true sun exposure of partici-
pants during their holidays and that our findings are unlikely to
be due to bias.
An adult should use roughly 35 mL of sunscreen per single
whole-body application to correspond to the doses used by labo-
ratories for measuring the SPF of a sunscreen (20). In that re-
spect, our study participants should have consumed at least three
to four times the quantities actually used, and it is thus probable
that, in most participants, the effective SPF of the sunscreens
used was about three to four times lower. However, our study
shows that an increased ability to delay sun-induced skin ery-
themal reactions is sufficient to cause longer sun exposure, even
when moderate quantities of sunscreen are used.
The increase we observed in sun-exposure duration may ex-
plain why sunscreen use has been reported to be a risk factor for
melanoma, basal cell cancer, and nevus development. It also
demonstrates that the longer sun exposure allowed by sunscreen
use is an unconscious phenomenon, which makes individual
control difficult, particularly where children are concerned.
Sunburn or skin-reddening experience among participants
was independent of the SPF and of the quantity of sunscreen
used. This observation suggests that sunscreen use during rec-
reational sun exposure does not imply protection against sun-
burns. Sunburns are essentially due to the UV B radiation (1).
Equivalence of sunburns and skin-reddening experiences in the
two groups suggest that doses of UV B radiation received by
skin cells were probably similar in the two groups. However, the
delivery of these doses to skin cells of SPF 30 participants would
have taken a longer time than that to skin cells of SPF 10
participants.
The issue addressed by this study is common to all sun-
screens. Because we did not want to single out the products of a
specific company, we chose not to disclose the commercial name
and the exact composition of the sunscreens used in this trial.
From our results, it is reasonable to infer that equivalent or
greater differences in sun-exposure duration would have been
observed if one had compared subjects using a sunscreen with
subjects not using any sunscreen. One could have considered a
placebo-controlled trial using as placebo a lotion without any
chemical or physical substance able to block UV radiation. In
this study, a placebo group was not possible. First, it was ethi-
cally difficult to allow a placebo sunscreen when the sun-
protection virtues of sunscreens are widely acknowledged. Sec-
ond, it was not easy to provide a placebo sunscreen without
informing subjects of both study groups that they should be
careful in their sun exposure to avoid severe sunburns. Third,
many subjects in the placebo group would have rapidly changed
to a real sunscreen, which would have endangered the trial.
Experiments that tested the ability of sunscreens to reduce the
incidence of UV-induced lesions have not examined the possi-
bility that these products could modify the sun-exposure behav-
iors of subjects eager to acquire a tan or to stay in the midday sun
with large parts of the body uncovered. The two human placebo-
controlled trials that showed the ability of sunscreen use to re-
duce the incidence of actinic keratoses (6,7) enrolled subjects
having a mean age of 64 years who had a history of nonmela-
noma skin cancer or of other sun-induced skin lesions, who were
highly aware of the hazards of sun exposure, who were not keen
to acquire a suntan, and who apparently never had sunburn dur-
ing the trials. Clearly, these trials did not reproduce the normal
or reasonably foreseeable conditions of sunscreen use in North
America and Europe, where sunscreen use by younger people
remains largely driven by the desire to enjoy the sun and to
acquire a “safe suntan” (21–24).
The protective effect of sunscreen use against skin cancer,
particularly melanoma, has not been demonstrated in the general
population, but there are compelling data that show a strong
relationship between duration of recreational sun exposure and
skin cancer. It is therefore desirable that people should be
warned against the danger that using a sunscreen may inadver-
tently prolong recreational sun exposure.
















1 II 24 1 6.00 1st
2 II 20 2 4.75 10th
3 II 25 9 3.00 15th
4 III 43 4 4.00 30th
5 III 15 0 5.00 12th
Total hours of sunbathing with naked breasts 22.75
Mean (95% confidence interval) duration of sunbathing with naked breasts .......................................................4.55 (3.15–5.95)†
SPF 30 group
1 I 16 10 11.50 2d
2 II 21 1 5.00 11th
3 II 28 2 28.50 2d
4 III 28 3 47.00 1st
5 III 28 1 3.50 4th
6 III 16 0 38.00 5th
7 III 16 3 31.00 1st
8 III 23 3 18.00 2d
Total hours of sunbathing with naked breasts 182.50
Mean (95% confidence interval) duration of sunbathing with naked breasts ...................................................22.81 (9.57–36.06)†
*For definition, see footnote in Table 1.
†Wilcoxon rank sum test for the difference in median hours of sunbathing with naked breasts; two-sided P 4 .030.
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are in agreement with the concept that sunburns would be mark-
ers of both susceptibility to sunlight and of exaggerated sun
exposure rather than cause nevi or melanoma per se.
Our findings do not contradict results from experiments that
showed the ability of sunscreens to prevent ultraviolet-induced
lesions. Rather, they stress that these experiments did not repro-
duce actual sun exposure and sunscreen use habits of fair-
skinned populations. For instance, clinical trials (6,7) that
showed decreased incidence of solar keratoses or of nonmela-
noma skin cancers among subjects using high-SPF sunscreens
intentionally included subjects at high risk for actinic skin le-
sions, who were fully aware of the hazards associated with sun
exposure (many had a history of nonmelanoma skin cancer).
Thus, results from these trials are not generalizable to usual
populations.
There is no satisfactory animal model that mimics melanoma
occurrence in humans. Hence, results obtained while studying
the keratinocytic system may not be directly transposable to the
melanocytic system. However, if sunscreen use acts by allowing
prolonged sun exposure, then consequences would affect both
keratinocytic and melanocytic systems, and sunscreen use could
also be responsible for a part of the increase in nonmelanoma
skin cancers in white populations. The increased incidence of
basal cell carcinoma among sunscreen users observed in several
studies (10–12) supports this hypothesis.
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MINI REVIEW
Sunscreen use and increased duration of intentional sun exposure: Still a
burning issue
Philippe Autier1*, Mathieu Boniol1 and Jean-Franc¸ois Dore2
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Sunscreen use is often proposed for sun protection because of their
ability to block UV-induced sunburns (the sun protection factor –
SPF). Among suntan seekers, however, risk of cutaneous mela-
noma may be increased because of extended sun exposure dura-
tion. We made a systematic review of the evidence linking
sunscreen use to sun exposure duration. Five observational studies
found that when sun exposure was associated with willingness to
get a tan or to stay longer in the sun (i.e., intentional sun expo-
sure), sunscreen use was associated with duration of sun exposure
13–39% longer. Paradoxically, sunburns tend to be more frequent
among sunscreen users, probably because of greater natural sun
sensitivity. When sun exposure was not intentional, sunscreen use
did not increase time spent in the sun. Two European double-blind
randomized trials conducted among young sun seekers found daily
sun exposure duration, especially sunbathing, 19–25% longer with
use of SPF 30 than with use of SPF 10 sunscreens. One random-
ized trial in a holiday resort in France found a 3–13% increase in
sun exposure duration with use of SPF 12 versus SPF 40
sunscreen. But, the SPF 12 groups used 3.6–4.2 more sunscreen
than the SPF 40 group, and thus the actual SPF in the SPF 12
group was higher than in the SPF 40 groups. In conclusion,
sunscreen use leads to longer duration of sun exposure when sun
exposure is intentional, but not when sun exposure is non inten-
tional.
' 2007 Wiley-Liss, Inc.
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Sunscreens were primarily designed for sunburn prevention, but
animal and human experiments showed their ability to reduce UV-
induced skin lesions such as solar keratoses and squamous cell
carcinoma (SCC).1,2 The protection afforded increases with the
sun protection factor (SPF), i.e., the ability of a sunscreen to retard
UV-induced skin erythemal reaction. Consequently, high SPF
sunscreens (i.e., SPF  15) have often been recommended for sun
protection.
Sunscreen use for sun protection has been challenged by
repeated observation that not only sunscreen use (including recent
high-SPF broad-band sunscreens) did not protect against cutaneous
malignant melanoma (melanoma), basal cell carcinoma (BCC), and
higher nevus counts, but that it was often associated with increased
risk of these tumors, whereas wearing of clothes was associated
with no change or with decrease of these tumors.3–5
An alternative hypothesis was that sunscreen use could encour-
age sun exposures of longer duration, possibly leading to
increased risk of melanoma and of BCC. In this article, we review
observational and randomized studies that examined sunscreen
use and sun exposure duration, according to the sun exposure type
associated with sunscreen use.
Intentional and nonintentional types of sun-exposure
Substantial proportions of melanoma and BCC are associated
with intermittent sun exposure rather than with lifetime accumu-
lated sun exposure,6 i.e., light-skinned subjects spending most of
their daily life time indoor but enjoying intense sun exposure dur-
ing holidays, and often eager to acquire a sun tan. Intermittent sun
exposure is thus often intentional as subjects look for a biological
effect.1,2 During intentional sun exposure (ISE), significant por-
tions of the trunk, shoulders, and of the upper parts of limbs are
frequently uncovered. Sunbathing is the most typical ISE behav-
ior.
Nonintentional sun exposure (NISE) represents sun exposure
during daily life activities, without special willingness to acquire a
tan or to being able to spend long time in the sun. During NISE,
skin areas most usually sun exposed are the head and neck, the
hands, and the forearms. Examples of NISE are outdoor activities
such as walking, hiking, gardening, skiing, or work on building
construction sites or in farming fields. Lifetime accumulated NISE
is mainly associated with occurrence of solar keratoses and of
squamous cell carcinoma (SCC).
Methods for literature search
We started the literature search with materials gathered for the
IARC Handbook on Sunscreens1 and with bibliography gathered
by authors. We then performed a systematic literature search in
the MEDLINE until August 2006 without restriction on type and
language of article. Use of variable combinations of MeSH terms
‘‘sunscreen agent’’, ‘‘sunscreening agents’’, ‘‘sunlight’’, ‘‘sun-
burns,’’ and ‘‘time’’ until March 2006 conducted to a selection of
155 articles including words in the title or in the abstract (when
available) suggesting relevance for the study. Full copies of these
articles were obtained and independently revised by P.A. and
M.B. We made a similar search in the ISI Web of Knowledge,
Science Citation Index Expanded, covering the science literature
from 1945 until August 2006. Examination of title and available
abstracts of articles did not conduct to finding further articles than
those found using the MEDLINE. Data from relevant articles were
abstracted in a table summarizing key variables and results.
Reported data had to provide or to allow the calculation of time
spent in the sun during parts of day or during days during which
there was effective sun exposure, with knowledge of sunscreen
use before or during effective sun exposure. Relevant information
of methods or on results were sometimes found in the Discussion
section of articles, e.g., time spent in the sun in 1 Danish study,7
or the notion that during a randomized trial in France, an investi-
gator was permanently present in holiday villages and had daily
contacts with trial participants.8
Results
Observational studies on sunscreen use during ISE
We identified 6 observational studies conducted during predom-
inantly ISE situations that measured time spent in the sun accord-
ing to sunscreen use, and published in 7 articles.7,9–14 A cross-
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sectional study among Norwegian adolescents13 could not be used
because data on sunbathing time were not reported according to
sunscreen of to sun protection factor (SPF) used, and skin lotions
with SPF 0–2 were incorrectly considered as sunscreens. Table I
summarizes the 5 studies with relevant data.
In some studies, statistical tests for some results were not
reported, or data reporting precluded statistical analysis. In all 5
studies, for adults and for children, sunscreen use was associated
with duration of sun exposure 13–39% longer than if no sunscreen
was used. One study found that UV doses received were consider-
ably higher when sunscreens were used.7 Four studies recorded
sunburns and found higher proportions of subjects with sunburn
when a sunscreen was used, especially when the SPF was high.
According to reports, differences in sun sensitivity between
sunscreen users and nonusers were not likely reasons for explain-
ing results on durations and on sunburns, although these results
were never statistically adjusted on sun sensitivity of study partici-
pants. Interestingly, 1 study7 examined also gardeners (a NISE
behavior), and found no difference in UV dose received according
to sunscreen use. This study did not report data on sunburn occur-
rence during NISE.
These observational studies could however not assess whether
longer duration was a result of sunscreen use that sunscreen users
were not aware of, or a result of the willingness of sunscreen users
to spent long time in the sun without (did they believe) incurring
sunburn. Qualification of the exact cause-effect chain of events
could only be determined by randomized trials.
The European randomized trials
The European Organization for Research and Treatment of
Cancer (EORTC) Melanoma Group conducted 2 double-blind
randomized trials among students 18–24 years of age eager to
engage in intentional sun exposure during their summer holidays
(Table II).16,17 These trials were representative of sun exposure
behaviors of millions of light-skinned young subjects eager to ac-
quire a tan during holidays or during leisure times. The 2 trials
demonstrated that sun exposure, mainly sunbathing, was 19–25%
longer duration with use of SPF 30 than with use of SPF 10
sunscreens. High SPF susncreens also allowed more hazardous
sun exposure behaviors that would not be possible otherwise, like
for instance sunbathing with naked breasts. Average quantity of
sunscreen used was similar in randomization groups and the in-
holiday sunburn experience was identical for participants regard-
less of the SPF of the sunscreen used. For many participants, sun-
burn occurrence was the factor limiting sun exposure duration, but
sunburn occurred later in the high SPF group than in the low SPF
group. Hence, it was sunscreen use during ISE that led to longer
sun exposure sessions, without affecting sunburn occurrence, and
trial participants were not aware of this increase in sun exposure
duration.
In 2001, a Working Party convened by the IARC concluded
that ‘‘use of sunscreen can extend the duration of intentional sun
exposure, such as sunbathing. Such an extension may increase the
risk for cutaneous melanoma.’’1,2 The US National Cancer Insti-
tute and the US Preventive Services Task Force came to similar
conclusions.18,19
The French randomized trial
A randomized trial funded by a major sunscreen manufacturer
appeared to contradicted results of European trials, finding no sig-
nificant difference in the duration of time spent in the sun accord-
ing to sunscreen SPF.8 However, this trial involved a population
with low interest in sunbathing. Also the way this trial, was
designed and conducted was likely to produce a negative result,
i.e., no difference in sun exposure duration according to SPF of
sunscreen used.
Notwithstanding study design issues, interpretation of results
may be different than that provided by authors. The French trial
reported that the SPF 12 and SPF 40 sunscreens especially made
for the study had different textures, SPF 12 being easier to spread,
which may partly explain the 3.6- to 4.2-fold difference in amount
of sunscreen used in the SPF 12 group as compared with the 2
SPF 40 groups (Table II). Taking into account data on sunscreen
use in European randomized trials20 and differences in average
daily sunbathing duration in European and in the French trials,
participants in the SPF 40 groups may have applied between 0.25
and 0.5 mg/cm2 of sunscreen onto their skin. With a 0.25 or 0.5 g/
cm2 sunscreen application, the actual SPF is about the eighth and
the fourth square root of the SPF indicated on the bottle,12 i.e., 1.6
or 2.5. Assuming no difference in sun exposure duration according
to SPF used and of exposed skin areas, use of 3.6- to 4.2-fold
more SPF 12 sunscreen than of SPF 40 may have resulted in an
actual sun protection potency 2–3 times higher in the SPF 12
group than in the SPF 40 groups. The consequence was probably
the borderline statistically significant 12% increase in sunbathing
duration observed in 1 of the SPF 12 groups (Table II). Hence,
results from this French randomized trial were in fact quite similar
to results of the European randomized trials.16,17
Sunscreen use for protection against solar keratoses and
squamous cell carcinoma
Trials with solar keratoses and squamous cell carcinoma (SCC)
as endpoint were conducted among older subjects whose sun ex-
posure was not intentional but due to normal circumstances of
daily-life. Two trials in volunteers relatively aged and having a
history of sun-induced skin damage showed the ability of
sunscreen use to reduce new solar keratoses.21,22 The Nembour
trial showed that sunscreen use can reduce the incidence of
SCC.23 This trial was performed in Queensland, Australia, in a
population living in an area with high ambient sunshine all the
year round, and where skin cancer incidence is the highest in the
World. In these 3 trials, sun exposure was essentially noninten-
tional, and sunscreens (or placebo lotions) were mainly used dur-
ing daily life and applied essentially on the face, ears, neck, and
hands. Apparently, subjects did not experience sunburn or the
number of sunburns was significantly lower in the intervention
group.23,24 None of the 3 trials reported measurements of in-trial
sun exposure durations, but the Nembour trial stated there was no
evidence of differences in the time spent in the sun among subjects
allocated to the intervention group.23
Randomized trials on sunscreen use and numbers of acquired nevi
In 1998 until 2001, 2 randomized trials tested the ability of
broadband sunscreen use on the development of nevi in school-
children.25,26 The Vancouver trial in Canada found a reduction in
the development of new nevi in children with dense facial freck-
ling and found no effect in children without dense facial freck-
ling.25 The German trial failed to change patterns of sunscreen use
between the randomization groups because apparently, sunscreen
use was already highly prevalent in all groups at study start.26 The
Vancouver trial reported estimations of the total amounts of
time spent in the sun during the 3-year trial duration but did
not report duration of sun exposure per day with or without
sunscreen use.
Discussion
All available observational and experimental data in humans
provided evidence that intentional sun exposure tends to be of lon-
ger duration when a sunscreen is used or when SPF increases.
Results of the European randomized trials suggest that sunscreen
users are unaware of the impact sunscreen use has on their sun ex-
posure behaviors.
A paradoxical result of observational studies was the higher
numbers of subjects reporting sunburns when a sunscreen was
used, mainly when the SPF was high. It is well known that the ma-
jority of sunscreen users apply only a fifth to a third of quantities
of sunscreens used in laboratory for testing their SPF.11,20 Also,
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thickness of sunscreens of a same commercial brand does not
change much with SPF, and 1 study showed that quantities of
sunscreen applied onto the skin did not vary much with SPF.27
Observational studies did not perform adjustment of their results
on natural sun sensitivity of study participants. Hence, the higher
number of sunburns among (high SPF) sunscreen users in observa-
tional studies could have been due to greater sun sensitivity.
In contrast to what happens during ISE, during NISE, observa-
tional and experimental data in humans provide evidence that
sunscreen use would not increase time spent in the sun, and would
decrease sunburn occurrence. In this respect, impact of sunscreen
use during NISE situations would meet expectations raised by lab-
oratory experiments that showed the ability of sunscreens to
decrease the incidence of UV-induced skin erythemal reactions
and nonmelanocytic skin cancers.1 In ISE situations, these expect-
ations are not met because of the influence sunscreen use has on
behaviors of humans eager to get a tan or to stay long in the sun.
During the second half of the nineteenth century, the sun tan-
ning fashion exploded among light-skinned populations and growth
of sunscreen commercialization paralleled that fashion.28–30
Sunscreen are often considered as tanning aid,1,31 and advertising
sometimes persuade sun seekers that sunscreens may ensure
acquisition of a ‘‘safe tan’’. In spite of uncertainties about their
exact role in melanoma and BCC occurrence, and in spite of
recommendations that sunscreen use should just be an adjunct to
other more natural forms of protection, such as use of hats, shirts,
and search for shade, sunscreens remain the most frequently used
sun protection method, mainly among adolescents and young
adults, while in the same time, younger adults declare to be more
likely to sunbathe deliberately than other people.32 In Australia
sun protection no longer relies on sunscreen use.33
In conclusion, examination of studies on sun protection meth-
ods should always take into account the type of sun exposure
that was addressed. Also, information on sunscreens should
make a clear difference between situations of intentional or of
nonintentional sun exposure. When intentional sun exposure is
concerned, information to the general public should be closer to
uncertainties on their efficacy and to knowledge of the possible
impact they may have on sun exposure behaviors, and on mela-
noma risk.
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Skin cancer is caused by exposure to ultraviolet radiation (UV) and the sun is the
main source of this radiation. Sunscreens were initially formulated to prevent
sunburns; laboratory studies later revealed that in rodents they could reduce
UV-induced skin cancer which resembles human squamous cell carcinoma. Three
randomized trials in older adults showed the ability of sunscreens to moderately
reduce the occurrence of solar keratoses and of squamous cell carcinoma. How-
ever, no effect was observed for basal cell carcinoma. There is no animal model
for human melanoma and observational studies often found sunscreen use associ-
ated with a higher risk of nevus, melanoma and basal cell carcinoma. These
higher risks were found when sun exposure appeared to be intentional, that is,
with the desire to acquire a tan, a healthy look or simply to spend as long as
possible in the sun with as much skin exposed as possible. Three randomized tri-
als showed that sunscreen use by sun sensitive subjects engaging in intentional
sun exposure could increase the duration of exposure without decreasing sun-
burn occurrence. This increased duration could be the reason why melanoma risk
is increased when sunscreen is used. Hence, sunscreen abuse may extend sun
exposure duration thus allowing sun exposure behaviours that would not be pos-
sible otherwise. Advertising for sunscreens and labeling of sunscreen bottles
should inform consumers of the carcinogenic hazards associated with sunscreen
abuse. It would be good to use a personal UV dosimeter which would give an
alert when one’s individual sunburn threshold in the absence of sunscreen use is
nearing. The combination of sunscreen and a UV dosimeter may be an option
for reducing the melanoma risk among sun worshippers.
The advent of sunscreens paralleled the tanning fashion that
spread in light skinned populations starting in the 1930s.1
Their initial formulation was designed to block ultraviolet
(UV) B radiation (UVB, 280–320 nm), which causes most
sunburns. Epidemiological studies in the 1980s found a strong
link between sunburn history and skin cancer, including mela-
noma. At the same time many laboratory experiments showed
that besides delaying the erythemal reaction, sunscreens could
reduce a variety of other UV-induced skin lesions, including
squamous cell cancer. As a result, these products have been
advocated for the prevention of skin cancers, including mela-
noma despite the absence of a good animal model mimicking
human skin melanoma. Until recently, it was generally
assumed that the greater the ability of a sunscreen to delay
sunburn (i.e., its sun protection factor – SPF), the higher the
protection against deleterious effects of the sun. In the 1990s
the carcinogenic properties of ultraviolet A radiation (UVA,
320–400 nm) began to be suspected, and a new generation of
broad-band sunscreens has emerged, having high SPF (30 and
more) and containing agents specifically blocking the UVA.
However, contrary to the expectations based on laboratory
experiments, population-based case-control studies often
found an increased risk of melanoma associated with sun-
screen use (revised in ref. 2). Prospective and retrospective
cohort studies found sunscreen use to be associated with
increased risk of basal cell cancer in adult women,3 and higher
numbers of acquired melanocytic nevi among school children
and adolescents.4,5 Concerns raised by epidemiological studies
were emphasized by laboratory experiments showing that sun-
screens could enhance the stimulation of melanoma growth
by UV radiation.6
After 1995, epidemiological studies and randomized trials
found that the most probable reason why sunscreen use
increased the risk of melanoma was that by delaying sunburn
occurrence, these products extended the time spent in the
sun.7 In this paper, we review the evidence backing this find-
ing and propose a model for explaining why sunscreen
extended sun exposure may increase melanoma risk. Based on
this model, we propose a way to control time spent in the
sun when a sunscreen is used.
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Sunscreens and intentional or non-intentional
patterns of sun-exposure
Understanding the sunscreen-melanoma association requires
distinguishing between two different types of sun exposure
patterns.
The non-intentional sun exposure (NISE) pattern represents
sun exposure during daily life activities, without a special
willingness to acquire a tan or to be able to spend a long time
in the sun. The so-called chronic sun exposure pattern usually
equates to NISE. Examples of NISE are outdoor activities such
as walking, hiking, gardening, skiing, or construction and
farming work. Lifetime accumulated NISE is mainly associated
with solar keratoses and squamous cell carcinoma.
The intentional sun exposure (ISE) pattern is sun exposure
with an intention to stay in the sun with large uncovered skin
areas, or ⁄and to acquire a tan. ISE is characteristic of light-
skinned subjects who spend most of their daily life indoors
but enjoy intense sun exposure during holidays. The usually
called intermittent sun exposure pattern is often intentional as
subjects look for a biological effect. Sunbathing is the most
typical ISE behaviour. Melanoma is commonly found on the
usually covered sites such as the trunk, and this clinical evi-
dence fits with the ISE patterns being the cause of most mela-
noma.
Reasons for the increased melanoma risk
associated with sunscreen use
It was first hypothesized that the increased risk of melanoma
or high nevi numbers was found in populations not using
modern high SPF, anti-UVA broad-band sunscreens. However,
many of these studies are quite recent and included people
who already used the broad-band type of sunscreens.2
Secondly, it was argued that because sunscreen users were
generally more sun sensitive than non-users, the increased risk
of melanoma observed in sunscreen users merely reflected
their inherently greater risk of melanoma. The epidemiological
literature describes this phenomenon as ‘bias by indication’.
However, this bias can likely be excluded because of the ‘sun-
screen-clothes paradox’ found in many studies: sunscreen use
and wearing of clothes when in the sun are more prevalent in
sun sensitive subjects.2,8 The study on nevi in European
schoolchildren showed that during sunny holidays, an inverse
correlation existed between sunscreen use and sun protection
through the wearing of clothes (Fig. 1): the more sunscreens
were used, the fewer clothes protected the skin against the
sun. This and other studies found that while sunscreen use
was associated with higher nevus counts, wearing clothing
was associated with decreasing numbers of nevi.4,5 Only one
population-based case-control study examined the risk of
melanoma with sunscreen use and wearing of clothes, and
found a melanoma risk reduced by 52% (P < 0Æ001) when
the primary site of the tumour was usually covered with
clothes during outdoor work in the summer.9 In contrast, the
melanoma risk associated with sunscreen use was 1Æ15 (95%
CI 0Æ78–1Æ68) in subjects who used sunscreens for 10 years
or more.
If wearing clothing and using sunscreen represent real bar-
riers against the transmission of UV to the skin, then why
does the former actually protect against melanoma and nevus
formation, while the latter seems unable to protect against
melanoma and rather increases nevus development. This para-
dox made credible the hypothesis that sunscreen use could be
involved in nevus and melanoma occurrence.
The third hypothesis was that due to their ability to delay
sunburns, sunscreen use would encourage sun exposures of
longer duration; this would be especially true when sun
exposure is motivated by a desire to tan or to remain in the
sun for longer periods. This hypothesis was supported by the
common observation that in NISE situations, sunscreen use
can reduce sunburn occurrence. In contrast, in ISE situations,
sunscreen use did not change the risk of sunburn.2,8
Sunscreen use and duration of sun exposure
Three randomized trials demonstrated that during ISE, use of
relatively small amounts of sunscreen (i.e., amounts 3–4 times
smaller that those used for measuring the SPF) was able to
increase time spent in the sun. Two trials were conducted in
France, Switzerland and Belgium with sun-sensitive volunteers
18–24 going to sunny areas for summer holidays.10,11 These
volunteers were randomized in a double blind design to
receive SPF 10 or SPF 30 sunscreen. These trials showed that
high SPF sunscreen extended sunbathing time by 19–25%,
while there was no difference in sunburn experience and no
difference in quantity of sunscreen used. Another key finding
of these two trials was that as their holiday progressed, sub-
jects using the SPF 30 sunscreen usually started sunbathing
around noon, whereas those using the SPF 10 sunscreen
tended to start sunbathing steadily later in the day. Hence, sun
exposure duration of sun sensitive subjects engaged in ISE is
limited by sunburn acquisition, and delaying sunburn occur-









































Fig 1. Correlation between sunscreen use and wearing clothes in 623
5- to 7-year-old European schoolchildren (R-square = 0Æ92,
P < 0Æ0001) (Ref. 4).
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The third trial took place in 2003 in a French holiday vil-
lage and randomized 308 adults 18–78 years of age into three
groups using sunscreen of different SPF and having different
labelling.12 Results of this trial indicated that after 1 week of
use, higher SPF was associated with longer ISE duration.7
What about sunscreen use and sun exposure duration dur-
ing NISE? The few available data suggest that in NISE situa-
tions, there is no increased duration of sun exposure
associated with sunscreen use. The Australian randomized tri-
als for prevention of squamous and basal cell carcinoma found
no evidence for increased duration of time spent in the sun
when high SPF sunscreen was used.13 A Danish group with
great experience in individual UV dosimetry monitored time
spent in the sun and UV doses experienced during various
types of outdoor activities (Fig. 2).14 Although samples were
relatively small, sunscreen use during a NISE activity like gar-
dening did not increase the UV dose received, while among
sun worshippers sunscreen use was associated with a consider-
able increase in UV dose received.
ISE, NISE, sunscreens and skin cancer
Three randomized controlled trials (two in Australia and one
in the U.S.A.) in subjects over 50 years old, many of whom
had a history of actinic skin lesions, have shown that when
used during NISE, sunscreen use (moderately) decreases the
incidence of squamous cell carcinoma and of solar keratoses,
but not of basal cell carcinoma.15–17
Essentially because of intractable practical and ethical diffi-
culties, no randomized trial has ever tested the ability of sun-
screen use to protect against skin cancer and melanoma in
particular during ISE situations. The trial in Vancouver, Canada
tested the ability of a broad-band sunscreen to limit nevi
numbers in schoolchildren.18 It is not clear whether the Van-
couver trial was representative of ISE situations. Results of this
trial are difficult to interpret, as, for yet unknown reasons, all
the effect of sunscreens was confined to children with high
freckling. Furthermore, the statistical analysis did not adjust
for nevi counts at baseline.
Epidemiological data relevant to the associations found
between sunscreen use and skin cancer is summarized in the
Table 1. Studies conducted during NISE situations were close
to conditions encountered in laboratory experiments that dem-
onstrated the cancer prevention properties of sunscreens, e.g.,
application of high doses of sunscreens, subjects eager to pro-
tect themselves from harmful effects of the sun and not
attracted by tan acquisition. These laboratory experiments did
not at all reflect sunscreen use during ISE situations.
These data led a Working Group convened by the IARC in
2000 to conclude that:2
1 Sunscreen use may decrease occurrence of SCC.
2 Sunscreen use has no demonstrated influence on BCC.
3 In ISE situations, sunscreen use may increase the risk of
melanoma.
The traditional and alternative view on the
biological effects of sunscreen use in humans
The traditional view is that the greater the SPF of the sun-
screen actually applied onto the skin (usually 2–4 times lower
than doses used for measuring the SPF), the greater the sun
protection. This view schematized in Figure 3a suggests that
















93 subjects 22 sun worshippers
Fig 2. UV doses [in standard erythemal dose (SED) per day] received
by volunteers wearing personal UV dosimeters, Denmark (Ref. 14).
Table 1 Likely effects of sunscreen use in sun sensitive subjects during non-intentional and intentional sun exposure
Non-intentional sun exposure Intentional sun exposure
Examples Outdoor professional activities, gar-
dening, skiing, walking
Sunbathing, outdoor sport with naked trunk
Type of subjects in studies Old adults or elderlies not sun to tan
attracted, often with history of acti-
nic skin damage
Young adults, suntan seekers
Sunburn occurence Decrease No differencea
Time spent in the sun No change Increase
Influence on risk of
Squamous cell carcinoma Decrease No data
Basal cell carcinoma No change No difference or increase
Cutaneous melanoma No data No difference or increase
aThe increase reported in some studies was probably due to lack of control for sun-sensitivity (ref. 7).
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dose delivered to the skin. The immediate consequence is the
prevention of sunburn. In this case, the decrease in erythemal
effect is paralleled by a proportional decrease in carcinogenic
effects. This view assumes that the duration of sun exposure
remains equivalent with or without sunscreen use. This tradi-
tional view mirrors the results from laboratory studies during
which exposure duration parameters are controlled.
The assumption that duration of sun exposure remains equiva-
lent with or without sunscreen use is not tenable as nothing
indicates to sunscreen users that without the sunscreen, they
would already be sunburned. So, the alternative view schema-
tized in Figure 3b is based on evidence that sunscreen use will
just delay sunburn occurrence but not prevent it, and lead to
increased duration of sun exposure. This increased duration is
sometimes labelled ‘compensatory behaviour’.2 Also, the alter-
native view assumes that the ability to prevent sunburns (as
measured by the SPF) probably does not imply the ability to
prevent melanoma or basal cell carcinoma. This view agrees
with results of randomized trials on sunscreen use and sun ex-
posure duration during ISE and also agrees with laboratory
data suggesting that wavelengths other than the UVB may be
involved in melanoma initiation and growth.6,19 Extension of
sun exposure duration induced by sunscreen use will result in
the increase from point A to point B of the carcinogenic
effects.
So, the traditional view would apply to typically UVB-induced
skin lesions, including squamous cell cancer and solar keratoses.
The alternative view would apply to cutaneous melanoma,
mainly for melanoma occurring on usually sun protected sites
such as the trunk.
Adding specific UVA filters to sunscreens is now common,
and is deemed to improve their anti-cancer properties. But
there is still disagreement on the standard test for evaluating
their anti-UVA properties.20 Indeed, filtering out some of
the UVA may affect biological pathways other than those
involved in erythema but possibly involved in skin carcino-
genesis. However, because the quantity of sunscreen typi-
cally applied to the skin is small and sunlight is very rich
in UVA, it is quite possible that the anti-carcinogenic
defences provided by UVA filters might be overwhelmed
during sunbathing in the midday sun, especially if exposure
time is increased due to a high SPF. We thus do not think
that the schematic view we outlined would be fundamen-
tally different if sunscreens did or did not contain specific
UVA filters. Our reasoning is supported by studies in volun-
teers using sunscreen of the same SPF formulated with
essentially UVB filters or with essentially UVA filters.21 No
difference between the two types of sunscreens was found




































































































Fig 3. Schematic representation of traditional
and alternative views on effects of use
(continuous lines, plain squares and triangles)
or no use (doted lines, open squares and
triangles) of sunscreens in humans. Squares
refer to sunburn occurrence according to UV
dose received in mJ cm)2 on the left Y-axis.
Triangles refer to carcinogenic effects, with an
arbitrary scale of Y-axis on the right. For
simplification, sunburn occurrence and
carcinogenic effects are assumed to linearly
increase with time spent in the sun. In this
example, a sunburn threshold of 30 mJ cm)2
was chosen, but this threshold varies from
subject to subject according to skin
complexion and phototype. Black arrows
indicate effects of sunscreens, and the large
double arrow indicates the threshold for the
alert displayed by an individual UV dosimeter.
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Sunscreen abuse
Sunscreen abuse has two complementary facets. The first is
that most subjects engaging in ISE use a sunscreen in order to
best take advantage of their sun exposure without, do they
believe, incurring side effects, mainly sunburns. The second,
less obvious facet is that sunscreen use during ISE allows sun
exposure behaviors that would not be possible otherwise. The
recommendation to re-apply sunscreen after a certain length
of sun exposure probably represents a form of abuse.
Many studies and prevention campaigns have been conducted
with the belief that recreational sun exposure, specially sun-
bathing, is safer when a sunscreen is used. When there is no
control of sun exposure duration, that belief is questionable.
So, the basic question is, ‘what is most dangerous: sunbathing
with or without using a sunscreen?’ Until a method is found
to prevent subjects unable to refrain from ISE from extending
the time they spend in the sun, they should be advised not to
use sunscreen but rather to let their skin adapt and set strict
limits on the time they spend in the sun. This may be some-
what shocking but it follows the logic outlined in the alterna-
tive view in Figure 3b, because not using a sunscreen would
prevent the stimulation of carcinogenic processes induced by
unfiltered radiation.
Sunscreen abuse is encouraged by the false sense of security
promoted by sunscreen advertisements, claiming or suggesting
that these products protect against carcinogenic processes
when used during ISE, and especially during tan acquisition.
Such advertising encourages sunscreen abuse during ISE and
thus contributes to increasing the risk of melanoma. This
raises consumer protection issues. One day, melanoma patients
could sue sunscreen makers because they were not warned
against excessive sun exposure induced by sunscreen use and
rather lulled by messages promoting sunscreen use during
sunbathing as a way to safely acquire a nice, deep tan. This is
not science fiction as in 2006 in the U.S.A., a class action suit
was filed at the Los Angeles Superior Court for misleading
advertising and fraudulent misrepresentation in the labelling
of sunscreen bottles that, according to the plaintiffs, did not
correctly indicate the hazards associated with the absence or
low UVA blocking capacity of sunscreens.22
How to avoid sunscreen abuse and its
deleterious consequences?
Trying to discourage tan acquisition and deliberate sun expos-
ure during the holidays is not very cost effective, especially
among teenagers and young adults.
Consumer information on sunscreens should better reflect cur-
rent knowledge of potential health hazards associated with
their use during ISE. Cosmetic companies should not pretend
that ‘safe tanning’ exists when using sunscreen.
Sunscreen bottles could bear messages on the hazards associ-
ated with ISE, mainly the longer stay in the sun that may end
up in sunburn and the possibility of higher melanoma risk.
However, such labelling of sunscreen products is not likely to
be well understood, especially if on the other hand, it is
rightly claimed that sunscreen use during non-intentional sun
exposure may decrease skin cancer risk. Sunburns would
remain frequent and no one would understand why lotions
preventing sunburns during NISE would be discouraged dur-
ing ISE.
A wiser approach would be to avoid excess sun exposure
thanks to information on individual UV exposure. Referring
back to Figure 3b, if a subject engaged in ISE is informed after
say 12 min that he or she is nearing his or her specific sun-
burn threshold in the absence of sunscreen use, and if that
subject covers up or moves to a shaded area, then the ery-
themogenic UV dose and the carcinogenic effect would be
lower than if no information was provided.
Practically speaking, UV dosimeters could inform sunscreen
users engaged in ISE. The dosimeter could be worn as a watch
22 or inlayed in the caps of the sunscreen bottle. Indeed, dosi-
meters should be calibrated according to individual sun sensi-
tivity in the absence of sunscreen use. The technology for
cheap individual UV dosimeters already exists that could be
adapted for controlling sun exposure duration.23–25
This approach would reconcile sunscreen and educational
efforts. If feasible such a method would transform an ISE situ-
ation into a NISE situation and sunscreen use could then
decrease skin cancer risk, and probably also melanoma.
Users of dosimeters and sunscreens will surely complain that
tan acquisition is longer, and that they would like to stay
longer in the bright sunshine than allowed by the dosimeter,
but at the end of the day, subjects complying with the
method will understand their health benefit.
Testing this approach may first be done though randomized
trials on sunburn occurrence comparing sunscreen users vs.
sunscreen and dosimeter users. Normally, the latter group
should experience fewer sunburn episodes. A second, test
would be the assessment of changes in nevi count and shape
on the trunk of young adults spending holidays in sunny
areas, again with randomization of sunscreen alone vs. sun-
screen combined with dosimeters.
References
1 Albert MR, Ostheimer KG. The evolution of current medical and
popular attitudes towards ultraviolet light exposure: part 3. J Am
Acad Dermatol 2003; 49:1096–106.
2 International Agency for Research on Cancer. IARC Handbooks of
Cancer Prevention, Vol 5, Sunscreens. Lyon: IARC Press, 2001.
3 Hunter DJ, Colditz GA, Strampher MJ et al. Risk factors for basal
cell carcinoma in a prospective cohort of women. Ann Epidemiol
1990; 1:13–23.
4 Autier P, Dore JF, Cattaruzza MS et al. Sunscreen use, wearing
clothes and nevi number in 6- to 7-year-old European children. J
Natl Cancer Inst 1998; 90:1873–81.
5 Bauer J, Buttner P, Wiecker TS et al. Effect of sunscreen and cloth-
ing on the number of melanocytic nevi in 1,812 German children
attending day care. Am J Epidemiol 2009; 161:620–7.
6 Wolf P, Donawho CK, Kripke ML et al. Effect of sunscreens on UV
radiation-induced enhancement of melanoma growth in mice. J
Natl Cancer Inst 1994; 86:99–105.
 2009 The Author
Journal Compilation  2009 British Association of Dermatologists • British Journal of Dermatology 2009 161 (Suppl. 3), pp40–45
44 Sunscreen and sunscreen exposure, P. Autier
78
7 Autier P, Boniol M, Dore´ JF. Sunscreen use and increased duration
of intentional sun exposure: still a burning issue. Int J Cancer 2007;
121:1–5.
8 Stanton WR, Janda M, Baade PD, Anderson P. Primary prevention
of skin cancer: a review of sun protection in Australia and interna-
tionally. Health Promot Int 2004; 19:369–78.
9 Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous
malignant melanoma to individual sunlight-exposure habits. J Natl
Cancer Inst 1986; 76:403–14.
10 Autier P, Dore´ JF, Ne´grier S et al. Sunscreen use and duration of
sun exposure: a double blind randomized trial. J Natl Cancer Inst
1999; 15:1304–9.
11 Autier P, Dore JF, Reis AC et al. Sunscreen use and recreational
exposure to ultraviolet A and B radiation: a double blind random-
ized trial using personal dosimeters. Br J Cancer 2000; 83:1243–8.
12 Dupuy A, Dunant A, Grob JJ. Randomized controlled trial testing
the impact of high-protection sunscreens on sun-exposure behav-
ior. Arch Dermatol 2005; 141:950–6.
13 Green A, Williams G, Neale R, Battistutta D. Betacarotene and sun-
screen use: author’s reply. Lancet 1999; 354:2163–4.
14 Thieden E, Philipsen PA, Sandby-Møller J, Wulf HC. Sunscreen use
related to UV exposure, age, sex, and occupation based on per-
sonal dosimeter readings and sun-exposure behavior diaries. Arch
Dermatol 2005; 141:967–73.
15 Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by
regular sunscreen use. New Eng J Med 1993; 329:1147–51.
16 Naylor MF, Boyd A, Smith DW et al. High sun protection factor
sunscreens in the suppression of actinic neoplasia. Arch Dermatol
1995; 131:170–5.
17 Green A, Williams G, Neale R et al. Daily sunscreen application and
betacarotene supplementation in prevention of basal-cell and squa-
mous-cell carcinomas of the skin: a randomised controlled trial.
Lancet 1999; 354:723–9.
18 Gallagher RP, Rivers JK, Lee TK et al. Broad-spectrum sunscreen use
and the development of new nevi in white children. JAMA 2000;
283:2955–60.
19 De Fabo EC. Initial studies on an in vivo action spectrum for mela-
noma induction. Prog Biophys Mol Biol 2006; 92:97–104.
20 Diffey B. Spectral uniformity: a new index of broad spectrum
(UVA) protection. Int J Cosmet Sci 2009; 31:63–8.
21 Young AR, Sheehan JM, Chadwick CA, Potten CS. Protection by
ultraviolet A and B sunscreens against in situ dipyrimidine photole-
sions in human epidermis is comparable to protection against sun-
burn. J Invest Dermatol 2000; 115:37–41.
22 Superior Court of the State of California for the county of Los
Angeles. JCCP No. 4352. Amended master complaint for the master
proceeding. Filed on 30 March 2006 at the Los Angeles Superior
Court.
23 Thieden E, Agren MS, Wulf HC. The wrist is a reliable body site
for personal dosimetry of ultraviolet radiation. Photodermatol Photoim-
munol Photomed 2000; 16:57–61.
24 Mills A, Grosshans P. UV dosimeter based on dichloroindophenol
and tin(IV) oxide. Analyst 2009; 134:845–50.
25 Moehrle M, Garbe C. Personal UV dosimetry by Bacillus subtilis spore
films. Dermatology 2000; 200:1–5.
 2009 The Author
Journal Compilation  2009 British Association of Dermatologists • British Journal of Dermatology 2009 161 (Suppl. 3), pp40–45














most compelling epidemiological evidence  to  the 1992 Monograph  for sunlight 
being causally associated with melanoma. They also corroborated the notion that 








We  performed  two  studies  on  childhood  sun  exposure  and  nevus  count  or 
melanoma.  The  first  study  was  linked  to  the  1992‐93  case‐control  study  in 







A  more  detailed  analysis  of  the  1992‐93  case‐control  study  showed  that 
melanoma  risk  decreased  with  decreasing  sun  exposure  (including  fewer 
sunburns) and increasing sun protection during childhood (Autier et al, 1996). 
 







and  during  adult  life,  using  the  data  collected  on  sun  exposure  and  sun 
protection  during  these  two  periods  of  life  (Autier  &  Doré,  1998).  The  main 
finding  was  that  regardless  of  the  level  of  sun  exposure  as  an  adult,  the 
development of a melanoma appeared unlikely in the absence of significant sun 
exposure  during  childhood  (Figure  4.1).  In  addition,  sun  exposure  during 
adulthood was mandatory for the development of melanomas initiated by heavy 
sun exposure during childhood.  
Fig. 4.1 -Melanoma risk and sun exposure during childhood and 
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We  then  examined  determinants  of  nevus  counts  in  children  using  statistical 
methods allowing multiple adjustments  for  the various host characteristics and 
sun exposure  factors  involved  in nevus development. We  found  that  the sharp 
gender  differences  in  body  site  distribution  of  adult  melanoma  are  already 
visible  for nevi  in  children  (Autier  et al, 2004). However,  the nevus density  in 
young girls was  lower on  lower  limbs  than on other body  sites, although girls 








The natural propensity  to burn or  to  tan when  in  the sun  (the skin phototype), 
and pigmentary  traits  (the eye  colour) were  risk  factors  for higher numbers of 
small  nevi  but  not  for  numbers  of  large  nevi.  These  host  factors  had  more 
influence on small nevi counts than sun exposure factors. We further found that 
the number  and duration  of holiday periods were moderately  associated with 
increasing numbers of nevi 2  to 4.9 mm, but not with nevi ≥ 5mm  (Autier et al, 















1/ Our study  in subjects who spent part of  their  life  in sunnier areas prompted 
the review by D Whiteman et al on migrations and melanoma (Whiteman et al, 
2001) in which they confirmed that both melanoma incidence and mortality were 
higher when migration  took place  at young  ages  than  if  it  took place  at older 
ages. According to Whiteman et al (2001) our study on migration from “high to 
lowʹʹ ambient sunlight “provided  the most persuasive evidence  that high  levels 












al,  2003;  Gallagher  et  al,  1990;  Harrison  et  al,  1999;  Synnerstad  et  al,  2004; 
Valiukeviciene et al, 2007). All these studies found that the anatomic distribution 
of  nevi  in  children  and  young  adolescents was  close  to  that  of melanoma  in 
adults, except  for  female  lower  limbs.  In  fact, nevus numbers on  female  lower 
limbs  rise  fast  during  adolescence  (Nichols  1973;  Gallagher  et  al,  1990)  and 
around 18 years of age, nevus density on  female  lower  limbs surpasses  that of 
other body  sites. Our additional  contribution was  that  that young girls  tended 
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Abstract
Background: Since 1950, the greatest increase in
cutaneous melanoma incidence in fair-skinned males
took place on the trunk and on the head and neck,
whereas in females, it took place on the limbs, mainly
on the lower limbs. We examined the influence of sex
on numbers and size of nevi on different body sites in
white European schoolchildren.
Methods: Information about each holiday period since
birth to interview was recorded from parents of six
hundred twenty-eight 6- to 7-year-old children in
four European cities (Brussels (Belgium), Bochum
(Germany), Lyons (France), and Rome (Italy)). Number
and anatomic location of small (2-4.9 mm) and large
(5 mm) nevi and individual susceptibility to sunlight
were independently assessed.
Results: After adjustment for host characteristics, sun
exposure, and sun protection habits, males had 7%
[95% confidence interval (95% CI), 7 to 19] more small
nevi than females. However, compared to females,
numbers of small nevi were increased by 17% (95% CI,
1-31) on the head and neck and by 16% (95% CI, 2-27)
on the trunk and shoulders. In contrast, in males, the
number of small nevi on upper limbs was decreased by
5% (95% CI, 26 to 13), and on lower limbs by 8%
(95% CI, 34 to 13). The number of large nevi was 6%
higher in males than in females (95% CI, 26 to 30).
Conclusions: The sex differences in small nevus
distribution in schoolchildren reflect the sex diffe-
rences in the anatomic distribution of melanoma in
adults. Sex differences in sun exposure behaviors,
dressing, and clothing would just add their effects to
the sex-dependent inherited propensity to develop
nevi on a given body site. These results reinforce the
hypothesis by which childhood would be a decisive
period for the occurrence of sun-induced biological
events implicated in the genesis of cutaneous
melanoma. (Cancer Epidemiol Biomarkers Prev
2004;13(12):2003–5)
Introduction
In most fair skinned populations, the incidence of
cutaneous malignant melanoma (melanoma) has consi-
derably increased in the past 50 years, most probably
because of the increase in intermittent sun exposure that
took place after World War II (1). In many populations,
the incidence of melanoma is slightly higher in females
than in males. But gender differences in melanoma
incidence are more pronounced when anatomic sites are
considered: in males, the greatest increase in melanoma
incidence over time took place on the trunk and the head
and neck, whereas in females, the greatest increase in
incidence over time took place on the limbs, mainly the
lower limbs (2-4).
The number of nevi is the best predictor of melanoma
occurrence in adults (5). The increase in nevus density
(i.e., the number of nevi per unit of skin surface) is
maximal before 15 years old (6-8). After nevus density
stabilization at around 30 to 35 years old, nevus
frequency steadily decreases with age. Nevus develop-
ment is strongly genetically determined, but sun expo-
sure would be necessary for complete phenotypic
expression of the nevus genotype (9, 10).
Little is known of association between gender and
nevus development. In this work, we examined the
influence of sex on numbers and size of nevi on different
body sites in white European 6- to 7-year-old children.
Methods
The study design has been described in a previous report
(11). Briefly, 6- to 7-year-old Caucasian children were
recruited between October 1995 and February 1997 in
elementary schools of Brussels (Belgium), Bochum
(Germany), Lyons (France), and Rome (Italy).
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Total Body Nevus Count. In each city, a physician
trained for the recognition of skin pigmented lesions
examined the entire skin of children in the primary
schools. The scalp, the genital area, and the buttocks
were not examined. Counting of nevi was done using
transparent plastic slides pierced with 2- and 5-mm
holes. We thus directly distinguished nevi with dimen-
sions in the range 2 to 4.9 mm (hereafter referred as small
nevi) from nevi with dimensions 5 mm (hereafter
referred as large nevi).
Statistical Analysis. Examination of the influence of
gender on nevus counts took into account the influence
of other host and environmental factors that could be
associated with gender. Details of the analysis proce-
dures have been reported in previous article (12). In brief,
two Poisson regression models were constructed, one
having as end point the number of small nevi, and the
other the number of large nevi. For small nevi, models
were applied separately to four body sites (trunk and
shoulders, upper limbs, lower limbs, and head and neck).
Poisson regression models for small nevi included
variables related to host characteristics and sun exposure
or sun protection habits. Models for large nevi were
further adjusted for number of small nevi. A result was
labelled as statistically significant if zero was not
comprised in the 95% confidence interval.
Results
Parents who agreed to participate represented 682 (55%)
out of the 1,234 apparently eligible children approached.
Fifty-one children were excluded from the study because
the child was not of Caucasian origin, or the skin
examination was not done (e.g., the child was not willing
to be examined), or the parents could not be reached for
the interview. Three children were further excluded
because of missing data in adjustment variables. The final
sample for statistical analysis comprised 628 children (319
boys and 309 girls).
The median was 6 nevi 2 mm per child (range,
0-77). Detailed body distribution of nevi has been
published elsewhere (13). In brief, of 5,933 nevi, 5,638
(95%) were small nevi (i.e., with one dimension
between 2 and 4.9 mm), and 295 (5%) were large nevi
(i.e., with one dimension 5 mm). Thirty-nine percent
of small nevi were located on the trunk and shoulders,
compared with 69% of large nevi, implying that large
nevi are more likely than small nevi to develop on
trunk and shoulders than on other body sites.
Table 1 shows that the total of small nevi was similar
for boys and girls. In males, small nevi were somewhat
more numerous on trunk and shoulders, and on head
and neck, but less numerous on limbs. Large nevi were
more numerous in males.
After multiple adjustments, small nevus numbers on
trunk and shoulders and on the head and neck became
significantly more associated with male than with female
gender. A positive association (although not significant)
with female gender was found in the upper limbs and in
the lower limbs.
Apparently, males had more large nevi than females.
But because (i) the number of small nevi is a strong
predictor of the number of large nevi (12) and (ii) that
most large nevi are located on the trunk and shoulders
(13), adjusting for small nevi decreased the apparent
association between male gender and the number of
large nevi. No gender difference was apparent when the
analysis of large nevus numbers was restricted to the
trunk and shoulders (data not shown).
Discussion
Our study assessed the predictors of nevus counts in
European young children according to body site, with
multiple adjustments for host characteristics, sun expo-
sure, and sun protection habits. Boys ages 5 to 6 years
had significantly more small nevi (2-4.9 mm) on the back
and shoulders, and on the head and neck than girls of
same age. In contrast, in girls, there was a tendency for
more small nevi on the limbs. Our results are comparable
to those from studies in Australian adolescents and
schoolchildren that found significantly larger numbers of
small nevi on the back (14, 15) and on the head and neck
(14) of males, whereas larger number numbers of small
nevi were observed on female lower limbs (15). Alike the
Australian study in schoolchildren (15), we found a
larger number of large nevi in boys than in girls, but
because the number of large nevi is strongly linked to the
Table 1. Numbers of nevi on body sites of 628 European children 6 to 7 years old
Body site Males (n = 319) Females (n = 309) % Difference males/females
Mean Range Mean Range Unadjusted* Adjusted
c
95% Confidence interval
Nevi, 2 to 4.9 mm (n = 5,638)
All sites 9.1 0-65 8.9 0-77 2 7 7 to 19
Head and neck 1.5 0-16 1.3 0-9 14 17 1-31
Trunk and shoulders 3.7 0-25 3.2 0-29 13 16 2-27
Upper limb 1.9 0-3 2.1 0-3 9 5 26 to 13
Lower limb 1.9 0-2 2.2 0-3 16 8 34 to 13
Nevi, >5 mm (n = 295) 0.5 0-10 0.4 0-8 19 6
b 26 to 30
NOTE: Buttocks, genital area, and scalp not included. Surface of selected body areas represent 86.5% of total body surface area.
*No unadjusted ratio reached statistical significance.
cMean adjusted difference between males and females, with females being the reference category, expressed in %, and 95% confidence interval. %
differences are derived from coefficients of a Poisson regression models, including variables related to sun exposure, the skin phototype, the eye color, the
average number of holiday periods, the average total duration of sun exposure, the average difference in latitude, the number of sunburn episodes, the
study place, the average wearing of trousers and shirt, the average wearing of hat, and the average sunscreen use during holidays.
bSame model as for nevi 2 to 4.9 mm, with inclusion of numbers of nevi 2 to 4.9 mm as a continuous variable.
Gender and Nevi Distribution2004
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number of small nevi, adjustment on small nevus
numbers cancelled most of the gender influence on large
nevus counts.
The gender difference we found in numbers of nevi 2
to 4.9 mm according to body site in school children is
similar to the gender difference in body site distribution
of melanoma found in adults (16-18). Studies with the
Swedish Cancer Registry showed that before 20 years
old, melanoma occurrence is more frequent on upper and
lower limbs in females, whereas in males, it is more
frequent on the trunk (19).
For explaining the gender difference in anatomic
distribution of melanoma, gender differences in sun
exposure behaviors and in dressing and clothing styles
have been evoked (e.g., longer hair in females, or
wearing of miniskirt by women versus pants by males;
ref. 16). However, previous reports on data used in this
study showed no significant gender difference in sun
exposure, sunburn history (during and outside holiday
periods), sun protection habits, sunscreen use, and
wearing of clothes when in the sun (11, 12, 20). Moreover,
that explanation cannot address the substantial gender
differences observed on the trunk and shoulders.
A study done in Canadian Hutterite children found
similar gender-specific differences in the body site
distribution of nevi (21). The traditional religious costume
of Hutterite children protects them from sun exposure,
and thus in this population, gender difference in clothing
or in sun exposure habits can hardly explain gender
differences observed in body site nevus distribution.
Our results suggest that anatomic location of melano-
ma diagnosed during adult life would be already
determined during the first years of life. Sex differences
in sun exposure behaviors, dressing, and clothing would
just add their effects to the inherited proneness to
develop nevi on a given body site.
Studies on migrants have provided the most com-
pelling evidence that childhood was a decisive period
for sun-induced biological lesions involved in the
genesis of melanoma (22). The results of this study
reinforce the likelihood of the childhood hypothesis.
The biological lesions acquired at these ages would
survive during all life.
The numbers of small nevi and of large nevi are
independent predictors of melanoma occurrence (23, 24).
The fact that we found gender to be a predictor of the
body site development of small, but not of large nevi,
supports the hypothesis by which small nevi and large
nevi would be related to different biological events
involved in the genesis of melanoma.
The genetic information is identical in all melanocytes
of an individual, and a nevus is a monoclonal expansion
of a single melanocyte (25, 26). From a study on body site
variations in benign melanocytic nevi adjacent to
melanoma, Green (27) proposed the hypothesis of site-
specific susceptibility to sunlight and to malignant
transformation. Studies in European and in Australian
children confirmed the site-specific differences in prolif-
eration potential of melanocytes (13, 15). We further
hypothesize that the likelihood for a melanocyte situated
in a given anatomic site to develop into a small nevus is
also influenced by gender. Thus, whatever happens in
sun exposure in later life, sex-linked genetic factors
acting during early life influence the likelihood that a
melanoma would occur on a given body site.
References
1. IARC. Solar and ultraviolet radiation. Monographs on the evaluation
of the carcinogenic risk of chemicals to humans. Vol. 55. Lyon: IARC;
1992.
2. Osterlind A, Hou-Jensen K, Moller Jensen O. Incidence of cutaneous
malignant melanoma in Denmark 1978-82. Anatomic site distribu-
tion, histologic types, and comparison with non-melanoma skin
cancer. Br J Cancer 1988;58:385 – 91.
3. MacKie R-M, Bray C-A, Hole D-J, et al. Incidence and survival from
malignant melanoma in Scotland: an epidemiological study. Lancet
2002;360:587 – 91.
4. Chen Y-T, Zheng T, Holford T-R, Berwick M, Dubrow R. Malignant
melanoma incidence in Connecticut (United States): time trends and
age-period-cohort modeling by anatomic site. Cancer Causes Control
1994;5:341 – 50.
5. Berwick M, Halpern A. Melanoma epidemiology. Curr Opin Oncol
1997;9:178 – 82.
6. Harrison S, MaKie R-M, MacLennan R. Development of melanocytic
nevi in the first three years of life. J Natl Cancer Inst 2000;92:1436 – 8.
7. English D-R, Armstrong B-K. Melanocytic nevi in children. I.
Anatomic sites and demographic and host factors. Am J Epidemiol
1994;139:390 – 401.
8. Green A, Swerdlow T. Epidemiology of melanocytic nevi. Epide-
miologic Rev 1989;11:204 – 21.
9. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. Genetics
of risk factors for melanoma: an adult twin study of nevi and freckles.
J Natl Cancer Inst 2000;92:457 – 63.
10. Wachsmuth R-C, Gaut R-M, Barret J-H, et al. Heritability and
gene-environment interactions for melanocytic nevus density
examined in a U.K. adolescent twin study. J Invest Dermatol
2001;117:348 – 52.
11. Autier P, Dore´ J-F, Cattaruzza M-S, Renard F, et al. Sunscreen use,
wearing clothes and nevi number in 6- to 7-year-old European
children. J Natl Cancer Inst 1998;90:1873 – 81.
12. Autier P, Severi G, Pedeux R, et al. Number and size of nevi are
influenced by different sun exposure components: implications for
the etiology of cutaneous melanoma (Belgium, Germany, France,
Italy). Cancer Causes Control 2003;14:453 – 9.
13. Autier P, Boniol M, Severi G, et al. The body-site distribution of
melanocytic nevi in 6 to 7 year old European children. Melanoma Res
2001;11:123 – 31.
14. Darlington S, Siskind V, Green L, Green A. Longitudinal study of
melanocytic nevi in adolescents. J Am Acad Dermatol 2002;46:715 – 22.
15. MacLennan R, Kelly J-W, Rivers J-K, Harrison S-L. The Eastern
Australian Childhood Nevus Study: site differences in density and
size of melanocytic nevi in relation to latitude and phenotype. J Am
Acad Dermatol 2003;48:367 – 75.
16. Bulliard J-L, Cox B, Elwood J-M. Comparison of the site distribution of
melanoma in New Zealand and Canada. Int J Cancer 1997;72:231 – 5.
17. Elwood J-M, Gallagher R-P. Body site distribution of cutaneous
malignant melanoma in relationship to patterns of sun exposure. Int J
Cancer 1998;78:276 – 80.
18. Green A, MacLennan R, Youl P, Martin N. Site distribution of
cutaneous melanoma in Queensland. Int J Cancer 1993;53:232 – 6.
19. Berg P, Lindelof B. Differences in malignant melanoma between
children and adolescents. A 35-year epidemiological study. Arch
Dermatol 1997;133:295 – 7.
20. Severi G, Cattaruzza M-S, Baglietto L, et al. Sun exposure and sun
protection in young European children. An EORTC multicentric
study. Eur J Cancer 2002;38:820 – 6.
21. Kwan T-Y, Belke T-W, Enta T. Sex differences in the anatomical
distribution of melanocytic nevi in Canadian Hutterite children.
J Cutan Med Surg 2000;4:58 – 62.
22. Whiteman D-C, Whiteman C-A, Green A. Childhood sun exposure
as a risk factor for melanoma: a systematic review of epidemiologic
studies. Cancer Causes Control 2001;12:69 – 82.
23. Bataille V, Newton-Bishop JA, Sasieni P, et al. Risk of cutaneous
melanoma in relation to the numbers, types and sites of naevi: a case-
control study. Br J Cancer 1996;73:1605 – 11.
24. Tucker M-A, Halpern A, Holly E-A, et al. Clinically recognized
dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA
1997;277:1439 – 44.
25. Robinson W-A, Lemon M, Elefanty A, et al. Human acquired nevi are
clonal. Melanoma Res 1998;8:499 – 503.
26. Harada M, Suzuki M, Ikeda T, Kaneko T, Harada S, Fukuyama M.
Clonality in nevocellular nevus and melanoma and expression-based
clonality analysis at the X-linked genes by polymerase chain reaction.
J Invest Dermatol 1997;109:656 – 60.
27. Green A. A theory of site distribution of melanomas: Queensland,
Australia. Cancer Causes Controls 1992;3:513 – 6.
Cancer Epidemiology, Biomarkers & Prevention 2005









This  Section  exploits  parts  of  our  works  suggesting  that  the  UVA  may  be 













On  the  public  health  side,  if  UVB  is  the  wavelength  involved  in  melanoma 
occurrence,  then sun protection  should aim at maximising  the  reduction  in  the 
amounts  of  UVB  reaching  the  skin;  this  philosophy  is  at  the  origin  of  the 
manufacturing of high SPF sunscreens. If UVA is the relevant wavelength, then 
sunscreens prepared with UVB filters may not be protective and  indoor “UVA‐
tanning”  is  a  real  health  hazard.  The  glass  blocks  the UVB  but  not  the UVA. 
Hence, staying behind a glass would not be that protective if UVA is involved in 
melanoma genesis. If both  the UVA and UVB are  implicated  in melanoma, sun 
protection needs to target reducing exposure to the entire UV spectrum.  
 
On  the  economic  side,  the  scientific  activities  surrounding  UVA  and  UVB 




UVB  as  the  carcinogenic  wavelength  and  UVA  having  no  demonstrated 
carcinogenic properties in humans.    
                                                 
1 Examples of sources of pure UVB are TL2 lamps for phototherapy of psoriasis. Examples of pure UVA 
sources are lamps used for PUVA treatments of severe psoriasis. 
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We did not measure UV wavelengths  in our studies, with  the exception of    the 
second  randomised trial on sunscreen use and sun exposure duration (Autier et 
al,  2000c).  Exposure  data  collected  by  epidemiological  studies  are  thus  by  no 
means  reflecting  exposure  to  pure  sources  of  UVA  or  UVB.  However,  some 
results of our studies can inform on the type of wavelength possibly involved in 
nevus  and  melanoma  occurrence.  Indeed,  wavelength  boundaries  in  our 
hypotheses  may  be  different  than  ranges  defined  by  physicists  and  in  the 
remainder of this section, the terms “UVA” and “UVB” are purely indicative of 







evidence  that  exposure  of  sun‐susceptible  individuals  to high UVA  fluxes  can 
trigger melanoma.  Indeed, some UVB  is always present  in  the UV spectrum of 
sun‐tanning  lamps  but  the  genuine  characteristics  of  the  majority  of  modern 
canopy‐like UV‐tanning units  is  to deliver UVA dosages  that are much higher 
than  what  is  delivered,  for  example,  by  the  summer  midday  sun  on  a 
Mediterranean beach.  
 
Second,  the  raised  melanoma  risk  associated  with  increased  ISE  duration 
induced  by  sunscreen  use  would  be  due  to  greater  exposure  to  the  UVA 
radiation (Autier 2009; Autier et al, 2011).  
 






the  SPF  30  group  had  greater  accumulation  of  UVA  over  the  entire  holiday 
period,  but  higher  exposure  to  UVB  during  days  with  sunbathing. 
Retrospectively,  we  consider  that  these  seemingly  contradictory  results  are 
attributable  to  dosimeters  measuring  UVA  and  UVB  exposure  but  not  the 
amounts of UVA or UVB passing through the sunscreen layer and reaching the 
skin. As high SPF sunscreens are probably better at blocking UVB than UVA and 






Fifth, we  found  sunburn  history  and  lower  latitude  holidays were  associated 
with large nevi (≥5mm) in children but not with small nevi (2 to 4.9 mm) (Autier 
et  al,  2003a).  In  contrast,  quantities  and durations  of holidays were  associated 
with numbers of small but not of large nevi. UVB is approximately one thousand 
times more potent than UVA in triggering sunburn (IARC, 1992). UVA and UVB 
fluxes  reaching  the  earth’s  surface  increase with  decreasing  latitude  but UVB 
increases more  rapidly  than UVA  fluxes. Hence,  latitudinal  differences  reflect 
more differences in UVB than in UVA fluxes (IARC, 1992). These results suggest 
that  the UVB would  be  the main  trigger  of  the  radial  growth  phase  of  nevi, 
leading to their enlargement and probably also to acquisition of clinical features 
of  “atypia”.  UV  wavelength  other  than  the  UVB,  i.e.,  the  UVA,  would  be 
involved in the initial steps triggering nevus formation. 
  
We  view  these  five  sets  of  results  as  providing  indirect  evidence  that  UV 
wavelengths in the UVA range might be involved in the genesis of melanoma.  
 
The effect of  sunburn and of  latitudinal differences between place of  residence 
and  holiday  locations  indicate  that  the  radial  growth  of  nevi would  compare 
with animal  experiments  that  showed  the  capacity of UVB  to  trigger nevus or 
melanoma‐like skin  lesions  in young suckling nude mice or  in human newborn 
foreskin grafted in mice. The key question is to establish what triggers initiation 
of  the  vertical  growth phase  (VGP). Animal  studies  favour  the UVB  radiation 





The  sunbed‐induced  melanoma  epidemic  we  described  in  Iceland  developed 






additional  clues  to  the  Icelandic  observations.  The  Breslow  thickness  is  the 
measure  of  the  vertical  growth  phase  of  a  melanoma,  i.e.  the  length  of  the 
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tumour that has invaded the dermis. The Breslow thickness is a strong predictor 
of  survival  ‐  the  thicker  a  melanoma,  the  greater  the  probability  of  distant 
metastases  in  lymph  nodes  or  in  distant  organs  and  thus  the  greater  the 
likelihood to die from it (Balch et al, 2009). Because of a multiplicity of biases (see 
section 2), this European multicenter could not conclude on existence or absence 
of  an  association  between  sunbed  use  and  melanoma.  Figure  5.1  displays  an 
intriguing unpublished statistical analysis:  the  thicker  the melanoma,  the  lower 
the  risk  associated  with  sunbed  use.  In  the  light  of  the  Icelandic  melanoma 
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Odds-ratio bootstrap (1000 simulations per point) of melanoma risk associated with sunbed use according to 
Breslow thickness, adjusted for sex and for age. Odds ratios are in bold and dotted lines represent the 95% CI.
Fig. 5.1 - Risk of being diagnosed with thin or a thick melanoma according to 







mainly  among  younger  female  subjects  (particularly  in  the  Nordic  countries, 
Australia and USA) (Giles et al, 1996; Severi et al, 2000; de Vries et al, 2003; Linos 






hot  hours, would  lead  to  a  “UVA‐shift”  in UV  exposure  that would  result  in 






1/ Ecological  studies  (e.g., Moan  et  al,  1999)   have  found  that  country‐specific 
incidence  of  non‐melanoma  skin  cancer  correlated  with  the  UVB  latitude 
gradient.  However,  these  studies  found  that  melanoma  incidence  correlated 
better with the UVA latitude gradient than with the UVB latitude gradient. These 
data proceeding  from ecological  considerations were  considered as  speculative 





fish  (Setlow  et  al,  1993).  This  unique  experiment  has  fuelled  the  UVA/UVB 
controversy  during  nearly  two  decades.  In  2009,  the  same  experiment  was 




3/  In vitro data have accumulated over  the  recent years on  the  capacity of  the 
UVA  to  induce DNA mutations and affect DNA  repair,  immune  function,  cell 
integrity, cell cycle regulation, and other critical biological functions [e.g., Ridley 
et  al,  2009; Rünger & Kappes,  2008; Mouret  et  al,  2006;  Petra  et  al,  2009;  von 






1/ Numerous experiments  failed  to show  that  irradiation of animals with UVA 
could  trigger  a  tumour  resembling  a human nevus or melanoma  (reviewed  in 
Zaidi et al, 2008, and summarised in Autier et al, 2011). An important finding of 
animal experiments is the greater vulnerability of newborn animals or of human 
skin  from babies  to carcinogenic effects of UVB.  In contrast, UVB  irradiation of 
adult  animals  or  on  skin  from  adult humans has  a  very  low  ability  to  induce 
melanocytic lesions (Noonan et al, 2001; Berking et al, 2002) The overall concern 
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regarding  these experiments  is  to establish how  their  results apply  to humans. 
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Purpose of review
Epidemiological data have contributed to the classification in 2009 of the full ultraviolet
(UV) radiation spectrum as carcinogenic to humans. We reviewed the epidemiological
evidence that UVA could be involved in the genesis of cutaneous melanoma.
Recent findings
Use of artificial UV tanning devices (sunbeds) consists mainly of repeated exposure to
high UVA doses. Epidemiological studies published over the last years confirmed the
association between sunbed use and melanoma. Sunbed use is the most probable
cause of an epidemic of melanoma that took place in Iceland from 1990 to 2006. The
four-fold increase in melanoma incidence was not followed by an increase in melanoma
mortality. Sunscreens were primarily devised for the prevention of sunburn, and
UVB is the wavelength causing most sunburns. All observational studies and
randomized trials show that sunscreen use may extend sun exposure intended for
getting a tan, while it does not necessarily decrease sunburn occurrence. Sunscreen
use for tan acquisition would thus lead to similar exposure to UVB and greater exposure
to UVA, which could explain the slightly higher melanoma risk often found among
sunscreen users.
Summary
UVA could be involved in the occurrence of nonlife-threatening melanoma. The
increasing use of sunbeds and of sunscreens may partly explain why melanoma
incidence increases in most light-skinned populations without concomitant increase in
mortality.
Keywords
indoor tanning, melanoma, sunscreens, ultraviolet radiation
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1040-8746Introduction
The burden of melanoma is still rising in most light-
skinned populations. There is now a large body of
scientific evidence that the ultraviolet (UV) wavelength
is the main environmental cause of skin cancer, includ-
ing melanoma. In 2009, the International Agency for
research on cancer classified the full UV spectrum
[including the UVA (>315–400 nm), UVB (>280 to
315 nm) and UVC (200–280 nm)], as well as artificial
UV tanning devices (sunbeds) as carcinogenic to
humans (group 1 carcinogens) [1]. In support of this
classification, the full sequencing of the genome of a
malignant melanoma showed that the dominant muta-
tional signature in melanoma cells reflects DNA
damage due to UV light exposure [2]. However,
the UV-induced biological mechanisms critical for initi-
ating the development of this potentially life-threaten-
ing cancer are still largely unknown.opyright © Lippincott Williams & Wilkins. Unauth
1040-8746  2011 Wolters Kluwer Health | Lippincott Williams & WilkinsThe UV radiation reaching the Earth’s surface is com-
posed of 2–10% UVB and of 90–98% UVA. By the
end of the 1980s, the carcinogenic properties of UVB
were already well documented and it was recognized as
the main environmental factor involved in squamous
cell carcinoma (SCC) [3]. Basic research data have
accumulated over the recent years on the capacity
of UVA to induce DNA mutations and affect DNA
repair, immune function, cell integrity, cell cycle regu-
lation, and other critical biological functions (e.g.,
[4–6,7]). These studies showed that the carcinogenic
mechanisms of UVA and UVB differ but sometimes
overlap.
Despite basic research findings, animal experiments
failed to show that irradiation with UVA could trigger
a tumour resembling a human nevus or melanoma
(reviewed in [8]). An experiment on Xiphophorus
fish by Setlow et al [9]. showed that UVA wasorized reproduction of this article is prohibited.
DOI:10.1097/CCO.0b013e3283436e5d
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C190 Melanoma and other skin neoplasmsas effective as UVB in triggering nonmetastasizing
melanomas in the fish. This unique experiment has
fuelled the UVA/UVB controversy during nearly two
decades. In 2009, the same experiment was repeated,
using a much larger number of Xiphophorus fish in
stringently controlled experimental conditions [10]. It
showed no impact of UVA on melanoma development
in the fish.
The overall concern regarding these experiments is to
establish how their results apply to humans. The bare
human skin is very different from rodent skin and labora-
tory experiments cannot reproduce the complex human
sun behaviours.
Epidemiological data have contributed to the IARC
classification of the full UV range and of artificial UV
devices as carcinogenic to humans. In this paper, we
review the evidence provided by epidemiological stu-
dies that UVA can be involved in the genesis of
cutaneous melanoma. We also present a hypothesis as
to the type of melanoma induced by UVA, and how this
hypothesis may explain epidemiological features of
this cancer.Sunbed use is associated with melanoma
occurrence
The majority of modern canopy-like UV-tanning units
are equipped with low-pressure fluorescent lamps with
a spectrum mainly emitting in the UVA range plus
some UVB (which is necessary for inducing a deep
long-lasting tan). High-pressure lamps producing large
quantities of long-wave UVA (>335–400 nm) per unit
of time are also marketed. Sunbeds deliver UVA
dosages that are 5–15 times higher than what is deliv-
ered by the summer mid-day sun on a Mediterranean
beach. Compared with the summer midday sunlight,opyright © Lippincott Williams & Wilkins. Unautho

























































Age-adjusted (World Standard population) incidence of cutaneous melano
[21]; 3-year moving average for Iceland).these machines emit much higher fluxes of UVA and
lower fluxes of UVB.
Observational studies
Observational studies from 1994 to 2005 have documen-
ted that exposure of sun-susceptible individuals to
sunbed can trigger melanoma, mainly when this
exposure started before 30 years of age [11,12]. Epi-
demiological data published after the IARC report of
2006 [11] further documented the links between arti-
ficial UV tanning and melanoma. They included three
large case–control studies in the USA [13,14,15], the
prospective U.S. Nurse’s Health Study [16] and the
confirmation of previous results of the Norwegian–
Swedish cohort study [17]. Even in Australia where
sunshine is abundant, a case–control study organized
within the Australian Melanoma Family Study found
sunbed use to be associated with increased risk of early-
onset melanoma [18].
The melanoma epidemic in Iceland
A few years ago, we predicted that melanomas associated
with solarium use would be preferentially localized to
anatomic sites that are usually only intermittently sun
exposed such as the trunk [19]. This phenomenon should
be mainly noticeable among women because sunbed use
allows unrestricted UV exposure of the trunk. Iceland is a
Nordic country situated at 64–668 north latitude where
bright, sunny days are rare. In a collaborative work with
the Iceland Cancer Registry and Icelandic dermatolo-
gists, we described an epidemic of melanoma starting in
1995 [20]. Before 1995, the melanoma incidence in
Iceland was lower than in Denmark and Sweden
(Fig. 1) [21]. In the 1990s, it started to rise steeply and
after 2000, it surpassed the incidence in other Nordic
countries. This phenomenon was mainly noticeable
among women. A particular feature of that epidemic
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Figure 2 Analysis of cutaneous melanoma incidence in Iceland (1955–2007)
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Join-point analysis of age-standardized (ASR, World Standard population) cutaneous melanoma incidence in Iceland (1955–2007) by morphologic
site for women (a) and for men (b). Adapted with permission from [20].the trunk of women under the age of 50. Around the year
2000, the incidence of trunk melanoma in women had
surpassed the incidence of lower limb melanoma (Fig. 2).
This latter aspect was in sharp contrast with the usual
observations prior to 1995 whereby the greatest increase
in melanoma incidence in women occurred on lower
limbs [22].
Our investigation concluded that the only plausible
explanation for this epidemic was the massive exposure
of Icelandic youths to artificial tanning devices after 1985
[23]. The decrease in incidence after 2001 in women and
2004 in men (Fig. 1) is most probably due to campaigns
initiated by the Icelandic health services at the end of the
1990s to discourage sunbed use.
Sunbed use and recent changes in melanoma incidence
in women
The Icelandic data are not a unique story. In the UK
and the USA, rebounds of increase of melanoma inci-
dence from 1998 onwards have been reported for
women 20–39 years old [24,25], possibly due to the
spread of the indoor tanning fashion. In Northern
Ireland and Scotland, the UK areas where sunbed
use is most prevalent [26], the highest increase in
incidence rates was observed on the female trunk
[27,28]. In the USA, after 1996, trunk melanomas
among younger women are increasing relative to all
other anatomic body sites [29]. Sunbed use has been
popular in Sweden since the beginning of the 1980s.
Over the last 20 years, the incidence of trunk melanoma
in Swedish women has caught up the incidence of lower
limb melanoma [30].opyright © Lippincott Williams & Wilkins. UnauthSunscreen use during intentional sun
exposure may increase the risk of melanoma
Sunscreens have the ability to prevent sunburn occur-
rence, and the higher the sun protection factor (SPF) of a
sunscreen, the greater the protection against sunburns.
Modern sunscreens contain both organic filters and
mineral oxides and may hence also filter a variable
proportion of UVA, but SPF is a UVB-dependent charac-
teristic since this wavelength is one thousand times more
efficient than UVA for triggering sunburn. Because of the
known association between sunburn and melanoma, it
was believed that prevention of sunburns through sunsc-
reen use would also prevent melanoma.
The sunscreen-melanoma quagmire
Retrospective and prospective population-based epide-
miological studies often found that sunscreen use during
intentional sun exposure (ISE, i.e., sunscreen use for
sunbathing or for allowing longer stays in the sun)
increased the risk of melanoma or of high nevus count
[31–33]. Various explanations, including residual con-
founding or bias by indication were proposed for these
unexpected results, as well as the possibility that sunsc-
reens would allow individuals with poor tanning ability to
spend more time in the sun than otherwise possible [34].
Randomized trials on sunscreen use and sun exposure
duration
In 1997 and 1998, two randomized controlled trials we
conducted within the frame of the EORTC Melanoma
Group showed that sunscreen use by young populations
during their holidays in sunny resorts increased theorized reproduction of this article is prohibited.
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Table 1 Comparison of sun behaviours of young sun-sensitive populations using a SPF 30 vs. a SPF 10 sunscreen during their
holidays in sunny resorts
Trial outcome Use of SPF 30 vs. SPF10 sunscreen
Quantity of sunscreen used Similar
Time spent in the sun during each day with sun exposure Increased
Time in the day for sun exposure More often around solar noon, when sunlight is richer in UVB
For women, sunbathing with naked breasts Increased
Number of sunburns Similar
Numbers of skin reddening episodes Similar
SPF, sun protection factor. Data from [35,36].duration of sun exposure [35,36] (Table 1), a phenom-
enon likely to explain the association found between
sunscreen use and melanoma risk. These trials contrib-
uted to the conclusion of the International Agency for
Research on Cancer that ‘in intentional sun exposure
situations, sunscreen use may conduct to increasing the
risk of melanoma’ [32,33].
In addition to extended sun exposure duration, a plethora
of other changes in sun exposure behaviours was
observed in the two trials, further documenting that
sunscreen use may allow sun exposure behaviours that
would not be possible otherwise [37,38]. For example,
the two randomized trials consistently showed that as a
holiday progressed, populations using high SPF sunsc-
reen tended to start sunbathing earlier in the day, while
populations using a low SPF sunscreen tended to start
sunbathing later in the afternoon (Fig. 3) [35,36]. During
the day, UVA and UVB fluxes peak around solar noon but
the solar spectrum in the morning and in the late after-
noon is poor in UVB [3]. Sunbathing typically entails
brisk exposure of the trunk to sunlight and trial results
suggested that in the absence of sunscreen use, this
usually sun protected site would not stand long exposure
to UVB-rich sunlight.opyright © Lippincott Williams & Wilkins. Unautho















Mean hour of start of sunbathing activities in days with sunbathing. Days w
‘summer hour’ in Continental Europe, equivalent to the solar hour plus 2 h.Sunscreen use increases sun exposure duration and
UVA
Table 1 summarizes the main results of the randomized
trials on sunscreen use by suntan worshippers. The
number of sunburns reported was similar for populations
using low or high SPF sunscreens, while sun exposure
duration was greater among high SPF sunscreen users. In
support of results of these two trials, all observational
studies and randomized trials studies that examined sun
exposure duration in relation to sunscreen use found
increased ISE and no change in sunburn occurrence
[33,37].
The apparent paradox of sunscreen use not associated
with decreasing sunburn occurrence suggests that
during ISE, amounts of UVB reaching the skin are
similar when a sunscreen is used or not. The only
difference is that with sunscreen use, more time is
needed to accrue the amount of UVB necessary to
tan or to burn (to tan or to burn first depends on the
skin phototype of sunscreen user). During that extra
time of ISE, more unfiltered UV wavelength can pass
through the sunscreen layer. These additional amounts
of UV presumably mainly consist in UVA. Would pre-
sence of UVA filters in the sunscreen avoid the greaterrized reproduction of this article is prohibited.
7 8 9 10 11 12 13 14
Holiday days with sunbathing
ithout sunbathing were skipped. The time in the figure is the so-called
Adapted with permission from [36].
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ST, sunburn threshold. See text for explanations.UVA exposure? Probably not if the goal of sunscreen
use is to acquire a tan or to stay long in the sun, as tan
acquisition is the signature that UV-induced DNA
damage occurred [39].
Figure 4 illustrates the relationships between sun-
screen use, UVB, sun exposure duration, sunburns and
UVA in sun-sensitive populations. Figure 4 assumes that
the sunscreen has no ability to block the UVA, and that
sun exposure is (definitely or temporally) discontinued
after sunburn occurrence. When no sunscreen is used,
populations engaging in ISE (e.g., in sunbathing) will
reach their specific sunburn threshold after (x) minutes,
(x) depending on their inherited sun sensitivity. The
UVB dose will thus be equivalent to sunburn threshold
and the UVA dose to (a). When a sunscreen is used, more
time [(y) (x)] is needed for reaching sunburn threshold.
During that extra time, an extra dose of UVA [(b) (a)]
will go through the sunscreen and reach the skin. The
quantity [(u) sunburn threshold] is the amount of UVB
blocked by the sunscreen.
UVA has a greater ability than UVB to penetrate deep
into the dermis and induce DNA damage in inner skin
layers [40], which would explain the increased risk of
higher nevus count and of melanoma associated with
sunscreen use.
In conclusion, sunscreen use enables populations to with-
stand high UVB fluxes, which in turn probably leads to
greater exposure to high UVA fluxes. This situation
would bemainly true for the trunk, the body site typically
intermittently exposed.opyright © Lippincott Williams & Wilkins. UnauthThere are indications that sunbed-induced
melanomas are less life threatening
The sunbed-induced melanoma epidemic we described
in Iceland developed without concomitant increase in
melanoma mortality. The steepest increases in mela-
noma incidence were observed in young subjects and
for trunk melanoma. Trunk melanoma is known to be
more dangerous than limb melanoma. However, Fig. 5
shows no appreciable change over time of melanoma
mortality in Icelandic men and women, with rare cases
of death before age 50.
Given the short-term poor prognosis of advanced mela-
noma and in view of the formidable increase in incidence
that took place between 1990 and 2006, it is unclear why
mortality remained stable at younger ages. Nonetheless,
the contrast between incidence and mortality trends
suggests that the rapid increase in incidence in the
1990s was confined to melanoma of limited capacity to
disseminate in distant organs.
The first epidemic of melanoma was described in the
Hunter District (New South Wales, Australia) in 1987–
1992 [41]. The cause of this sudden rise in melanoma
incidence remains unknown. Similarly to Iceland, the
sharp rise in incidence did not affect melanomamortality,
and it was concluded that the epidemic mainly consisted
of a nonmetastasizing form of melanoma [42].Formulation of the ‘UVA-shift’ hypothesis
We view the results on sunbed and sunscreen studies as
providing indirect evidence that UV wavelengths in theorized reproduction of this article is prohibited.
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Figure 5 Annual age-adjusted (World Standard population)
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From Nordcan database [21].UVA range might be involved in the genesis of mela-
noma. Also, time between ‘UVA exposure’ and mela-
noma occurrence would be a few years. One possible
hypothesis underlying a short lag time would be the
stimulation, by repeated high UVA doses, of melanocytes
in preexisting nevi that developed earlier during life.
The main limitation is that UV wavelength was rarely
measured during epidemiological studies on sunbeds and
sunscreens. Exposure data collected by epidemiological
studies are thus by no means reflecting exposure to pure
sources of UVA or UVB. However, these results can
inform on the type of wavelength possibly involved in
melanoma occurrence.
Melanoma incidence is still on the rise in most light-
skinned populations, in particular in young women. In
contrast, melanoma mortality stabilized in the 1980s and
1990s and even started to decrease slightly, mainly among
younger female populations in the Nordic countries,
Australia, UK and USA [27,43,44–47]. The incidence
rise was essentially due to thin melanoma less than 2mm
thickness. In contrast, the incidence of thick melanoma
(i.e., 2mm and more) has remained quite stable
[27,43,44,48]. The epidemics in the Hunter districtopyright © Lippincott Williams & Wilkins. Unauthoand in Iceland would represent extreme examples of
the discrepancy between incidence and mortality.
We hypothesize that sunbed and sunscreen use would
lead to a ‘UVA-shift’ in UV exposure that would con-
tribute to increasing the number of thin invasive mela-
noma having little potential for distant dissemination.
Sunbed use and sunscreen use are more common in
younger age groups, predominantly in women. This
hypothesis could partly explain why in most light-
skinned populations less than 60 years of age, and in
women in particular, melanoma incidence is still rising
without a concomitant rise in mortality.Conclusion
If the UVA hypothesis is grounded, the main question to
be solved is the nature of deadly melanoma: do they have
same risk factors as the thin, nonlife-threatening mela-
noma?Which wavelength is involved in their occurrence?
One clue may come from earlier studies on migrants.
Melanoma mortality is greater for populations born in
sunny areas than for those who migrated at later age [49].
Hence, probably deadly melanoma that occurs mainly in
older ages would develop from melanocytes initiated
during early life, whereas the major part of the rising
incidence would be due to melanocytes exposed to high
UVA doses during adolescence and adulthood that would
take less time to develop into thin melanomas.
In conclusion, growing epidemiological evidence suggests
that at least two different forms of melanoma exist, that
would have different clinical course. ‘UVA-induced’ mel-
anoma would be caused by intermittent exposure to high
UVA doses. These melanomas would develop rapidly but
usually, they would not be aggressive. The environmental
causes of more aggressive melanoma, most of which occur
in older ages, remain to be defined.References and recommended reading
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installation  and  operation  and  towards  providing  guidance  and  warnings  to 











In April 1993, we  sent  the  report on  the 1992‐93 EORTC  study  to  the “Europe 
Against  Cancer  Programme”.  The  half  a  page  section  dedicated  to  5‐MOP 






In  1995  the  European  Commission  issued  a  ban  on  products  incorporating 
psoralens  at  concentrations  exceeding  1mg/kg  of  product.  Such  a  low 
concentration  (sometimes  found  in  natural  products  and  fragrances)  has  no 



















• In  intentional  sun  exposure  situations,  sunscreen  use  may  conduct  to 
increasing the risk of melanoma. 
 
The  IARC  Handbook  on  sunscreens  contributed  to  shifting  the  focus  of  sun 
protection towards sun avoidance and the wearing of clothes, with sunscreens to 





These  studies  contributed  to  reinforcing  public  health  messages  on  sun 










Nevus  development  is  strongly  related  to  one’s  genetic  background,  but  sun 








they are most usually  located on  the  trunk. Their number directly depends on 
numbers of smaller nevi.  
 
Several  studies  have  illustrated  the  good  correlation  between  site‐specific 
distribution  of  nevi  in  adults  and  of  melanoma  in  adults  (See  Section  4).  In 
contrast,  studies  in  adults,  including  meta‐analyses,  showed  practically  no 
correlation between the anatomical distribution of nevi (according to whole‐body 
counting) and of melanoma (older papers reviewed in Autier et al, 2000a; Caini 
et  al,  2009; Randi  et  al,  2006; Chang  et  al,  2009). Furthermore, with  aging,  the 





Altogether,  results  of migrant  studies  and  studies  on  anatomic  distribution  of 
nevi  and  of  melanoma,  strongly  support  the  notion  that  key  UV‐induced 
biological  events  for melanoma  occurrence  and  death  in  adult  life  take  place 
during  childhood.  The  incidence‐mortality  contrast  further  suggests  that  if 
melanocytes  in  adults  were  not  UV‐initiated  during  childhood,  sun  exposure 
could still induce nevus formation or non life‐threatening melanoma (i.e., in situ 
melanoma or  thin  indolent melanoma), but no  longer melanoma  that  could be 
life threatening. 
  
Differences  in  gene  expression  (phenotype)  of melanocytes  in  response  to UV 
irradiation according  to anatomic  location was  initially  formulated by A Green 
(1992).  Our  data  on  nevi  in  children  suggests  the  existence  of  site‐specific 
biological pathways that combine their effects with sex‐specific biological events. 
The  trunk  for  instance, would  be most  susceptible  to UV  carcinogenic  effects. 
Although  it  is  usually  sun  protected,  the  density  of  small  nevi  is  high  and 
associated with recreational sun exposure; large nevi are influenced by UVB‐rich 
environments and  tend  to develop more on  this  site  than on any other  site.  In 
addition  to  site‐specific  factors,  male  sex  would  amplify  the  influence  UV 
exposure on  trunk melanocytes  (or nevocytes).  In contrast,  the development of 




of  melanocytes  or  of  their  microenvironment  against  the  type  of  biological 
lesions not directly associated with the development of small nevi, for  instance, 
105
the  type of  cellular damage due  to UVB  radiation. Male gender probably  also 







cumulative  doses  of  UV  received  by  the  head  and  neck  skin  over  lifetime. 
Because  nevi  number  decreases  with  age,  and  because  sun  exposure 
accumulation  is probably  involved  in  the  involution and disappearance of nevi 






Recent  statistics  from  the  USA  (Criscione  &  Weinstock,  2009)  summarised  in 
Table 5.1  show  that  the diagnosis of a  thin melanoma  is associated with a  low 
probability  to  die  from  it. However,  approximately  one  quarter  of melanoma 
deaths  occur  in patients diagnosed with melanoma  less  than  1 mm  thick  and 
another quarter with melanoma 1 to 1.99 mm thick.  
 
Table 5.1 - Melanomas numbers and deaths in the USA, 1988-2008 in 17 SEER  
cancer registries, by Breslow thickness (Criscione & Weinstock, 2009)
Incident melanomas







% of incident 
melanomas
Ratio of death 
probability
<1.01 2,472 27.1 2.7 ref.
1.01–2.00 2,142 23.5 10.5 3.9
2.01–4.00 2,474 27.1 21.1 7.8
>4 2,041 22.4 29.6 10.9




We  believe  that  at present,  the  focus  for  epidemiology  research  on melanoma 
ought  to  be  the  search  for  reasons  why  some  patients  are  diagnosed  with 
indolent cancers, whilst others are diagnosed with aggressive cancer.  
 













1. Lack  of  skin  surveillance  is  not  a  sufficient  explanation  for  the  elderly 
often  displaying  thick  melanoma.  Nodular  melanoma  (the  most 
aggressive  type of melanoma) occurs  in greater  frequency  in  the elderly 
and its occurrence has nothing to do with early detection. 
 
2. Delays  in presentation  to doctors of suspicious pigmented spots seem  to 
be unassociated with more advanced disease (Richard et al, 1999).  
 
3. In  the  classic multistep model  of melanoma  growth  (Miller  and Mihm, 
2006), decreasing  incidence of advanced melanoma would  represent  the 
best  evidence  that  early  detection  contributes  to  decreasing  melanoma 
mortality. However  to date, no quality population‐based  cancer  registry 
operating in areas where early detection is widespread (e.g., Queensland, 











The question on why  some  individuals develop  fatal melanoma and others do 
not needs to be well defined. Studies of melanoma  in  immune depressed organ 
transplant  recipients  show  that  melanoma  can  metastasize  in  distant  organs 
without being able to expand  in these organs (Strauss & Thomas, 2010). Hence, 
local and systemic environment exerts a strong control on melanoma tendency to 




malignant  potential  according  to  the  type  of  underlying  biological  lesion  and 















The  second  question  that  immediately  follows  is  how  factors  presumably 
associated  with  deadly  melanoma  would  be  associated  with  aging  and  with 
gender.   
 
For  the  sake  of  operational  and  time  efficiency,  research  may  focus  on 
intermediary  outcome  markers  (e.g.,  Breslow  thickness,  ulceration,  mitotic 





of  dying  from  it.  It may  also  help  in  better  targeting  primary  and  secondary 
prevention efforts. The primary goal of early detection is to decrease melanoma 




the  relevance  of  this  approach,  another  research  area  for  epidemiology  is  the 
evaluation of growth patterns of melanoma with attempts to estimate the sojourn 






The melanoma epidemic  is still ongoing  in most  light‐skinned populations. The 





In  2010,  certain  treatments  seem  to  increase  the  survival  of  patients  with 








Control  of melanoma mortality  through primary prevention will  only  become 
possible  when  we  have  good  knowledge  of  factors  associated  with  the 





1. The  indoor  tanning  fashion  will  probably  somewhat  decline  after  the 
numerous works  that  lead  to  tougher regulations and better  information 




2. Sunscreens  are  still  largely  perceived  by  the  public  and  many  health 
professionals as the most efficient sun protection method during leisure or 
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holidays  in sunny  locations,  including for children. As  long as sunscreen 
use is associated with “safe tan”, sunscreens use during ISE will continue 




3. There  is  a  strong  parallel  between  rising  melanoma  incidence  and  the 
number  of  travels  abroad  (Bentham  et  al,  1996; Westherdahl  et  al  1992; 
Agredano  et  al,  2000)  and  travel  statistics  show  that holidays  in distant 
sunny resorts are increasingly popular. 
 
4. The  increasing  awareness  of  skin  cancer  will  stimulate  early  detection 
activities  that will contribute  to  the  increase  in  the diagnosis of non  life‐
threatening  in situ and  thin  invasive melanoma  (Rees, 2008; Welsh et al, 
481; Edman & Klaus, 2000).    
 
We  therefore  believe  that  for  melanoma  incidence,  the  perspectives  are  quite 
dismal.  However,  we  have  now  sufficient  knowledge  on  the  environmental 
causes of melanoma to pursue public health action towards reducing the impact 
of  these  factors  on  the  melanoma  burden.  Establishing  why  some  subjects 












risk  factors  for  cutaneous  melanoma  and  on  sun  protection,  including 
exposure  to  artificial  UV  tanning  devices,  sunscreen  use  for  melanoma 
prevention, and on childhood being a critical period for melanoma initiation. 
 
Our works  took  the  IARC Monograph on Solar and ultraviolet  radiation of 
1992  as  starting  point.  This  Monograph  classified  the  solar  radiation  as 
carcinogenic  to  humans  (group  1).  However,  the  UVA,  UVB  and  the 




In  Section  2 we presented  studies  on  sunbed use  and melanoma. The  first 
European case‐control study in 1992‐93 showed the increased risk associated 
with  artificial UV  tanning,  mainly  when  exposure  started  about  ten  years 
earlier.  A  second  European  case‐control  study  in  1999‐2001  failed  to 
investigate the sunbed‐melanoma association because prevention campaigns 
had  started warning  about  health  hazards  associated with  indoor  tanning. 
Knowledge of these hazards by melanoma patients and controls led to biases 
that made results impossible to interpret. We then turned to meta‐analyses of 
observational  studies  that  showed  substantial  increase  in  melanoma  risk 
when sunbed use started before around 30 years old, a result in line with the 
known susceptibility of youths to carcinogenic effects of UV radiation. More 
recently, we described an epidemic of melanoma  in  Iceland  that  took place 
after 1990, a  rare  epidemiological phenomenon most probably  triggered by 






of  their  ability  to  delay  sunburn  and  to  decrease  the  occurrence  of  UV‐
induced  keratinocytic  cancers  in  rodents,  sunscreens were  considered  as  a 
method  of  choice  for  skin  cancer  prevention.  However,  contrary  to 
expectations,  population‐based  epidemiological  studies  showed  moderate 
increased  risk  of  melanoma  associated  with  sunscreen  use,  and  rarely  a 
decreased  risk.  These  intriguing  findings  were  deemed  to  be  due  to 
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inappropriate  control  of  confounding  by  sun  exposure  or  by  host 
characteristics. In addition, in 1992, some sunscreens sold in France, Belgium 




In  the  case‐control  study  of  1992‐93, we  showed  that poor  tanner using  5‐
MOP sunscreens had a risk of melanoma higher  than subjects using normal 
sunscreens.  This  study  also  showed  that  the  higher  melanoma  risk  of 
sunscreen users was not due  to  lack of control of  the confounding effects of 
sun exposure or of host characteristics.  
 
The number of nevus  is  the main  individual predictor of melanoma. Nevus 
development  is  influenced by the same environmental and host factors than 
melanoma.  In 1995‐97, we performed a  retrospective cohort study  in 6‐to‐7‐
year‐old schoolchildren  in Belgium, France, Germany and Italy  that showed 
higher  numbers  of  nevi  when  sunscreens  were  used.  In  contrast,  wearing 
clothes  when  in  the  sun  was  associated  with  decreasing  number  of  nevi. 
Sunscreen use  and wearing  clothes when  in  the  sun were more  frequently 
adopted by children having characteristics of higher nevus count or of higher 
melanoma  risk. The  sharp  contrasts  in  results obtained  for wearing  clothes 
and sunscreen use excluded an explanation by confounding.   
 
Probably  that  the  higher  melanoma  risk  observed  when  sunscreens  were 
used was due  to  longer  stays  in  the  sun. For verifying  this hypothesis, we 
organized two randomized controlled trials during the summers of 1997 and 
1998. In these trials, students 18 to 25 years old willing to spend their holidays 
in  sunny  areas were  randomly  assigned  to  a  group  that  received  a  potent 
sunscreen  (i.e., a sunscreen with good ability  to prevent sunburns) and  in a 
group that received a less potent sunscreen. Both trials demonstrated that use 
of  potent  sunscreens  increased  the  duration  of  sunbathing  but  did  not 
decrease  sunburn  occurrence. Hence,  extension of  intentional  sun  exposure 




showed  longer  duration  of  intentional  sun  exposure  when  sunscreens  are 
used. However,  this  is  not  the  case when  sunscreens  are  used  during  sun 
exposures not associated with willingness to acquire a tan or to stay  long  in 
the sun (the non‐intentional sun exposure (NISE) like for instance, gardening 





retrospective cohort study  in children  that allowed exploring  in more depth 
the relationships between sun exposure and sun protection during childhood 
and  melanoma  occurrence  during  adulthood.  We  found  that  melanoma 
occurrence  in  adults  was  unlikely  in  the  absence  of  sun  exposure  during 
childhood.  Conversely,  melanoma  initiated  by  sun  exposure  in  childhood 
necessitated  further  sun  exposure during  adult  life  for  it  s  occurrence. We 
also  found  that  the anatomic distribution of nevi  in children was correlated 
with the anatomic distribution of melanoma in adults. Also, sex differences in 
nevus  body distribution  in  children were  similar  to  those  found  in  adults. 
These similarities between nevi  in children and melanoma  in adults were  in 
sharp  contrast  with  the  near  absence  of  correlation  between  the  anatomic 




In  Section  5, we  formulate  two hypotheses based  on  the data we gathered 
during  18  years  of  epidemiological  research  on  sunbeds,  sunscreens  and 
childhood  sun  exposure.    The  first  hypothesis  is  that  the  UVA  might  be 
involved  in  melanoma  occurrence.  Epidemiological  evidence  comes  from 
studies on sunbeds, on sunscreens and on nevus counts in small children.  
 
The  second hypothesis  is  that  invasive melanoma mainly  induced by UVA 
exposure would have low potential for invading surrounding skin layers and 
dissemination  in  distant  organs.  This  hypothesis  was  prompted  by  the 
sunbed‐induced melanoma epidemic in Iceland that was not paralleled by an 
increase  in melanoma mortality. This hypothesis  is  also  supported by data 
from studies on indoor tanning and Breslow thickness, and on sunscreen use. 
 
Our  works  on  indoor  tanning  and  melanoma  contributed  to  the 
reinforcement of regulations on  installation and operation of tanning salons, 












ons werk  rond  enerzijds de omgevingsfactoren die het  risico op melanoma 
verhogen,  en  anderzijds  over  zonnebeschermingsmaatregelen.  Dit  omvat 
zonnebanken  die  werken  met  kunstmatige  ultraviolette  straling  (artificiële 




De  monografie  van  het  Internationale  Agentschap  voor  Kankeronderzoek, 
IARC,  “Solar  and  ultraviolet  radiation”  uit  1992  werd  gebruikt  als 
uitgangspunt.  Deze  monografie  categoriseerde  zonnestraling  als 
kankerverwekkend voor de mens (groep 1). Desondanks werden UVA, UVB, 





en  melanoma.  Het  eerste  Europese  patiënt‐controle‐onderzoek  uit  1992‐93 
toonde  een  verhoogd  risico  aan  geassocieerd  met  artificieel  UV  zonnen, 
voornamelijk wanneer de blootstelling ongeveer  tien  jaar eerder begon. Een 
tweede  Europees  patiënt‐controle  onderzoek  uit  1999‐2001  naar  de  relatie 
tussen  het  gebruik  van  zonnebanken  en  melanoma  mislukte,  omdat 
preventiecampagnes  opgezet  waren  die  waarschuwden  voor  de 
gezondheidsrisico’s verbonden aan binnenshuis zonnen met kunstmatig UV 
licht. De kennis over deze gezondheidsrisico’s bij patiënten met melanoom en 
gezonde  controlepersonen  leidden  waarschijnlijk  tot  aanzienlijke 
vertekeningen,  waardoor  de  resultaten  onmogelijk  geïnterpreteerd  konden 
worden.  We  zijn  hierna  overgegaan  op  meta‐analyses  van  observationele 
studies  die  een  aanzienlijke  verhoging  aantoonden  van  de  prevalentie  van 
melanoma wanneer het gebruik van zonnebanken startte rond de leeftijd van 
30  jaar.  Dit  resultaat  stemt  overeen  met  de  bekende  gevoeligheid  van 
jongeren  voor  de  kankerverwekkende  effecten  van  UV‐straling.  Recent 
bestudeerden we een epidemie van melanoom  in  IJsland die plaatsvond na 
1990, een zeldzaam epidemiologisch fenomeen dat waarschijnlijk veroorzaakt 
werd door de grote verspreiding van  indoor  zonneapparatuur bij  IJslandse 
jongeren  na  1985.  Het  regelmatig  gebruik  van  zonnebanken  is  de  meest 
waarschijnlijke  oorzaak  van de  epidemie,  aangezien  voornamelijk de  romp 




In  Sectie  3  presenteren  we  studies  over  het  gebruik  van  zonnecrèmes  en 
melanoom.  Dankzij  hun  vermogen  om  zonnebrand  uit  te  stellen  en  het 
optreden  van  door  UV‐straling  geïnduceerde  keratinocyten‐kankers  in 
knaagdieren  te  verminderen,  werden  zonnecrèmes  gedurende  lange  tijd 
beschouwd  als  de  beste  methode  ter  preventie  van  huidkanker.  In 
tegenstelling  tot  de  verwachtingen,  toonden  epidemiologische  studies  in 
populaties echter een matig verhoogd risico op melanoom geassocieerd met 
het  gebruik  van  zonnecrèmes,  en  zelden  een  verminderd  risico.  Er  werd 
aangenomen dat deze  intrigerende  resultaten het gevolg waren van onjuist 
corrigeren voor blootstelling aan de zon of voor specifieke eigenschappen van 
de  proefpersoon.  Bovendien  waren  sommige  zonnecrèmes  verkocht  in 
Frankrijk, België  en Griekenland  in  1992  bereid met  5‐methoxypsoralen  (5‐
MOP),  een  sterke  bruinend  middel,  ook  bekend  vanwege  zijn 





risico  hadden  op  melanoom  dan  proefpersonen  die  normale  zonnecrèmes 
gebruikten. Dit onderzoek toonde ook aan dat het hoger risico op melanoom 
bij gebruikers van zonnecrèmes niet te wijten was aan het gebrek aan controle 





beïnvloed door dezelfde  omgevingsfactoren  als melanoom. Tussen  1995  en 
1997, voerden we een  retrospectief  cohort onderzoek uit bij  schoolkinderen 
van 6 en 7 jaar in België, Frankrijk, Duitsland en Italië. Een groter aantal naevi 
werd aangetoond wanneer zonnecrèmes werden gebruikt, terwijl het dragen 
van  kleding  bij  zonnen  geassocieerd  werd  met  een  daling  van  het  aantal 
naevi. Het  gebruik  van  zonnecrèmes  en  het dragen  van  kleding  in de  zon 
werd frequenter toegepast door kinderen die een hoger aantal naevi hadden 




Het was waarschijnlijk dat het  hogere  risico  op melanoom  bij  gebruik  van 
zonnecrèmes  gevonden  werd  doordat  de  personen  die  de  zonnecrèmes 










van  de  expositie  aan  de  zon  tot  zonverbranding  ontstond  is  de  meest 
aannemelijke  oorzaak  voor  de  verhoging  van  het  risico  op  melanoom  dat 
vaak  waargenomen  werd  bij  gebruikers  van  zonnecrèmes.  Systematisch 
onderzoek  dat  wij  uitvoerden  binnen  observationele  onderzoeken  en  bij 
experimenten  met  proefpersonen  toonde  onveranderlijk  een  langere  duur 
van  de  opzettelijke  zonneblootstelling  aan  wanneer  zonnecrèmes  werden 
gebruikt.  Dit  was  echter  niet  het  geval  wanneer  zonnecrèmes  gebruikt 
werden  tijdens  zonneblootstelling  die  niet  geassocieerd  is  met  het  willen 
bruinen  of  tijdens  langere  verblijven  in  de  zon  zoals  tuinieren  of  skiën 
(non‐intentional  sun exposure, NISE). Het gebruik van zonnecrèmes  tijdens 






en  zonnebescherming  bij  kinderen  en  het  optreden  van  melanoom  bij 
volwassenen  te  onderzoeken.  We  constateerden  dat  het  optreden  van 







kinderen  gelijk  aan  deze  gevonden  bij  volwassenen. Deze  overeenkomsten 
tussen naevi bij kinderen en melanooma bij volwassenen stonden  in scherp 
contrast  met  de  bijna  afwezige  correlatie  tussen  de  anatomische 





tijdens  het  18‐jarig  epidemiologisch  onderzoek  over  zonnebanken, 
zonnecrèmes en zonneblootstelling bij kinderen. De eerste hypothese stelt dat 
UVA  betrokken  zou  kunnen  zijn  bij  het  optreden  van  melanoom. 





De  tweede  hypothesis  stelt  dat  invasieve  melanomen  die  hoofdzakelijk 
veroorzaakt  worden  door  UVA‐blootstelling  een  laag  potentieel  zouden 
hebben  om  de  omringende  huidlagen  binnen  te  dringen  en  zich  te 
verspreiden  in  afgelegen  organen. Deze hypothese werd  ondersteund door 
de  IJslandse melanoma  epidemie door het gebruik van  zonnebanken. Deze 
epidemie  ging  niet  gepaard  met  toenames  in  de  melanoom‐sterfte.  Deze 
hypothese wordt  ook  ondersteund  door  data  uit  onderzoeken  over  indoor 
zonnen en de Breslow‐dikte, en door het gebruik van zonnecrèmes. 
 
Onze  onderzoeken  over  indoor  zonnen  en  melanoom  droegen  bij  aan  de 
bekrachtiging van de wetgeving over de  installatie en het management van 
zonnebankcentra, en tot de formulering van aanbevelingen voor het publiek. 




opzettelijke  zonneblootstelling  het  risico  op melanoom  kan  verhogen.  Ons 
werk  leverde  doorslaggevende  data  voor  de  regulerende  instanties,  en  in 
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